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Abstract	
The	sheathing	of	axons	with	myelin	by	oligodendrocytes	constitutes	a	necessity	for	sufficient	and	
rapid	nerve	conduction	within	the	vertebrate	central	nervous	system	(CNS).	However	to	date,	the	
complex	molecular	mechanisms	controlling	distinct	signalling	cascades	of	myelination	are	still	not	
decrypted.	Recent	studies	have	proposed	G-protein	coupled	receptors	(GPCRs),	such	as	Gpr17,	as	
crucial	 regulators	 of	 oligodendrocyte	 development	 and	 myelination.	 Herein,	 this	 study	
investigates	the	implication	of	Gpr17	in	myelination	in	its	native	signalling	environment	by	using	
zebrafish	(Danio	rerio),	an	ideal	suited	vertebrate	model	system	for	studying	myelination	in	vivo.	
Additionally,	 further	 functionality	 studies	 evaluate	 responsiveness	 of	 zebrafish	 and	 chimeric	
human/zebrafish	Gpr17	receptors	in	extrinsic	mammalian	cellular	backgrounds.	
While	 zebrafish	 Gpr17	 transiently	 transfected	 in	 HEK293	 cells	 remained	 unresponsive	 towards	
the	 small	 molecule	 agonist	 MDL29,951,	 stimulation	 of	 chimeric	 human/zebrafish	 receptors	
containing	 the	 human	 binding	 domain	 led	 to	 concentration-dependent	 response	 curves	 in	
Dynamic	mass	redistribution	assays.	These	results,	further	confirmed	by	 in	vivo	assays	revealing	
unaffected	oligodendrocyte	development	and	myelination	after	bath	treatment	with	MDL29,951,	
imply	an	 impaired	 zebrafish	 receptor-ligand	 interaction	both	 in	 vivo	 and	 in	 vitro.	 Investigations	
with	zebrafish	demonstrated	sustained	Gpr17	expression	in	oligodendrocyte	lineage	cells	during	
CNS	development	from	1	to	5	dpf.	Moreover,	morpholino-induced	receptor	knockdown	provoked	
a	 significant	 reduction	 of	 pre-mature	 and	 mature	 oligodendrocyte	 numbers	 and	 disturbed	
myelination.	 The	 reduced	 cell	 numbers	 are	 assumed	 to	 result	 from	 impaired	migration	 of	 pre-
mature	 pre-oligodendrocytes	 (pre-OLs)	 accumulating	 in	 the	 ventral	 spinal	 cord	 region.	 On	 the	
contrary,	 overexpression	 of	 Gpr17	 in	 early	 stages	 did	 not	 influence	 oligodendrocyte	
development.	Together,	the	data	confirm	a	crucial	role	of	zebrafish	Gpr17	in	vivo.	Clearly,	future	
studies	 with	 knockout	 animals	 are	 strictly	 necessary	 to	 corroborate	 these	 findings	 and	
conclusively	delineate the	impact	of	Gpr17	on	oligodendrocyte	development	and	myelination.	
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Kurzfassung	
Im	 zentralen	 Nervensystem	 (ZNS)	 stellt	 die	 Myelinisierung	 durch	 Gliazellen,	 den	 sogenannten	
Oligodendrozyten,	 eine	 essentielle	 Grundlage	 für	 die	 erfolgreiche	 Reizweiterleitung	 von	
Nervenzellen	 dar.	 Trotz	 zahlreicher	 Studien	 bestehen	 jedoch	 weiterhin	 Unklarheiten	 bezüglich	
der	Entwicklung	von	Oligodendrozyten	sowie	ihrer	Aufgabe	Myelin	zu	produzieren.	Permanente	
Forschung	 in	 diesem	 Gebiet	 hat	 kürzlich	 erwiesen,	 dass	 G-Protein-gekoppelte	 Rezeptoren	
(GPCRs),	wie	 etwa	Gpr17,	 entscheidende	 Rollen	 in	 der	 Reifung	 von	Oligodendrozyten	 sowie	 in	
der	Myelinisierung	übernehmen.	 Innerhalb	dieser	Arbeit	wurde	der	Zebrafisch	 (Danio	 rerio)	als	
Tiermodell	 verwendet,	 um	den	 Einfluss	 von	Gpr17	 auf	 die	Myelinisierung	 zu	 untersuchen.	 Des	
Weiteren	 wurden	 der	 Zebrafisch-Gpr17	 sowie	 chimäre	 Human/Zebrafisch-Rezeptoren	 auf	 ihre	
Funktionalität	gegenüber	postulierten	Gpr17	Liganden	in	zellulären	Hintergründen	überprüft.	
Während	der	Agonist	MDL29,951	den	in	HEK293	Zellen	rekombinant	überexprimierten	Zebrafish-
Gpr17	 nicht	 zu	 aktivieren	 vermochte,	 führte	 die	 Stimulation	 von	 chimären	 Human/Zebrafisch-
Rezeptoren	 zu	 einer	 konzentrationsabhängigen	 Zellantwort	 in	 dynamischen	
Massenumverteilungs-Experimenten.	 Diese	 Ergebnisse	 wurden	 durch	 weitere	 in	 vivo	 Studien	
bestätigt,	 die	 zeigten,	 dass	 die	 Reifungen	 von	 Oligodendrozyten	 sowie	 die	 darauffolgende	
Myelinisierung	durch	eine	5-tägige	Applikation	von	MDL29,951	nicht	beeinträchtigt	wurde.	Daher	
wurde	geschlussfolgert,	dass	die	Bindung	von	MDL29,951	am	Zebrafisch-Rezeptor	sowohl	in	vitro	
als	auch	in	vivo	verhindert	sein	muss.	
Der	 zweite	 Teil	 dieser	 Arbeit	 befasste	 sich	 mit	 der	 Expression	 und	 der	 Rolle	 von	 Gpr17	 im	
Zebrafisch.	Zunächst	konnte	bewiesen	werden,	dass	Gpr17	innerhalb	der	ersten	5	Tage	während	
der	 ZNS	 Entwicklung	 von	 unreifen	 Oligodendrozyten-Vorläufer-Zellen	 exprimiert	 wird.	 Um	
weitere	 Rückschlüsse	 auf	 den	 Einfluss	 von	 Gpr17	 auf	 die	 Oligodendrozyten-Reifung	 zu	 ziehen,	
wurde	 mittels	 Morpholino-Injektion	 ein	 Rezeptor-Knockdown	 hervorgerufen,	 der	 eine	
signifikante	 Reduktion	 von	 unreifen	 sowie	 reifen	 Oligodendrozyten	 im	 dorsalen	
Rückenmarksbereich	 und	 eine	 gestörte	Myelinisierung	 zur	 Folge	 hatte.	 Hierbei	 wird	 vermutet,	
dass	 die	 Abwesenheit	 von	 Gpr17	 nicht	 nur	 die	 Reifung,	 sondern	 auch	 die	 Migration	 von	
Oligodendrozyten	 zu	 den	 Axonen	 beeinträchtigt.	 Im	 Gegensatz	 zum	 Rezeptor-Knockdown	
bewirkte	die	Überexpression	von	Gpr17	in	frühen	embryonalen	Phasen	keinerlei	Veränderung	in	
der	 Entwicklung	 sowie	 in	 der	 Myelinisierung	 der	 Oligodendrozyten.	 Zusammenfassend	
implizieren	die	erhobenen	Daten,	dass	Gpr17	eine	wichtige	Rolle	während	der	Oligodendrozyten-
Reifung	im	Zebrafisch	einnimmt.	Letztendlich	sind	jedoch	weitere	Studien,	wie	die	Untersuchung	
von	Knockout-Mutanten,	unabdingbar,	um	die	vorhandenen	Hypothesen	zu	bestätigen.	
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1 Introduction	
The	 central	 nervous	 system	 (CNS)	 consists	 of	 giant	 cells	 conducting	 electrical	 signals	 over	 long	
distances	 throughout	 the	 body	 of	 living	 beings	 to	 innervate	 their	 targets.	 These	 cells	 called	
neurons	exhibit	 large	calibre	axons	that	are	wrapped	in	multilamellar	 insulating	myelin	sheaths.	
Through	periodic	unmyelinated	breaks	on	the	neuronal	plasma	membrane,	the	nodes	of	Ranvier,	
enormous	 velocities	 of	 saltatory	 conduction	 between	 neurons	 and	 their	 targets	 are	 achieved	
(Hartline	 and	 Colman,	 2007)	 allowing	 rapid	 physiological	 reactions.	 The	 importance	 of	
myelination	 in	 the	 CNS	 is	 underscored	 by	 several	 destructive	 neurological	 disorders	 such	 as	
multiple	 sclerosis	 (MS),	 an	 inflammatory	 autoimmune	 disease	 caused	 by	 myelin	 sheath	
breakdown	 (Compston	 and	 Coles,	 2008).	 Moreover,	 Alzheimer’s	 disease	 (George	 Bartzokis,	
2011),	 cerebral	 palsy	 (Azzarelli	 et	 al.,	 1996)	 or	 schizophrenia	 (Azzarelli	 et	 al.,	 1996)	 display	
abundance	 of	 demyelination.	 Although	 a	 range	 of	 studies	 unveiled	 distinct	 signalling	 cascades	
controlling	myelination	 of	 axons	 (Marinelli	 et	 al.,	 2016),	 the	 complex	molecular	mechanism	 of	
myelin	synthesis	remain	poorly	explored.	Thus,	there	is	an	urgent	need	of	fundamental	research	
to	identify	candidate	pathways,	targets	and/or	therapeutic	molecules	that	promote	myelination	
when	 endogenous	 remyelination	 fails.	While	 in	 vitro	 studies	 help	 to	 uncover	 key	molecules	 or	
downstream	 signalling	 cascades,	 in	 vivo	 models	 such	 as	 zebrafish	 present	 an	 ideal	 system	 to	
investigate	myelination	in	its	native	signalling	environment	(Preston	and	Macklin,	2015).	
Herein,	 this	 thesis	 aims	 to	 establish	 whether	 the	 zebrafish	 is	 useful	 as	 a	 model	 to	 study	 a	
potential	target	protein	 in	vivo,	the	G-protein	coupled	receptor	17,	which	has	been	reported	to	
modulate	the	myelination	process	in	a	crucial	manner.	
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1.1 Myelination	
1.1.1 Oligodendrogenesis		
In	the	vertebrate	central	nervous	system	(CNS),	specialized	glia	cells,	so	called	oligodendrocytes,	
generate	 axon-wrapping	 myelin	 sheaths	 that	 promote	 rapid	 conduction	 of	 action	 potentials	
(Pfeiffer,	Warrington	 and	 Bansal,	 1993).	 During	 development,	 oligodendrocytes	 originate	 from	
multipotent	neural	precursor	(NP)	cells	(or	NG2	glia)	that	give	rise	to	oligodendrocyte	precursor	
cells	(OPCs)	within	a	region	in	the	ventral	neural	tube,	the	primary	motor	neuron	(pMN)	domain	
(Figure	1).	Through	expression	of	transcription	factors	such	as	Olig2	and	Sox10,	OPCs	proliferate	
and	begin	to	migrate	throughout	the	CNS	(Sun	et	al.,	2006).	The	onset	of	terminal	differentiation	
of	 OPCs	 into	 axon-associated,	 postmitotic	 pre-oligodendrocytes	 (pre-OLs)	 is	 initiated	 by	 the	
expression	of	Nkx2.2	transcription	factor,	while	OPCs	lacking	Nkx2.2	expression	remain	as	slowly	
dividing,	non-myelinating	OPCs	throughout	life	(Kucenas,	Snell	and	Appel,	2010).	Pre-OLs	extend	
numerous	processes	wrapping	multiple	neuronal	axons,	before	finally	transition	into	fully	mature	
oligodendrocytes	 forming	 compact	 multilayer	 membrane	 sheaths,	 the	 myelin.	 This	 process	 is	
called	myelination	and	is	accompanied	by	the	expression	of	a	variety	of	terminal	markers	such	as	
myelin	 basic	 protein	 (Mbp),	 proteolipid	 protein	 (Plp),	 myelin-associated	 glycoprotein	 (Mag)	 or	
myelin	oligodendrocyte	glycoprotein	(Mog)	(Pfeiffer,	Warrington	and	Bansal,	1993).	
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Figure	 1:	 Oligodendrocyte	 development	 (Oligodendrogenesis)	 in	 zebrafish.	Neural	 precursor	 (NP)	 cells	
give	 rise	 to	 oligodendrocyte	 precursor	 cells	 (OPCs)	 within	 the	 pMN	 domain	 of	 the	 neural	 tube.	 OPCs	
expressing	 Olig2	 proliferate	 and	 start	 migrating	 dorsally	 throughout	 the	 developing	 CNS.	 The	 onset	 of	
terminal	 differentiation	 into	 pre-oligodendrocytes	 (pre-OLs)	 is	 accompanied	 by	 the	 expression	 of	 the	
transcription	 factor	Nkx2.2.	 Pre-OLs	 extent	processes	 that	wrap	axons,	 but	do	not	myelinate	 yet.	 Finally	
pre-OLs	 transition	 into	 mature	 myelin-producing	 oligodendrocytes	 (OLs).	 Shown	 are	 lateral	 images	 of	
oligodendrogenesis,	 complemented	 with	 a	 table	 presenting	 the	 time	 line	 and	 corresponding	
characteristical	markers.	
1.1.2 Oligodendrocyte	remyelination	as	therapy	of	demyelinating	disorders	
Myelination	is	a	continuous	process	that	does	not	only	occur	during	developmental	stages	of	the	
vertebrate	 system,	 but	 also	 persists	 until	 adulthood.	 Healthy	 adults	 display	 an	 increase	 of	
myelination,	peaking	in	the	mid-30s,	that	declined	again	beyond	the	middle	age	(Lu	et	al.,	2013).	
Meanwhile,	it	is	known	that	myelination	is	not	only	required	for	efficient	saltatory	conduction	of	
action	 potentials	 but	 also	 contributes	 to	 the	 stability	 and	 health	 of	 axons.	 Furthermore,	 it	 is	
assumed	that	myelination	is	necessary	for	higher	cognitive	function	during	learning	phases	both	
in	 child	 and	 adulthood	 (Emery,	 2010;	 Nave,	 2010).	 Thereby,	 adult	 OPCs	 remaining	 in	 the	 CNS	
retain	 the	 capability	 of	 proliferating	 and	 dividing	 into	mature	myelinating	 oligodendrocytes	 in	
health	and	also	in	disease	(Harlow,	Honce	and	Miravalle,	2015).		
Loss	 of	 myelin	 during	 young	 adulthood,	 a	 defining	 pathological	 feature	 of	 demyelinating	
disorders	 such	 as	 multiple	 sclerosis	 (MS)	 (Compston	 and	 Coles,	 2008),	 can	 be	 rescued	 by	
endogenous	 regenerative	 remyelination	 through	 adult	 OPCs.	 However,	 this	 repair	 exhibits	
abnormalities	 in	myelin	 thickness	 and	 fails	 as	 the	 disease	 progresses	 (Perier,	 O.	 and	 Gregoire,	
1965;	 van	 Wijngaarden	 and	 Franklin,	 2013).	 Ongoing	 research	 has	 discovered	 impaired	
differentiation	 and	 maturation	 of	 OPCs	 accounting	 for	 demyelination	 and	 degeneration	 of	
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neurons	 in	 demyelinating	 injuries	 (Hagemeier,	 2012).	 Hence,	 the	 identification	 of	 potential	
remyelinating	 strategies	 that	 promote	 the	 survival	 and	 maturation	 of	 oligodendrocytes	 could	
restore	neuronal	function	and	prevent	clinical	disabilities.		
Though	 the	 repair	 mechanism	 is	 unknown,	 previous	 studies	 reported	 that	 established	
immunomodulatory	 therapies	 induce	 beneficial	 consequences	 on	 remyelination	 in	 animal	
models.	However,	MS	patients	treated	with	immunomodulators	still	revealed	damaged	myelin	in	
the	 progressive	 phase	 of	 the	 disease	 (Aharoni	 and	 Aharoni,	 2016).	 Promising	 results	 were	
achieved	with	 a	monoclonal	 antibody	 (Opicinumab)	 targeted	 to	 the	 Nogo	 receptor	 interacting	
protein-1	 (Lingo-1),	 a	 protein	 negatively	 regulating	 both	 oligodendrocyte	 maturation	 and	
myelination.	 Inhibition	 of	 Lingo-1	 promotes	 remyelination	 in	 vitro	 and	 in	 vivo	 (Mi	et	 al.,	 2005,	
2007;	Pepinsky	et	al.,	2011),	hence	it	was	evaluated	in	clinical	trials.	Although	Opicinumab	failed	
in	 reaching	 its	primary	goal	 in	a	phase	2	 trail,	a	 slight	glimmer	of	hope	emerged	with	a	middle	
dose	that	seemed	to	be	most	beneficial	for	patients	(Mellion	et	al.,	2017).	Another	recombinant	
human	IgM	antibody	(rHIgM22)	was	found	to	promote	oligodendrocyte	remyelination.	However,	
the	mechanism	is	unclear	since	OPC	differentiation	is	inhibited	(Stoffels	et	al.,	2013;	Watzlawik	et	
al.,	2013).	Nonetheless,	a	phase	1	clinical	trial	with	rHIgM22	has	been	completed	and	subsequent	
trials	follow	(Acorda	Therapeutics;	PRA	Health	Sciences,	2015).		
Noteworthy,	 a	 large	number	of	 nuclear	 (Marinelli	et	 al.,	 2016)	 and	 guanine	nucleotide	binding	
protein	 (G-protein)	 receptors	 (Mogha,	 Rozario	 and	 Monk,	 2016)	 have	 been	 identified	 to	
intervene	 in	 oligodendrocyte	 developmental	 processes	 and	 consequently	 display	 therapeutic	
potential	after	injury	and	in	myelin	disorders.		
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1.1.3 The	role	of	G-protein	coupled	receptors	in	oligodendrocyte	development	
and	myelination	
The	 guanine	 nucleotide	 binding	 protein	 receptors	 (GPCRs)	 present	 the	 largest	 membrane	
receptor	family	of	pharmacological	drug	targets	in	the	mammalian	genome	(Bjarnadóttir,	2006).	
Involved	 in	a	 variety	of	physiological	 events,	many	distinct	diseases	 such	as	 cardiovascular	 and	
neurodegenerative	 disorders	 or	 cancer	 can	 be	 modulated	 through	 their	 selective	 activation	
(Neves,	 Ram	 and	 Iyengar,	 2002;	 Howard	 et	 al.,	 2011).	 Intriguingly,	 recent	 studies	 implicate	
manifested	key	roles	of	GPCRs	in	PNS	and	CNS	myelinating	glia.	Thereby,	receptors	belonging	to	
the	 rhodopsin,	 frizzled,	 adhesion	 and	 glutamate	 families	 seem	 to	 control	 the	 development	 of	
myelinating	cells	in	distinct	manners	and	at	different	developmental	time	points	(Mogha,	Rozario	
and	Monk,	2016)	(Figure	2).		
	
Figure	 2:	 Expression	 of	 GPCRs	 during	 oligodendrocyte	 development.	 G-protein	 coupled	 receptors	 are	
known	 to	 regulate	 oligodendrogenesis	 in	 different	 developmental	 stages.	 Ongoing	 research	 revealed	 a	
handful	 GPCRs	 (Gpr17,	 Gpr30,	 S1P1,	 KOR)	 that	 might	 pose	 potential	 therapeutic	 targets	 for	 forcing	
remyelination	when	endogenous	myelination	fails.	Modified	from	(Mogha,	Rozario	and	Monk,	2016).		
For	 instance,	 the	 adhesion	 Gpr56/Adgrg1,	 expressed	 in	 early	 stages	 during	 oligodendrocyte	
development,	 was	 reported	 as	 a	 crucial	 regulator	 of	 OPC	 proliferation	 and	 differentiation.	
Previous	work	in	zebrafish	and	mice	showed	that	depletion	of	Gpr56	produces	hypomyelination	
resulting	from	decreased	OPC	proliferation	(Ackerman	et	al.,	2015;	Giera	et	al.,	2015).	A	further	
study	 in	 mice	 has	 shed	 light	 in	 how	 Gpr37,	 a	 rhodopsin	 family	 GPCR	 affects	 late-stage	
!OPC!
Gpr56,'Cxcr4,'mGlu4'
pre(OL! !premyelina0ng!OL! !myelina0ng!OL! remyelina0ng!OL!
Gpr17'
Gpr37,'Gpr98'
Gpr17,'Gpr30,'S1P1,'KOR'
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oligodendrocyte	development.	 Expressed	 and	maintained	 in	mature	oligodendrocytes,	 absence	
of	 Gpr37	 leads	 to	 precocious	 oligodendrocyte	 differentiation,	 entailing	 hypermyelination	 that	
persisted	until	adult	stages	(Yang	et	al.,	2016).	Last	but	not	least,	a	third	GPCR,	Gpr17,	expressed	
in	 pre-mature	 stages	 of	 oligodendrocyte	 development	 and	 abundant	 in	 demyelination	
pathologies,	will	be	portrayed	more	extensively	in	the	next	chapter	(1.2).		
Noteworthy,	further	GPCRs	such	as	Gpr30,	CxCr4,	S1P1	and	KOR	were	found	to	intervene	in	CNS	
remyelination,	underscoring	once	more	the	potential	of	this	receptor	family	as	potential	targets	
in	injury	and	disease	(Mogha,	Rozario	and	Monk,	2016).		
1.2 The	G-protein	coupled	receptor	17	
Gpr17	 is	 a	 member	 of	 the	 superfamily	 of	 the	 rhodopsin-like,	 seven	 transmembrane	 (7TM)	 G-	
protein	 coupled	 receptors	 (Raport	 et	 al.,	 1996).	 It	 is	 also	 called	 P2Y-like	 receptor,	 since	 it	 is	
phylogenetically	 located	 between	 P2Y	 purinergic	 and	 cysteinyl	 leukotriene	 receptors	 (CysLTRs)	
(Ciana,	Fumagalli,	L.	Trincavelli,	et	al.,	2006).		
1.2.1 Gpr17	localization	
Two	isoforms,	a	 long	form	(Gpr17-L,	369	amino	acids)	that	 is	present	 in	heart	and	kidney	and	a	
short	form	(Gpr17-S,	339	amino	acids)	that	adopts	a	role	in	brain	and	spinal	cord	were	analysed	
by	Benned-Jensen	 and	Rosenkilde	 (2010).	 In	 the	CNS,	 short	 form	Gpr17	 is	mainly	 expressed	 in	
OPCs	and	pre-OLs	and	disappears	when	cells	 achieve	 functional	maturation	 (Chen	et	al.,	 2009)	
(Figure	2).	While	additionally	expressed	 in	ependymal	 cells,	 lining	ventricle	 cavities	 (Marucci	et	
al.,	 2016),	 the	 occurrence	 of	 Gpr17	 in	 neurons	 still	 remains	 controversial	 (Maisel	 et	 al.,	 2007;	
Lecca	et	al.,	2008;	Chen	et	al.,	2009).	Due	to	this	expression	pattern,	Gpr17	 is	assumed	to	be	a	
regulator	of	 the	pre-mature	stage	during	oligodendrogenesis	 (Ciana,	Fumagalli,	 L.	Trincavelli,	et	
al.,	2006;	Fumagalli	et	al.,	2011).	
Besides	its	expression	during	oligodendrocyte	development,	Gpr17	was	found	to	be	upregulated	
under	pathological	conditions,	such	as	traumatic	brain	injury	or	stroke	(Lecca	et	al.,	2008;	Ceruti	
et	 al.,	 2009;	 Zhao	 et	 al.,	 2012).	 Moreover,	 it	 was	 shown	 that	 experimental	 autoimmune	
encephalomyelitis	 (EAE)	 mouse	 models	 display	 abundance	 of	 Gpr17	 in	 demyelinating	 regions	
(Fumagalli	 et	 al.,	 2015).	 Similar	 observations	 were	 reported	 by	 Ou	 et	 al.	 (2016),	 additionally	
demonstrating	 that	 loss	 of	 Gpr17	 in	 mice	 leads	 to	 an	 earlier	 onset	 of	 remyelination	 after	
lysolecitihin-induced	demyelination.	Last	but	not	least,	human	white	matter	plaques	of	multiple	
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sclerosis	patients	exhibit	high	expression	levels	of	Gpr17,	suggesting	that	therapeutic	inhibition	of	
the	receptor	might	foster	remyelination	(Chen	et	al.,	2009).	
1.2.2 Ligand-mediated	signaling	of	Gpr17	
In	 search	 of	 the	 endogenous	 agonist,	 Ciana	 et	 aI.	 (2006)	 introduced	 uracil	 nucleotides	 and	
cysteinyl	leukotrienes	as	activators	of	Gpr17.	However,	several	independent	laboratories	failed	to	
completely	recapitulate	the	original	deorphaning	report	 (Bläsius	et	al.,	1998;	Heise	et	al.,	2000;	
Benned-Jensen	and	Rosenkilde,	2010;	Hennen	et	al.,	2013b;	Qi	et	al.,	2013;	Simon	et	al.,	2017),	
wherefore	 Gpr17	 must	 still	 be	 considered	 as	 orphan.	 Conversely,	 a	 small	 synthetic	 molecule,	
MDL29,951	 (2-carboxy-4,6-dichloro-1H-indole-3-propionic	 acid),	 was	 identified	 as	 a	 selective	
activator	of	Gpr17	in	heterologous	expression	systems	and	primary	oligodendrocytes	(Hennen	et	
al.,	2013b).	So	 far,	MDL29,951	 is	 the	only	credible	activator	of	Gpr17,	 thus	 this	 ligand	provides	
the	opportunity	to	further	investigate	the	role	of	Gpr17	during	oligodendrocyte	development.		
In	addition,	three	different	antagonists	of	uracil	nucleotide	(cangrelor)	and	cysteinyl	leukotriene	
receptors	(pranlukast,	montelukast)	were	proposed	to	inhibit	LTD4	and	UDP-glc	activated	Gpr17	
(Ciana,	 Fumagalli,	 M.	 L.	 Trincavelli,	 et	 al.,	 2006).	 Here	 again,	 receptor	 inhibition	 was	 only	
reproducible	for	pranlukast	(Hennen	et	al.,	2013).		
1.2.3 Role	of	Gpr17	during	oligodendrocyte	development	
Since	high	expression	of	Gpr17	was	found	in	oligodendrocyte	lineages	cells,	researchers	aimed	to	
investigate	the	role	of	Gpr17	during	oligodendrogenesis.	Studies	 in	mice	revealed	that	receptor	
loss	 induces	 an	 early	 onset	 of	 oligodendrocyte	 maturation,	 while	 overexpression	 results	 in	
impaired	oligodendrocyte	differentiation	and	myelination	(Chen	et	al.,	2009).	These	results	were	
supported	 by	 further	 studies	with	 primary	 rat	 oligodendrocytes,	 that	 demonstrated	 decreased	
Mbp	 expression	 levels	 upon	 receptor	 activation,	 mainly	 mediated	 through	 the	 Gαi/o	 pathway	
(Simon	et	al.,	2016).	Furthermore,	it	has	been	shown	that	Gpr17	desensitization	leads	to	terminal	
differentiation	 of	 OPCs	 (Daniele	 et	 al.,	 2014).	 However,	 findings	 obtained	 by	 other	 research	
groups	 implicate	 opposing	 results,	 whereby	 Gpr17	 activation	 through	 postulated	 endogenous	
ligands	 resulted	 in	 promoted	 OPC	 maturation	 and	 myelination,	 while	 receptor	 inhibition	 by	
antagonists	 as	 well	 as	 specific	 silencing	 RNAs	 caused	 opposite	 effects	 (Ceruti	 et	 al.,	 2009;	
Fumagalli	 et	 al.,	 2011).	 Contradicting	 their	 own	 findings,	 some	 years	 later,	 the	 same	 research	
group	 presented	 Gpr17,	 overexpressed	 in	 cultured	 OPCs,	 as	 an	 inhibitor	 of	 oligodendrocyte	
maturation	(Fumagalli	et	al.,	2015).		
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1.3 Zebrafish	as	a	model	to	study	myelination	in	vivo	
In	 scientific	 research,	 cell	 cultures	 or	 tissue	 samples	 are	 extremely	 useful	 in	 providing	 initial	
approaches	 for	 probing	 human	 diseases	 and	 discovering	 new	 human	 drugs.	 However,	 to	
ascertain	 whether	 patient’s	 symptoms	 are	 caused	 by	 genetic	 alternations	 or	 alleviated	 by	
therapeutical	compounds,	the	use	of	in	vivo	model	organisms	is	still	the	gold	standard.	Likewise,	
for	 the	 identification	of	pathways	and	key	molecules	 that	 control	developmental	processes,	 an	
analysis	in	a	native	in	vivo	environment	is	superior	to	in	vitro	systems.		
In	the	field	of	myelination,	rodents	display	the	preferred	animal	models	since	over	90	%	of	their	
genes	 can	be	aligned	with	 the	human	genome	 (Waterston	et	al.,	 2002).	However,	 long	 rearing	
periods	 and	 low-throughput	 evince	 limitations	 of	 this	 model	 organism	 (Cole	 et	 al.,	 2017).	
Nevertheless, during	the	 last	couple	of	decades,	a	smaller	vertebrate	animal,	 the	zebrafish,	has	
emerged	as	powerful	model	system	to	study	myelination	and	remyelination	in	vivo	(Driever	et	al.,	
1994;	Buckley,	Goldsmith	and	Franklin,	2008;	Ackerman	and	Monk,	2015;	Preston	and	Macklin,	
2015).		
1.3.1 The	zebrafish	
At	the	first	sight	the	zebrafish	(Danio	rerio),	a	small	freshwater	teleost	native	to	South-East	Asia	
(Kari,	 Rodeck	 and	 Dicker,	 2007),	 seems	 to	 have	 not	 much	 in	 common	 with	 humans,	 but	 its	
remarkable	genome	homology	over	70%	with	mammals	made	it	a	very	useful	vertebrate	genetic	
model	organism	to	study	key	developmental	processes,	 investigate	human	diseases	or	conduct	
pharmacological	 drug	 screenings	 (Langheinrich,	 2003;	 Howe	 et	 al.,	 2013).	 One	 of	 its	 unique	
advantages	includes	the	short	life	circle	accompanied	by	a	rapid	ex	utero	development	that	can	
be	 perused	 by	 distinct	 non-invasive	 imaging	 methods.	 The	 ability	 to	 follow	 developmental	
processes	 in	 a	 live	 intact	 organism	 is	 further	 supported	 by	 the	 optical	 clarity	 of	 the	 embryos.	
Within	 5	 days,	 a	 zebrafish	 develops	 from	 a	 fertilized	 egg	 to	 a	 fish	 exhibiting	 most	 of	 the	
mammalian	organs	(Figure	3)	(Kari,	Rodeck	and	Dicker,	2007).	The	ability	of	zebrafish	to	produce	
every	 two	 to	 three	 days	 large	 clutch	 sizes	 with	 hundreds	 of	 individuals,	 already	 at	 the	 age	 of	
three	months,	displays	a	feature	that	facilitates	genetic	analysis,	since	research	depends	on	fast	
and	 reproducible	 replication	 (Driever	 et	 al.,	 1994).	 Noteworthy,	 low	 costs	 and	 less	 space	 for	
maintenance	makes	this	animal	especially	attractive	in	the	scientific	community	(Goldsmith	and	
Solari,	2003).	
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Figure	 3:	 Development	 of	 zebrafish	 during	 the	 first	 5	 days	 post	 fertilization	 (dpf).	 hpf	 =	 hours	 post	
fertilization.	Modified	from	(Haffter	et	al.,	1996)	
1.3.2 Myelination	and	remyelination	in	zebrafish	
Studies	 with	 zebrafish	 established	 that	 oligodendrocyte	 development	 and	 myelination	 is	
conserved	from	fish	to	mammals	(Raphael	and	Talbot,	2011).	Expression	of	transcription	factors	
such	as	Olig1	and	Olig2,	 Sox10	and	Nkx2.2.	 is	 identical	 across	 species	 (Monk	and	Talbot,	2009;	
Kucenas,	 Snell	 and	 Appel,	 2010)	 and	 although	 there	 is	 some	 variation	 in	 expression	 pattern	
compared	to	mammals,	homologs	for	myelin	proteins	such	as	myelin	basic	protein	(Mbp)	(Nawaz	
et	 al.,	 2013),	 proteolipid	 protein	 (Plp/DM20)	 (Schweitzer	et	 al.,	 2006)	 and	myelin	 protein	 zero	
(P0)	(Bai	et	al.,	2011)	are	present	 in	zebrafish.	Besides	the	major	proteins,	several	novel	myelin	
membrane-associated	proteins	like	Zwilling-A	and	-B	(Schaefer	and	Brosamle,	2009)	and	Claudin	
K	(Münzel	et	al.,	2012)	have	been	identified,	although	their	roles	in	mammalian	myelination	still	
18#hpf#1#hpf# 4#hpf# 6#hpf# 10#hpf#
29#hpf#
48#hpf#
5#dpf#
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remain	unknown.	Another	interesting	protein,	the	short-chain	dehydrogenase/reductase	protein	
36k	was	also	found	to	be	highly	expressed	in	oligodendrocytes	in	the	CNS	of	teleosts,	while	it	is	
missing	 in	 rodents	 (Morris	 et	 al.,	 2004).	 However,	 Morris	 et	 al.	 (2004)	 determined	 a	 human	
homolog	(FLJ13639)	that	is	abundant	in	oligodendrocytes	and	neurons	of	the	adult	human	brain.	
Probably,	the	presence	of	these	newly	discovered	proteins	implicates	an	evolutionary	adaption	of	
the	aquatic	vertebrate	zebrafish	 (Buckley,	Goldsmith	and	Franklin,	2008).	Since	the	 initiation	of	
developmental	 and	 myelinating	 processes	 occurs	 earlier	 in	 zebrafish,	 at	 3	 dpf	 (Brösamle	 and	
Halpern,	2002)	compared	 to	mice	exhibiting	myelination	at	P6	 (Foran	and	Peterson,	1992),	 the	
zebrafish	represents	an	ideal	model	to	follow	myelination	in	real-time	in	its	native	environment.	
In	 comparison	 to	mammals,	 zebrafish	exhibit	 the	unique	ability	 to	 regenerate	 injured	axons	by	
continuous	 endogenous	 remyelination	 (Becker	 and	 Becker,	 2008;	 Ohnmacht	 et	 al.,	 2016).	
Goldsmith	et	al.	(2012)	assumed	that	efficient	axon	regeneration	capability	is	likely	to	be	present	
because	 of	 lacking	 glial	 scar	 formation.	 Since	 major	 reasons	 remain	 speculative	 at	 the	 time,	
further	studies	with	zebrafish	may	help	to	elucidate	pathways	or	tractable	key	molecules	that	are	
necessary	 for	 successful	 and	 continuous	 OPC	 differentiation,	 thus	 following	 remyelination	 in	
health	and	disease.		
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1.3.3 Zebrafish	as	a	model	to	study	myelination	and	remyelination	
During	 the	 last	 decades	 a	 wide	 variety	 of	 different	 techniques	 for	 studying	 myelination	 and	
remyelination	in	zebrafish	have	been	created.	One	big	strength	was	the	generation	of	transgenic	
zebrafish	 reporter	 lines	 that	 express	 exogenous	 proteins	 under	 control	 of	 cell	 or	 subcellular	
structure	specific	regulatory	DNA.	Meanwhile,	hundreds	of	different	lines,	expressing	fluorescent	
proteins	 in	distinct	cell	 types	are	available	(Preston	and	Macklin,	2015).	Beside	others,	reporter	
lines	such	as	tg(olig2:EGFP)	(Shin	et	al.,	2003),	tg(claudinK:Gal4;UAS:mGfp)	(Münzel	et	al.,	2012),	
tg(plp:EGFP)	 (Yoshida	 and	 Macklin,	 2005)	 or	 tg(mbp:EGFP)	 (Jung	 et	 al.,	 2009)	 label	
oligodendrocyte	 lineage	 cells	 or	myelin	 sheaths	 and	 provide	 the	 opportunity	 to	 gain	 profound	
insights	in	OPC	generation,	migration	and	myelination	in	the	spinal	cord.	Furthermore,	expression	
of	specific	proteins	can	be	easily	obtained	by	microinjections	of	either	capped	mRNA	or	plasmids	
into	 the	 one-	 or	 two-cell	 stage	 of	 zebrafish	 embryos,	 leading	 to	 an	 expression	 throughout	 the	
whole	 animal,	 unless	 the	 injected	 nucleic	 acids	 contain	 tissue	 specific	 promoters	 (Kari,	 Rodeck	
and	Dicker,	2007).	 In	doing	 so,	 zebrafish	 can	also	be	humanised	with	genes	 involved	 in	human	
diseases	(Goldsmith,	2004).	On	the	contrary,	Zink	Fingers	(Urnov	et	al.,	2010),	TALEN’s	(Campbell	
et	 al.,	 2012)	 or	 more	 current	 CRISPR	 (Blackburn	 et	 al.,	 2013)	 methodologies	 display	 the	
opportunity	to	generate	knockout	zebrafish.	A	timesaving	alternative	to	knockout	animals	offers	
the	 morpholino	 antisense	 oligonucleotides	 mediated	 gene	 knockdown,	 which	 impairs	 the	
translation	 machinery	 by	 hybridizing	 to	 translation-initiating	 or	 splicing	 donor	 sites	 of	 specific	
mRNAs.	However,	this	method	provides	no	guaranty	for	a	transient	protein	disruption,	wherefore	
it	has	 to	be	demonstrated	by	rescue	experiments	 (Corey	and	Abrams,	2001;	Zon	and	Peterson,	
2005).	
Besides	genetic	screening,	zebrafish	are	well	suited	as	a	pharmacological	tool	for	small-molecule	
drug	 discovery	 (Langheinrich,	 2003;	 Goldsmith,	 2004;	 Kari,	 Rodeck	 and	 Dicker,	 2007).	 As	
producing	 high	 numbers	 of	 offspring,	 they	 provide	 a	 rapid	 and	 low	 cost	 high-throughput	
screening	model.	Drugs	can	be	easily	administered	by	bath	treatment.	From	1	to	3	dpf,	embryos	
are	 able	 to	 absorb	 substances	 across	 the	 skin,	 while	 after	 3	 dpf	 the	 oral	 route	 dominates	
(Goldsmith,	2004).	At	this,	compounds	have	to	overcome	the	blood	brain	barrier	that	allows	the	
transition	of	molecules	smaller	than	1000	kD	(Joeng	et	al.,	2008).	In	case	of	large	molecule	drugs,	
microinjection	 of	 embryos	 display	 an	 alternative	 drug	 administration	 (Goldsmith,	 2004).	 After	
treatment,	 several	 methods	 such	 as	 fluorescent	 and	 electron	 microscopy,	 quantitative	
polymerase	 chain	 reaction	 (qPCR),	 Whole-mount	 in	 situ	 hybridization	 (WISH)	 or	
immunohistochemistry	(IHC)	assays	can	be	performed	to	examine	potential	effects	(Pruvot	et	al.,	
2014;	 Guo	et	 al.,	 2015).	 Until	 now	 a	 few	 chemical-screening	 studies	 have	 been	 published.	 For	
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instance,	 Buckley	 et	 al.	 (2010)	 generated	 a	 robust	 screening	 platform	 and	 identified	 several	
compounds	 with	 pro-myelinating	 features.	 Recently	 it	 has	 been	 shown	 that	 treatment	 of	
zebrafish	 larvae	 with	 the	 antihistaminic	 drug	 clemistine	 rescued	 hypomyelination	 in	 mct8	
mutants	 that	 display	 a	 key	 symptom	 of	 Allan-Herndon-Dudly	 syndrome	 (ADHS)	 (Zada	 et	 al.,	
2016).	Noteworthy,	Kulkarni	et	al.,	(2017)	developed	an	adult	EAE	zebrafish	model	as	a	quick	 in	
vivo	screening	system	that	serves	for	the	identification	of	premyelinating	drugs.		
1.3.4 GPCR’s	studied	in	zebrafish		
Since	 researchers	 discovered	 that	 G-protein	 coupled	 receptors	 intervene	 in	 the	 myelination	
process	(Mogha,	Rozario	and	Monk,	2016),	a	zebrafish	myelination	screen	identified	the	orphan	
Gpr126/Adgrg6	as	a	crucial	 regulator	of	Schwann	cells	differentiation	 in	 the	PNS.	 It	was	 shown	
that	 absence	of	Gpr126	 restrains	 Schwann	 cells	 in	 its	 premyelinating	 stage	 (Monk	et	al.,	 2009,	
2011).	 Meanwhile,	 two	 different	 working	 groups	 postulated	 type	 IV	 collagen	 (Paavola	 et	 al.,	
2014)	as	well	as	Laminin-211	(Petersen	et	al.,	2015)	as	activators	of	Gpr126	by	means	of	zebrafish	
animal	models.	Another	GPCR,	Gpr56,	enriched	in	oligodendrocyte	lineage	cells,	was	found	to	be	
a	 key	 regulator	 of	 oligodendrocyte	 development	 in	 the	 central	 nervous	 system	 (Giera	 et	 al.,	
2015).	Ongoing	studies	 in	zebrafish,	uncovered	Gα12/13-Rho	signalling	as	key	pathway	for	Gpr56	
dependent	 OPC	 proliferation	 (Ackerman	 et	 al.,	 2015).	 These	 studies	 further	 demonstrate	 the	
strength	 of	 the	 zebrafish	model	 system	 to	 investigate	 key	 regulators	 and	 pathways	 controlling	
myelination	in	vivo.		
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1.4 Aims	of	this	study		
Since	 the	 orphan	G-protein	 coupled	 receptor	Gpr17	was	 first	 characterized	 by	 Raport	et	 al.	 in	
1996,	several	working	groups	have	made	great	efforts	in	order	to	prove	that	this	receptor	is,	inter	
alia,	a	crucial	regulator	of	oligodendrocyte	development	in	health	and	disease	(Lecca	et	al.,	2008;	
Ceruti	et	al.,	2009;	Chen	et	al.,	2009b;	Fumagalli	et	al.,	2011;	Coppi	et	al.,	2013;	Hennen	et	al.,	
2013b;	 Schneider	 et	 al.,	 2016;	 Simon	 et	 al.,	 2016;	 Seyedsadr	 and	 Ineichen,	 2017).	 However,	
discrepancies	between	published	 literature	query	Gpr17	agonist	and	antagonist	profiles	as	well	
as	 its	 function	 in	 demyelinating	 pathologies	 (Marucci	 et	 al.,	 2016).	 Thus,	 further	 studies	 are	
necessary	 to	 clarify	 its	 role	 and	 discover	 new	 therapeutic	 compounds	 with	 activity	 on	 human	
Gpr17.	 Herein,	 this	 thesis	 scrutinize	 whether	 the	 zebrafish	 (Danio	 rerio)	 is	 a	 suitable	 animal	
model,	 not	 only	 in	 terms	 to	 confirm	 receptor’s	 role	 in	 myelination	 but	 also	 in	 relation	 of	
presenting	an	 in	vivo	screening	platform	for	new	ligands	of	human	Gpr17	as	modulators	of	CNS	
remyelination.		
The	 first	 element	 of	 this	work	 intends	 to	 verify	 activity	 of	 zebrafish	Gpr17	 upon	 expression	 in	
mammalian	cells	towards	the	postulated	ligands	(Ciana,	Fumagalli,	M.	L.	Trincavelli,	et	al.,	2006),	
and	 the	 small-molecule	 agonist	MDL29,951	 (Hennen	et	al.,	 2013b)	by	 label-free	Dynamic	mass	
redistribution	(DMR)	technology.	At	this,	two	variants	of	zebrafish	Gpr17,	zfAGpr17	and	zfBGpr17	
sharing	an	AA-identity	of	56	and	44	%	with	the	human	Gpr17	(Kleinert,	2018)	are	examined	with	
a	special	focus	on	zfA.	To	further	investigate	zebrafish	Gpr17	in	its	native	environment,	zebrafish	
embryos	 are	 bath	 exposed	 to	 MDL29,951	 and	 screened	 for	 alterations	 in	 oligodendrocyte	
development	 and	 myelination.	 Additionally,	 chimeric	 receptors	 containing	 the	 ligand	 binding	
domain	 of	 human	 Gpr17	 and	 the	 intracellular	 loops	 of	 zebrafish	 Gpr17	 are	 constructed	 and	
evaluated	in	functional	DMR	assays	as	potential	tools	for	an	in	vivo	zebrafish	screening	platform.	
The	second	part	of	the	thesis	focuses	on	Gpr17	expression	and	role	in	the	zebrafish	itself.	To	this	
end,	 expression	 pattern	 will	 be	 analysed	 by	 Whole-mount	 in	 situ	 hybridization	 (WISH)	 and	
Western	 blot	 analysis.	 Finally,	 genetic	 manipulation	 of	 transgenic	 zebrafish	 lines	 such	 as	
tg(olig2:EGFP)	and	tg(claudinK:EGFP)	through	receptor	overexpression	and	morpholino	antisense	
oligonucleotide	mediated	gene	knockdown	sheds	light	on	Gpr17	function	in	vivo.		
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2 Material	
2.1 Cell	culture	
2.1.1 Mammalian	cell	lines	
Table	1.	Cell	lines	
Name	 Biological	source	 Producer/Owner	
HEK293	 Human	embryonic	kidney	 Research	group	of	Prof.	Dr.	Evi	
Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
PAC2	fibroblasts	 Zebrafish	 Research	group	of	Prof.	Dr.	
Nicholas	Foulkes,	Karlsruhe	
Institute	of	Technology	(KIT),	
Germany		
2.1.2 HEK293	cell	culture	medium	
Table	2.	HEK293	cell	medium	
Constituent	 Volume	(mL)	 Final	concentration	
Dulbecco’s	Modified	Ea-	gle	
Medium	(DMEM)		
500	 	
Fetal	calf	serum	(FCS)		 50	 ≈10	%		
Penicillin-Streptomycin	 5	 ≈100	U/mL	Penicillin,	0.1	
mg/mL	Streptomycin		
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2.1.3 PAC2	cell	culture	medium	
Table	3.	PAC2	cell	medium	
Constituent	 Volume	(mL)	 Final	concentration	
Leibovitz’s	L15	Medium	 500	 	
Fetal	bovine	serum	(FBS)		 75	 ≈15	%		
Penicillin-Streptomycin	 5	 ≈100	U/mL	Penicillin,	0.1	
mg/mL	Streptomycin		
Gentamicin	 0.5	 0.05	mg/mL	
2.2 Zebrafish	lines	
Table	4.	Zebrafish	lines	
Name	 Producer/Owner	
Tg(cldnk:GAL4,	UAS:EGFP)	 Münzel	et	aI.,	2012	
Tg(olig2:EGFP)	 Shin	et	aI.,	2003	
TU	(wild	type)	 Item	#1173	European	Zebrafish	Resource	Center,	Karlsruhe,	
Institute	for	technology	
TL	(wild	type)	 Item	#1174	European	Zebrafish	Resource	Center,	Karlsruhe,	
Institute	for	technology	
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2.3 Zebrafish	maintenance	
2.3.1 Zebrafish	water	
Table	5.	Danieau	300%	
Constituent	 Volume	(mL)	 Concentration	(M)	 Final	concentration	(mM)	
NaCl	 60	 2.9	 174	
KCl	 30	 0.07	 2.1	
MgSO4x7H2O	 30	 0.04	 1.2	
Ca(NO3)2	 30	 0.06	 1.8	
HEPES	 30	 0.5	 15	
MilliQ	water	 820	 -	 -	
Table	6.	Danieau	30	%	
Constituent	 Volume	(L)	
Danieau	300	%	 1	
MilliQ	water	 9	
Table	7.	Danieau	30	%	with	Methylenblue	
Constituent	 	Volume	(mL)	 Final	concentration		
Methylenblue	500x	 	2	 10-5	%	
Danieau	30	%	 	998	 	
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Table	8.	Danieau	30	%	with	PTU	
Constituent	 Volume	(mL)	 Final	concentration		
N-Phenylthiourea	50x	 20	 0.003	%	
Danieau	30	%	 980	 	
2.4 Antibodies	
2.4.1 Primary	antibodies	
Table	9.	Primary	antibodies	
Antibody	 Species	 Product	number																						Company	
Anti-36k	(flj13639)	 rabbit	 QPE0580	 Thermo	Fisher	Scientific	
Anti-β-actin-HRP	 mouse	 A3854	 Sigma-Aldrich	
Anti-ClaudinK	 rabbit	 QPE0581	 Thermo	Fisher	Scientific	
Anti-Cleaved	Caspase3	 rabbit	 9579	 Cell	Signaling	Technology	
Anti-Digoxigenin-AP	 sheep	 11093274910	 Roche	
Anti-EGFP	 mouse	 JL8-632381	 Takara	Clontech	
Anti-HA	 mouse	 11583816001	 Roche	
Anti-MbpA	 guinea	pig	 QOJ1724	 Thermo	Fisher	Scientific	
Anti-P0		 rabbit	 QOJ1722	 Thermo	Fisher	Scientific	
Anti-zfAGpr17	 chicken	 QOJ1726	 Thermo	Fisher	Scientific	
Anti-zfBGpr17	 rabbit	 QoJ1723	 Thermo	Fisher	Scientific	
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2.4.2 Secondary	antibodies	
Table	10.	Secondary	antibodies	
Antibody	 Species	 Product	number																															Company
Anti-chicken-HRP	 goat	 ab97150	 Abcam	
Anti-guinea	pig-AlexaFlour546	 goat	 A-11074	 Molecular	Probes	
Anti-mouse-HRP	 goat	 115-035-003	 Jackson	Immuno	Research		
Anti-mouse-HRP	 goat	 A4416	 Sigma-Aldrich	
Anti-rabbit-HRP	 goat	 111-035-144	 Jackson	Immuno	Research		
Anti-mouse-Cy2	 goat	 AP124J	 Millipore	
2.5 Media,	buffers	and	solutions	
2.5.1 Media,	buffers,	supplements	and	growth	factors	
Table	11.	Media,	buffers,	supplements	and	growth	factors	
Name	 Product	number																															 Company	
Ampicillin-Natrium		 10835242001	 Roche		
CutSmart®	10x	 B72049	 New	England	Biolabs®	
Dulbecco’s	Modified	Eagle	
Medium	(DMEM)	
41965	 Thermo	Fisher	Scientific	
DPBS	1x	 14190-094	 Gibco	by	life	technologiesTM	
Fetal	calf	serum	(FCS)		 P30-3702	 PANTM	Biotech	GmbH	
Fetal	bovine	serum	(FBS)	 F7524	 Sigma-Aldrich	
Hank’s	balanced	salt	solution	
(HBSS)	
14025050	 Thermo	Fisher	Scientific	
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Leibovitz’s	L15	Medium	 11415064	 Thermo	Fisher	Scientific	
Normal	Goat	Serum	 G9023	 Sigma-Aldrich	
Nuclease-free	water	 129144	 Qiagen	
Opti-MEM		 1616013	 Thermo	Fisher	Scientific	
Penicillin-Streptomycin	
solution		
15140122	 Thermo	Fisher	Scientific	
Pierce	Ripa	Buffer	 89900	 Thermo	Fisher	Scientific	
Sheep	Serum	 S2263	 Sigma-Aldrich	
SSC	buffer	20x	 15557-044	 Gibco	by	life	technologiesTM	
T4	DNA	Ligase	buffer	10x	 EL0011	 Thermo	Fisher	Scientific	
Trypsin-EDTA	(0.05	%)		 25300054	 Thermo	Fisher	Scientific	
2.5.2 Solutions	
Solution	1.	1	M	HEPES	
Component	 Total	amount	 Final	concentration		
HEPES	 23.8	g	 1	M	
NaOH	 q.s.	 pH	7.2-7.4	
dH2O	 ad	100	mL	 	
After	adjusting	the	pH	to	7.2-7.4	with	NaOH,	solution	was	sterilized	by	sterile	filtration	and	stored	
at	-	20	°C.	
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Solution	2.	ELISA	Blocking	buffer	
Component	 Total	amount	 Final	concentration		
Dry	milk	 3	g	 3	%	
Tris-HCl	1	M,	pH	7.4-7.8	 5	mL	 50	mM	
MilliQ	water	 ad	100	mL	 	
Solution	3.	ICC	Blocking	buffer	
Component	 Total	amount	 Final	concentration		
Normal	goat	serum	 5	mL	 10	%	
Bovine	serum	albumin	 0.5	mL	 1	%	
MilliQ	water	 ad	50	mL	 	
Solution	4.	WB	Lysis	buffer	
Component	 Volume	(mL)	 Final	concentration		
Tris	1	M,	pH	7.4	 1.5	 25	mM	
NaCl	5	M	 1.8	 150	mM	
EDTA	0.5	M	 0.12		 1	mM	
TritonX100	 0.6	 1	%	
IGEPAL®	 0.6	 1	%	
MilliQ	water	 ad	60		 	
1.5	mL	aliquots	were	prepared	and	stored	at	-	20°C.	
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Solution	5.	WB	Washing	buffer	
Component	 Volume	(mL)	 Final	concentration		
Tween20	 1	 0.1	%	
PBS	 1000	 	
Solution	6.	PBST	
Component	 Total	amount	 Final	concentration		
Tween20	20	%	 25	µL	 0.1	%	
DPBS	1x	 ad	500	mL	 	
Solution	7.	4	%	paraformaldehyde	(PFA)	
Component	 Total	amount	 Final	concentration		
Paraformaldehyde	 4	g	 4	%	
Citric	acid	monohydrate	 q.s.	 pH	7.3	
DPBS	1x	 ad	100	mL	 	
After	regulation	of	the	pH	to	7.2-7.4	with	citric	acid,	the	solution	was	sterilized	by	sterile	filtration	
and	10	mL	aliquots	were	stored	at	-	20	°C.	
Solution	8.	Buffer	I	Dot	blot	
Component	 Volume	(mL)	 Final	concentration		
Tris-HCl	1	M	pH	7.5	 20	 100	mM	
NaCl	5	M		 6	 150	mM	
DEPC	water	 ad	200	 	
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Solution	9.	Buffer	II	Dot	blot	
Component	 Volume	(mL)	 Final	concentration		
TritronTMX-100	 0.05	 0.1	%	
DPBS	1x	 ad	50		 	
Solution	10.	Buffer	III	Dot	blot	
Component	 Volume	(mL)	 Final	concentration		
Tris-HCl	1	M	pH	9.5	 5	 100	mM	
NaCl	5	M	 1	 100	mM	
MgCl2	1	M	 2.5	 50	mM	
Tween20	20	%	 0.25	 0.1	%	
DEPC	water	 ad	50		 	
Solution	11.	WISH	Hybridization	buffer	(HM)	for	probe	
Component	 Volume	(mL)	 Final	concentration		
Formamide	 25	 50	%	
SSC	20x	 12.5	 SSC	5x	
Heparin	5	mg/mL	 0.5	 50	µg/mL	
tRNA	10	mg/mL	 2.5	 500	µg/mL	
Tween20	20	%	 0.5	 0.2	%	
Acide	citrique	1	M	 q.s	 pH	6	
DEPC	water	 ad	50	 	
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Solution	12.	WISH	Hybridization	buffer	(HM	wo)	for	washing	steps	
Component	 Volume	(mL)	 Final	concentration		
Formamide	 25	 50	%	
SSC	20x	 12.5	 SSC	5x	
Tween20	20	%	 0.25	 0.1	%	
Acide	citrique	1	M	 q.s	 pH	6	
DEPC	water	 ad	50	 	
Solution	13.	WISH	Alkaline	tris	buffer	
Component	 Volume	(mL)	 Final	concentration		
Tris-HCl	1	M	pH	9.5	 5	 100	mM	
NaCl	5	M	 1	 100	mM	
MgCl2	1	M	 2.5	 50	mM	
Tween20	20	%	 0.25	 0.1	%	
DEPC	water	 ad	50	 	
Solution	14.	WISH	NBT/BCIP	labelling	solution		
Component	 Volume	(mL)	
NBT	(Nitro	Blue	
Tetrazolium)	
0.0225	
BCIP	(5-Bromo	4-Chloro	3-
indolyl	Phosphate)	
0.175	
Alkaline	tris	buffer	 ad	50	
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Solution	15.	IHC	Tris	buffer	
Component	 Total	amount	 Final	concentration		
Tris	Base	 1.8171	g	 150	mM	
HCl	 q.s.	 pH	9	
DEPC	water	 ad	100	mL	 	
Solution	16.	IHC	Sodium	phosphate	buffer	
Component	 Total	amount	 Final	concentration		
NaH2PO4	 3.1	g	 100	mM		
Na2HPO4	 10.9	g	 100	mM	
DEPC	water	 ad	1000	mL	 	
The	buffer	can	be	stored	up	to	one	month	at	4	°C.	
Solution	17.	IHC	PBTx	
Component	 Total	amount	 Final	concentration		
TritonX100	 800	µL	 0.8	%	
100	mM	IHC	sodium	
phosphate	buffer	
ad	100	mL	 	
Solution	18.	IHC	NGS/BSA/PBTx	blocking	solution	
Component	 Total	amount	 Final	concentration		
Normal	goat	serum	 1	mL	 10	%	
Bovine	serum	albumin	 0.2	g	 2	%	
IHC	PBTx	 ad	10	mL	 	
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Solution	19:	IHC	NGS/BSA/PBTx	antibody	blocking	solution	
Component	 Total	amount	 Final	concentration		
Normal	goat	serum	 200	µL	 2	%	
Bovine	serum	albumin	 0.2	g	 2	%	
IHC	PBTx	 ad	10	mL	 	
2.6 Water	purification	
Purified	water	was	generated	by	the	MilliQ-Water	system	(AG	Kostenis)	and	the	Reverse	Osmosis	
Mobil	Filtration	System	MobilRO16	(AG	Odermatt)	and	used	for	all	for	media	and	solutions.	
2.7 Chemicals	
Table	12.	Chemicals	
Substance		 Product	number	 Company	
Agarose	Type	IX-A,	Ultra-low	
Gelling	Temperature	
A2576	 Sigma-Aldrich	
LE	Agarose	 840004	 Biozym	
Albumin	Fraction	V	(pH	7.0)	for	
western	blotting	
A1391	 PanReac	Applichem	
Ampuwa,	water	for	injections	 40676.00.00	 Fresenius	Kabi	Deutschland		
BCIP/NBT		 S3771		 Promega		
Blotting-Grade	Blocker,	Dry	
milk	for	western	blotting	
applications	
1706404	 Bio-Rad	Laboratories	
Carbachol		 212385		 Merck	
Citric	acid	monohydrate	 100244	 Merck	
Complete	Tablets	Easypack	
Protease	Inhibitor	
046931166001	 Roche	
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DEPC	water	 T143.3	 Roth	
DMSO	 A1584	 PanReac	Applichem	
DNA	Loading	Dye	6x	 R0611		 Thermo	Fisher	Scientific	
dNTP	Set,	100	mM	Solutions		 R0182		 Thermo	Fisher	Scientific	
EDTA-disodium	 39760.01	 Serva	
Ethanol	absolute	 A1613	 PanReac	Applichem	
Ethidiumbromide	1	%		 46067		 Sigma-Aldrich	
Ethyl	3-aminobenzoate	
methansesulfonate	salt	
(MS222)	
A5040	 Fluka	Analytical	
NorthernMax®Formaldehyde	
Load	Dye	
AM8552	 Thermo	Fisher	Scientific	
Formamide	 47671	 Sigma	Life	Science	
FuGENE	HD®	Transfection	
Reagent		
E2312		 Promega	
GeneRuler	1	kb	DNA	Ladder	 SM0311	 Thermo	Fisher	Scientific	
GeneRuler	100	bp	Plus	DNA	
Ladder	
SM0321	 Thermo	Fisher	Scientific	
Glycerol	 104093	 Merck	
Heparin	Sodium	Salt	from	
porcine	intestinal	mucosa	
H3393	 Sigma-Aldrich	
HEPES	(4-(2-hydroxyethyl)-1-	
piperazineethanesulfonic	acid)		
54457		 Fluka	
Hydrochloric	acid	37	%	 9057	 Merck	
IGEPAL®	 CA-630	 Sigma-Aldrich	
Kaleidoscope	Prestained	
Standard		
161-0324		 Bio-Rad	Laboratories	
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MagicMark™	XP	Western	
Protein	Standards		
LC5602		 Invitrogen	
Magnesium	chloride	
hexahydrate	
A4425	 PanReac	Applichem	
MDL29,951		 SEWO6645SC		 Maybridge	
Methanol	 131091.1212	 PanReac	Applichem	
Mineral	Oil		 M5904	 Sigma-Aldrich	
Mowiol		 81381		 Sigma-Aldrich	
Normal	Goat	Serum	 G9023	 Sigma-Aldrich	
NuPAGE®	Antioxidant		 NP0005		 Novex™	by	Life	Technologies	
NuPAGE®	LDS	Sample	Buffer	4x	 NP0007		 Novex™	by	Life	Technologies	
NuPAGE®	MOPS	SDS	Running	
Buffer	20x		
NP0001		 Novex™	by	Life	Technologies	
NuPAGE™	Novex™	10	%	Bis-Tris	
Protein	Gels,	1.5	mm,	10-well		
NP0315Box		 Novex™	by	Life	Technologies	
NuPAGE®	Sample	Reducing	
Agent	10x		
NP0009		 Novex™	by	Life	Technologies	
NuPAGE®	Transfer	Buffer	20x		 NP000P-6		 Novex™	by	Life	Technologies	
Paraformaldehyde	 158127	 Sigma-Aldrich	
PierceTM	Comassie	Plus	
(Bradford)	
23236	 Thermo	Fisher	Scientific	
Phenol	red	solution	 P0290	 Sigma-Aldrich	
N-Phenylthiourea	 P7629	 Sigma-Aldrich	
Poly-D-lysine	hydrobromide	
(PDL)	
P6407	 Sigma-Aldrich	
N-Propylgallate	 P3130	 Sigma-Aldrich	
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Protease	inhibitor	cocktail		 P8340		 Sigma-Aldrich	
Protease	from	Streptomyces	
griseus	Type	XIV	
P5147	 Sigma-Aldrich	
Proteinase	K	 A3830	 PanReac	Applichem	
Ribonucleic	acid	from	torula	
yeast	Type	VI	
R6625	 Sigma-Aldrich	
Roti®-Block		 A151.2		 Roth	
Sodium	actetate	anhydrous	 6268	 Merck	
Sodium	chloride	 A2942	 PanReac	Applichem	
Sodium	dihydrogen	phosphate,	
anhydrous	
71640	 Fluka	
Sodium	hydrogen	phosphate	 131679.1211	 PanReac	Applichem	
Sulfuric	acid	 109073	 Merck	
3,3’,5,’-	Tetramethylbenzidine	
Liquid	substrate	system	(TMB)	
T8665	 Promega	
TRIS	PUFFERAN®	≥99,9	%	Ultra	
Qualität	
5429.3	 Roth	
TritronTMX-100	 X100	 Sigma-Aldrich	
TRIzol	Regent	 T9424	 Ambion	by	life	technologiesTM	
Tween20	 P9416	 Sigma-Aldrich	
UltraPureTM	Distilled	water		 10977035		 Thermo	Fisher	Scientific	
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2.8 Enzymes	
Table	13.	Enzymes	
Enzyme	 Product	number	 Company	
DreamTaq®	DNA	Polymerase	 EP0701	 Thermo	Fisher	Scientific	
EcoRI-HF	 R3101S	 New	England	Biolabs®	
FastAP	Thermosensitive	
Alkaline	Phosphatase	
EF0651	 Thermo	Fisher	Scientific	
HindIII	 R0104S	 New	England	Biolabs®	
iScriptTM	Reverse	Transcription	
Supermix	for	RT-	qPCR	
170-8841	 Bio-Rad	Laboratories	
KpnI-HF	 R3142S	 New	England	Biolabs®	
MfeI	 R3589S	 New	England	Biolabs®	
Phusion®	High-Fidelity	DNA	
Polymerase	
F-534S	 Thermo	Fisher	Scientific	
SacI-HF	 R3156S	 New	England	Biolabs®	
SpeI-HF	 R3133S	 New	England	Biolabs®	
T4	DNA	Ligase	 EL0011	 Thermo	Fisher	Scientific	
XhoI	 R0146S	 New	England	Biolabs®	
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2.9 Oligonucleotides	
2.10 Oligonucleotides	for	RT-qPCR		
Table	14.	Oligonucleotides	for	RT-qPCR	from	Sigma	Aldrich	
Name	 Sequence	5’-3’	 ZFIN	ID	
actin_forward	 GCCAACAGAGAGAAGATG	
ZDB-GENE-000329-1	actin_reverse		 GCGTAACCCTCATAGATG	
actin_reverse_probe	 [6FAM]ACCATCACCAGAGTCCATCACAAT[B
HQ1]	
ef1a_forward	 GGAGTGATCTCTCAATCTTG	
ZDB-GENE-990415-52	ef1a_reverse	 CTTCCTTCTCGAACTTCTC	
ef1a_reverse_probe		 [6FAM]TCTCTTGTCGATTCCACCGCA[BHQ1]	
mbp_forward		 CTGGGCAGAAAGAAGAAG	
ZDB-GENE-030128-2	
mbp_reverse		 GATGACCACGAAATGAAC	
mbp_forward_probe	
	
[HEX]CTCCTCCGAAGAACCTGCTGAT[BHQ1]	
plp_forward	 CAGGAATCACCCTTCTTG	
ZDB-GENE-030710-6	plp_reverse		 GAACCTAGCAACGGATTC	
plp_forward_probe	 [HEX]CCACCACCTACAACTACGCTATTCT	
[BHQ1]	
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2.11 Morpholino	oligonucleotides	
Table	15.	Morpholino	oligonucleotides	from	Gene	Tools,	LLC	
Name	 Sequence		5’-3’	 Concentration	
zfAgpr17	MO	 GTTCTGTCAAGGAGGACTCCAT
TT	
2.54	mg	(300	nmol),	M=8465	
Control	MO	 CCTCTTACCTCAGTTACAATTTA
TA	
0.833	mg	(100	nmol),	M=8328	
2.12 Plasmids	
Table	16.	Plasmids	
Plasmid	 Size	(bp)	 Host	
pBlueskriptII	SK	 2961	 Invitrogen™	
pcDNA3.1+		 5428		 Invitrogen™	
EGFP	in	N1	 720	 Addgene	
hGpr17	in	pcDNA3.1+	 1020	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-hGpr17	in	pcDNA3.1+	 1151	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-zfAGpr17	in	pcDNA3.1+	 1155	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-zfBGpr17	in	pcDNA3.1+	 1080	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
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3HA-h+zfAGpr17	in	pcDNA3.1+	 1137	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-h+zfBGpr17	in	pcDNA3.1+	 1110	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-zfA+hGpr17	in	pcDNA3.1+	 1149	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
3HA-zfB+hGpr17	in	pcDNA3.1+	 1107	 Research	group	of	Prof.	Dr.	
Evi	Kostenis,	Institute	of	
Pharmaceutical	Biology,	
University	of	Bonn,	Germany	
mbpA	in	pGEM®-T	Easy	Vektor	 411	 Research	group	of	Dr.	Hauke	
Werner,	Department	of	
Neurogenetics,	MPI	for	
Experimental	Medicine,	
Göttingen,	Germany	
nkx2.2	in	pBlueskriptII	SK	 700	 Research	group	Bart	and	
Wilson,	Developmental	
Biology	Research	Centre,	
Randall	Institute,	King's	
College	London,	UK	
tdTomato	in	pBlueskriptII	SK	 1428	 Clontech	Laboratories	
zfAGpr17	in	pBlueskriptII	SK	 1020	 Research	group	of	Prof.	Dr.	
Benjamin	Odermatt,	Institute	
of	Anatomy,	University	of	
Bonn,	Germany	
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2.13 Assay	kits	
Table	17.	Assay	kits	
Assay	Kit	 Product	number	 Company	
Amersham	ECL	prime	Western	
Blotting	Detection		
RPN2236		 GE	Healthcare	
DIG	RNA	Labeling	Kit	(SP6/T7)	 11175025910	 Roche	
DyNAmo®	Flash	Probe	qPCR	
Kit	
F-455S	 Thermo	Fisher	Scientific	
iScriptTM	cDNA	synthesis	Kit	 170-8890	 Bio-Rad	Laboratories	
mMessage	mMachineTM	T7	
Ultra	Kit	
AM1345	 Invitrogen	by	Thermo	Fisher	
Scientific	
NucleoBondR	Xtra	Maxi		 740414.10		 Macherey-Nagel	
NucleoSpin	Gel	and	PCR	Clean-
UP	
740609.250	 Machery-Nagel	
Qubit	RNA	HS	Assay	Kit		 Q32855	 Molecular	Probes	by	life	
technologiesTM	
Rapid	DNA	Ligation	Kit	 K1422	 Thermo	Fisher	Scientific	
Pierce	BCA	Protein	Assay	Kit	 23225	 Thermo	Fisher	Scientific	
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2.14 Consumables	
Table	18.	Consumables	
Consumables	 Product	number	 Company	
Assay	plate,	384	well		 784080		 Greiner	
Blue	1000	µL	tips		 686290		 Greiner	bio-one	
Cell	culture	flasks,	25/75/175	
cm2		
430168/430729/431079		 Corning	
Cell	scraper		 3926.90.97		 Corning	
Centrifuge	tubes,	15ml/50mL		 430791/430829		 Corning	
Compound	plate,	384	well	g	 3657		 Corning	
Cryogenic	vials		 5000-1020	Nalgene®	 Nalgene®	by	Thermo	Fisher	
Scientific	
Culture	dishes	21/55	cm2		 430166	/	430167		 Corning	
Culture	dishes	(untreated)		 430591		 Corning	
Disposable	filter	unit	0.2	µL		 FB30/0.2	CA-s		 Whatman®	
EPIC	cell	assay	plate,	384	well		 9027.90.50		 Corning	
Glass	Bottom	viewplate,	96-
well,	high	performance	#1.5	
cover	glass	
P96-1.5H-N	 Cellvis	
Gelloading	200	µL	tips		 B71932		 Bioplastics	
MicroSeal	B	Seal	Hard-Shell	
PCR	Plate	96-well,	thin-wall	
HSP9601	 Bio-Rad	Laboratories	
Nitrocellulose	membranes	
HybondTM-C	Extra		
RPN203E		 GE	Healthcare	
ParafilmTM		 1447011		 Labomedic	
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Pasteur	pipettes,	glass			 447016	 Labomedic	
Precellys	Bulk	beads	for	500pp	
Zirconium	oxie	beads	
KT03961-1-103.BK	 PEQLAB	Biotechnologie	
SNAP	i.d.®	2.0	MultiBlot	
Holders	(4.5	x	8.4	cm)	
SNAP2BHMB-K	 Merck	
Sponge	Pad	for	Blotting		 EI9052	 Thermo	Fisher	Scientific	
Stripette®	serological	pipettes		 4486	–	4490		 Corning	
TC-Platte	24-well	Standard,	F	 83.3922.005	 Sarstedt	
Tip,	Gelloading		 B71932		 Bioplastics	BV	
Whatman	paper		 GB005		 Biometra	
Yellow	200	µL	tips		 760.002		 Sarstedt	
2.15 Sterilization	method	
All	heat-stable	solutions	and	materials	were	autoclaved	at	121	°C	and	1.2	bar	for	21	min	with	the	
Varioklav®.	All	other	solutions	were	sterilized	with	a	membrane	filter	of	0.2	µm	pore	size.	
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2.16 Laboratory	instruments	and	equipment	
Table	19.	Laboratory	instruments	and	equipment	
Instruments/	Equipment	 Product	number	 Company	
Apotome.2	microscope	 -	 Zeiss	
Apochromat	63x/1.4	objective	 -	 Zeiss	
Autoclave	Varioklav®	 -	 H+P	Labortechnik	
Axiocam	503	mono	 -	 Zeiss	
Balances	TE64	(precision	
balance)	TE6101		
BL310		 Satorius	
Biofuge	pico	 -	 Hereaus	by	Thermo	Fisher	
Scientific	
Biofuge	primo	 -	 Hereaus	by	Thermo	Fisher	
Scientific	
Camera	CoolSNAP	HQ2		 DFC	360	FX	 Photometrics	Leica	
CFX96TM	Real-Time	System	 185-5196	 Bio-Rad	Laboratories	
Counting	chamber		 Neubauer	 Labomedic	
Detection	System	DeVision	
DBOX	Detection	System		
-	 Decon	
Digital	Sight	DS-U3	 -	 Nikon	
Dual-Stage	Class	Micropipette	
Puller	
PC-10	 Narishige	
EnSightTM	 HH34000000	 Perkin	Elmer	
Epic	System	Reader	 -	 Corning	
Eppendorf	
BioPhotometer®D30	
6133000001	 Eppendorf	AG	
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Eppendorf	µCuvette®	G1.0	 6138000018	 Eppendorf	AG	
Eppendorf	Multipipette	M4	 4982000012	 Eppendorf	AG	
Eppendorf	ThermoMixer®		 5436	 Eppendorf	AG	
Fluorescence	microscope	DM	
IL	LED	Fluo		
-	 Leica	
Freezer	(-80	°C)		 -	 Heraeus	
Freezer	(liquid	nitrogen)	 MVE	815P-190	 Chart	BioMedical	Ltd	
Geldoc	2000	 -	 Bio-Rad	Laboratories	
CO2	incubator	(cell	culture)		 HERAcell®	240	 Heraeus	
Incubator	IN	 ASTM304	 Memmert	
Assab	CO2-Inkubator	 T303	 Medicin	AB	
Innova	4000	Incubator		 8261-30-1007	 New	Brunswick	Scientific	
InSightTM	DeepSeeTM	 -	 Spectra	Physics	
Intenslight	CHFIE	 -	 Nikon	
KL	1500	LED	Plus	 150500	 Lighting	and	Imaging	Schott	
KL	200	LED	 120200	 Lighting	and	Imaging	Schott	
KL	2500	LED	 250400	 Lighting	and	Imaging	Schott	
TriM	scope	2	 -	 LaVision	BioTec	
Microscope	 CKX31SF		 Olympus	
Microscope	Stemi	 Stemi	508	 Zeiss	
Model	302	RM	 -	 ConOptics	
MPPI-3	Pressure	Injector	 -	 Applied	Scientific	
Instrumentation,	Inc.	
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Nikon	AZ100	 -	 Nikon	
Nikon	Eclipse	Ni-U	 -	 Nikon	
PerfectSpin	Mini	 91-PSPIN-M	 PEQLAB	Biotechnologie	
pH	electrode		 -	 Mettler	Toledo	
Pipettes	0.5-10	μl;	10-100	μl;	
100-	1000	μl		
	 Eppendorf	
Pipetboy	acu2	 612-0926	 Integra	Bioscience	
PlateFugeTM	Microplate	
Microcentrifuge	
C2000	 Benchmark	Scientific	
Power	Pac	300	 164-5070	 	
Precellys	24	 91-PCS24	 PEQLAB	Biotechnologie	
Qubit®	2.0	Fluorometer	 Q32866	 Life	Technologies	
RMS-30V	Roller	 -	 NeoLabs	
Semi-automatic	pipettor	
CyBi®-Selma		
-	 Cybio	
SevenEasy™	pH-meter	 -	 Mettler	Toledo	
SNAP	i.d.®	2.0	Protein	
Detection	System	
SNAP2MB1	 Merck	
T100	Thermal	Cycler	 1861096	 Bio-Rad	Laboratories	
Tecan	Sunrise		 -	 r-biopharm	
UV/VIS	spectrophotometer	
SmartSpecTM	Plus		
-	 Bio-Rad	Laboratories	
Vacuum	pump	system	AP	15	
Membrane	Vacuum	Pump		
-	 HLC	BioTech	
Vacuum	pump	system	
220V/50HZ	
WP6122050	 Merck	
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Vortex	Mixer	 F202A0173	 Velp	Scientifica	
Water	purification	A	Milli-Q	
Water	System		
-	 Merck	Millipore	
XCell	SureLock®	Mini-Cell	and	
XCell	II™	Blot	Module		
EI0002	 Thermo	Fisher	Scientific	
X-Cite	SERIES		 120Q	 Excelitas	Technologies	
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2.17 Software	
Table	20.	Software	
Software	 Company	
Application	Suite	3.3.1		 Leica	
CFX	Manager	 Bio-Rad	Laboratories	
ChemDraw		 PerkinElmer	
ImageJ	 NIH	
ImSpector	 LaVision	
MikroWin2000		 Berthold	Technologies	GmbH	&	Co.	KG	
NIS-Elements	Viewer	4.20		 Nikon	Instruments	Europe	B.V.	
Gel-Pro	Analyzer		 Media	Cybernetics,	L.P	
Gelscan	software	V6.0		 Bioscitec	
GraphPad	Prism6		 GraphPad	Software	
Microsoft	Exel	2010		 Microsoft®	Corporation	
Microsoft	PowerPoint	2010		 Microsoft®	Corporation	
Microsoft	Word	2010		 Microsoft®	Corporation	
Serial	Cloner	2.6	 http://serialbasics.free.fr/Serial_Cloner.html	
XFluor4		 Microsoft®	Corporation/Tecan	sunrise	
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3 Methods	
3.1 Cell	biological	methods	
Human	embryonic	kidney	cells	(HEK293)	were	cultivated	at	37	°C	in	a	5	%	CO2	and	96	%	humidity	
air	atmosphere	until	they	were	ready	to	be	subcultured.	Zebrafish	PAC2	fibroblast	cells	were	kept	
in	 room	 atmosphere	 at	 28	 °C.	 To	 prevent	 contamination,	 all	 cell	 culture	 procedures	 were	
performed	under	 sterile	 conditions	by	using	 laminar	airflow	cabinets.	All	 solutions,	buffers	and	
media	were	pre-warmed	to	the	appropriate	culturing	temperatures	before	use.		
3.1.1 Passaging	cell	lines	
3.1.1.1 HEK293	cells	
The	 immortalized	 cell	 line	 was	 passaged	 two	 times	 a	 week	 and	 used	 for	 experiments	 until	
passage	70-80	was	 achieved.	Under	 laminar	 air	 flow	 conditions,	HEK293	 cell	medium	 (Table	2)	
was	removed	and	cells	were	rinsed	once	with	5	mL	PBS.	Subsequently,	2	mL	of	0.05	%	Trypsin-
EDTA	were	added	and	flasks	were	incubated	for	1-5	min	at	37	°C	until	complete	detachment	of	
the	cells	was	achieved.	By	adding	8	mL	of	HEK293	cell	medium	trypsination	was	stopped	and	cell	
solution	was	thoroughly	resuspended	to	disperse	clumps.	Cells	were	splitted	1:10	in	a	75	cm2	cell	
culture	flask	and	supplied	with	14	mL	of	fresh	cell	medium.		
3.1.1.2 PAC2	fibroblast	cells	
PAC2	 fibroblast	 cells	 proliferate	 rather	 slowly.	 Hence,	 they	were	 passaged	 every	 10	 days	 after	
reaching	100	%	confluency.	Cells	were	washed	once	a	week	with	15	mL	PBS	and	provided	with	
new	 L15	 medium	 (Table	 3).	 For	 passaging,	 cell	 medium	 was	 removed	 and	 cells	 were	 washed	
twice	with	10	mL	of	PBS	to	remove	trypsin	inhibitors	of	the	serum.	2	mL	of	0.05	%	Trypsin-EDTA	
was	added	and	cells	were	incubated	for	10-15	min	at	28	°C.	As	soon	as	cells	were	fully	detached,	
8	mL	PAC2	medium	was	added.	Cells	were	splitted	1:2	and	supplemented	with	fresh	medium	to	a	
total	volume	of	20	mL.	
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3.1.2 Cryopreservation	and	thawing	of	cells	
3.1.2.1 HEK293	cells	
To	avoid	aging,	mammalian	cells	were	cryopreserved	and	stored	in	liquid	nitrogen	vapour	phase	
at	-	196	°C.	For	this	purpose,	cells	were	trypsinized	as	described	(see	3.1.1.1)	and	subsequently	
centrifuged	at	800	g	for	4	min.	After	removing	the	supernatant,	the	pellet	was	resuspended	in	1	
mL	freshly	prepared	freezing	medium	(=	growth	medium	containing	20	%	FCS,	10	%	DMSO)	and	
transferred	 into	cryogenic	vials.	To	achieve	a	freezing	rate	of	 -	1	°C/min,	vials	placed	 in	a	warm	
styrofoam	box	were	frozen	at	-	80	°C	and	the	day	after	transferred	into	the	liquid	nitrogen	tank	
for	long-time	conservation.		
For	insuring	the	highest	level	of	viability	after	long-time	storage,	cells	were	quickly	thawed	at	37	
°C	in	the	water	bath	and	supplied	with	10	mL	pre-warmed	medium.	After	centrifugation	at	800	g	
for	 4	 min,	 supernatant	 was	 discarded	 and	 cells	 were	 gently	 resuspended	 in	 the	 respective	
HEK293	cell	medium	without	antibiotic.	After	24	h	medium	was	exchanged	to	standard	HEK293	
cell	medium.		
3.1.2.2 PAC2	fibroblast	cells	
Cryopreservation	 and	 thawing	 was	 conducted	 as	 described	 in	 3.1.2.1,	 however	 distinct	 media	
were	used.	The	L15	freezing	medium	for	PAC2	fibroblasts	was	L15	medium	containing	30	%	FBS	
and	10	%	DMSO.	For	thawing	growth	medium	with	antibiotic	was	used.	Additionally,	cells	were	
washed	24	h	after	revitalization	with	10	mL	PBS	and	then	passaged	as	described	in	3.1.1.2.	
3.1.3 Cell	counting	
Cell	 counting	 was	 conducted	 with	 Neubauer	 counting	 chamber	 that	 contained	 two	 counting	
areas.	Before	loading	10	µL	of	cell	suspension,	a	glass	cover	was	placed	over	the	central	area	of	
the	chamber.	Using	a	microscope,	cells	were	counted	in	four	of	nine	squares	without	taken	those	
into	 account	 that	 touched	 the	 upper	 and	 the	 left	 limits.	 Cell	 number	 was	 averaged	 and	 cell	
density	calculated	with	following	formula:	cell	density	[cells/mL]	=	counted	cells	x	dilution	factor	x	
104.	
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3.1.4 Transient	transfection	of	recombinant	cells	with	FuGENE	HD®	
Transient	 transfection	 is	 a	 temporary	 non-viral	 delivery	 of	 genetic	 material	 into	 cultured	
eukaryotic	cells.	
The	 non-liposomal	 transfection	with	 FuGENE®	 HD	was	 conducted	 according	 to	manufacturer’s	
instructions.	One	day	before	 transfection,	5	 x	106	 cells	were	plated	on	6	 cm	cell	 culture	dishes	
such	that	they	reached	a	confluency	of	50	%	at	the	day	of	transfection.	For	medium-DNA-FuGENE	
complex	formation,	19	µL	of	FuGENE®	HD	reagent	were	gently	added	to	6	µg	of	DNA	in	500	µL	of	
pre-warmed	Opti-MEM	and	mixed	by	brief	pipetting.	After	5	min	 incubation	at	RT,	 transfection	
mixture	was	pipetted	in	drops	onto	the	cells	in	the	dish.	Cell-based	assays	were	performed	48	h	
after	transfection.	
3.1.5 Coating	cell	culture	dishes	and	plates	
For	ELISA	and	ICC	experiments,	culture	plates	and	coverslips	were	coated	with	poly-D-lysine	(PDL)	
for	 achieving	 sufficient	 attachment	 and	 effective	 growth	 of	 cells.	 Cell	 culture	 surfaces	 were	
covered	with	 0.1	mg/mL	 PDL	 solution	 and	 incubated	 for	 1	 h	 in	 a	 37	 °C	 incubator.	 The	 coating	
solution	was	 aspirated	 and	 surfaces	were	washed	 three	 times	with	 sterilized	 PBS.	 After	 drying	
under	UV	light,	plates	were	stored	at	4	°C	until	needed.	
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3.2 Cell	based	assays	
3.2.1 Dynamic	mass	redistribution	assay		
Dynamic	mass	redistribution	(DMR)	is	a	pathway-unbiased	and	label-free	technology	to	examine	
receptor	 functionality	 in	 living	 cells	 in	 real-time.	 Upon	 application	 of	 stimuli,	 a	 holistic	 cell	
response	 emerging	 as	 a	movement	 of	 biomass	 (mass	 redistribution)	 is	 captured	 by	 a	 resonant	
waveguide	grating	(RWG)	biosensor	(Fang	et	al.,	2007).	Distinct	events	 including	 ligand	binding,	
receptor	activation,	internalization	or	recycling	as	well	as	protein	recruitment	can	be	recorded	by	
this	method.	 The	 readout	 is	 based	on	 changes	of	 the	wavelength	of	 polarized	broadband	 light	
reflected	by	the	biosensor	depending	the	optical	density	of	the	cell	layer	within	150	nm	from	the	
plate	 bottom.	 The	 shifts	 in	 wavelength	 (Δpm)	 are	 recorded	 over	 time	 relative	 to	 the	 baseline	
value.	An	accumulation	of	mass	causes	positive	DMR	responses	(reflection	of	longer	wavelength),	
while	 reduction	of	mass	 leads	 to	negative	shifts	 (reflection	of	shorter	wavelength)	 (Schröder	et	
al.,	2011).	
3.2.1.1 Experimental	procedure		
The	day	prior	to	the	assay,	transiently	transfected	cells	were	seeded	with	a	density	of	21	kc/well	
in	a	fibronectin-coated	384-well	Epic®	biosensor	microplate.	The	plate	was	centrifuged	at	800	g	
for	10	s	and	incubated	at	37	°C	and	5	%	CO2	for	24	h.	The	next	day,	cells	were	washed	twice	with	
HBSS	containing	20	mM	HEPES	(Solution	1)	and	0.4	%	DMSO	to	match	exactly	with	respect	to	the	
DMSO	 content	 of	 compound	 dilutions.	 Buffer	 was	 aspirated	 by	 using	 a	 manifold	 and	 a	 final	
volume	of	30	µL	was	added	to	each	well.	The	microplate	was	equilibrated	1	h	at	37	°C	onto	the	
DMR	reader.	In	the	meantime	a	serial	dilution	of	the	compound	was	produced	and	transferred	in	
a	 384-well	 compound	 plate.	 With	 respect	 to	 the	 compound	 dilution	 during	 addition	 to	 the	
biosensor	plate,	compounds	were	prepared	4-fold	concentrated.	The	compound	plate	was	kept	
for	30	min	at	37	°C	in	the	incubator	of	the	semi-automatic	pipetting	system	CyBi®	Selma.	Before	
starting	 the	measurement,	 the	 cell	 plate	was	 aligned	 to	 the	 camera	by	using	 the	Epic®	Aligner	
tool.	A	baseline	 signature	was	 recorded	 for	5	min	and	subsequently	 compound	solutions	of	10	
µL/well	were	transferred	with	CyBi®	Selma	into	the	plate.	Optical	changes	were	measured	in	real-
time	for	at	least	4800	s.		
DMR	measurements	of	PAC2	fibroblast	cells	were	conducted	at	28	°C,	hence	the	compound	plate	
was	kept	at	28	°C	equally.	
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3.2.1.2 Data	evaluation	
Once	the	measurement	was	finished,	data	were	transformed	with	the	Transform	table	to	column	
macro	 and	 finally	 analysed	 with	 GraphPad	 Prism®.	 All	 DMR	 data	 were	 buffer-corrected	 and	
concentration-effect	 curves	 were	 calculated	 based	 on	 maximal	 response	 until	 1800	 s.	
Representative	 optical	 traces	 were	 illustrated	 as	 mean	 values	 (+	 SEM),	 while	 resulting	
concentration-effect	curves	were	shown	as	mean	values	(±	SEM).	
3.2.2 Enzyme-linked	immunosorbent	assay		
In	this	thesis	Enzyme-linked	immunosorbent	assay	(ELISA)	was	used	to	quantify	the	amount	of	N-
terminally	 3HA-tagged	 GPR17	 receptors	 on	 the	 cell	 surface.	 The	measurement	 is	 based	 on	 an	
indirect	detection	strategy,	where	an	antigen	targeted	by	a	primary	antibody	is	detected	with	an	
HRP-conjugated	secondary	antibody.	
3.2.2.1 Experimental	procedure	
24	 h	 after	 transfection,	 HEK293	 cells	 were	 detached	 and	 seeded	 into	 PDL-coated	 96-well	
microtiter	plates	at	a	density	of	50	kc/well.	Cells	were	cultivated	overnight	at	37	°C	under	5	%	CO2	
conditions.	On	the	day	of	the	assay	(48	h	after	transfection),	cell	medium	was	quickly	aspirated	
and	cells	were	 fixed	with	4	%	paraformaldehyde	 (100	µL/well)	 for	20	min	at	RT.	After	 fixation,	
cells	were	washed	three	times	for	5	min	with	200	µL	PBS	at	RT	and	blocked	with	blocking	buffer	
containing	3	%	dry	milk	(Solution	2)	for	60	min	at	37	°C.	Blocking	buffer	was	removed	and	75	µL	
of	first	antibody	(mouse	anti-HA,	2.4.1)	diluted	1:400	in	blocking	buffer	were	added	to	the	wells.	
Following	incubation	for	1	h	at	37	°C,	cells	were	washed	three	times	with	200	µL	PBS	for	15	min	
at	37	°C.	Subsequently,	75	µL	HRP-conjugated	goat	anti-mouse	(Sigma,	2.4.2)	diluted	1:1000	were	
added	and	cells	were	kept	for	1	h	at	37	°C.	After	three	washes,	secondary	antibody	was	detected	
by	 adding	 100	 μL/well	 of	 the	 colorimetric	 horseradish	 peroxidase	 substrate	 3,3ʹ,5,5ʹ-
tetramethylbenzidine	 (TMB).	 After	 3-5	min,	 reaction	was	 terminated	with	 50	 µL/well	 of	 0.5	M	
H2SO4.	 130	 µL	 supernatant	 were	 transferred	 into	 a	 new	 96-well	 plate	 with	 clear	 bottom	 and	
colorimetric	readings	were	obtained	using	Tecan	Sunrise	reader	at	450	nm.	
3.2.2.2 Data	determination	
The	 resulting	 sample	 data	 were	 subtracted	 by	 the	 value	 of	 the	 empty	 vector	 control	 and	
normalized	in	GraphPad	Prism®.	Quantified	results	were	shown	as	mean	values	(+	SEM).		
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3.2.3 Immunocytochemistry	assay		
Immunocytochemistry	 (ICC)	 is	 a	 fluorescent	 dye-based	 laboratory	 technique	 that	 uses	 specific	
antibodies	 to	 visualize	 the	 localization	 of	 proteins	 in	 cells.	 In	 this	 case,	 a	 primary	 antibody	
targeted	 against	 the	 N-terminal	 3HA-tag	 of	 GPR17	 constructs	 was	 used	 in	 conjunction	 with	 a	
fluorescent-labelled	secondary	antibody.	
3.2.3.1 Experimental	procedure	
The	day	prior	 to	 the	assay,	 transiently	 transfected	HEK293	cells	were	 seeded	onto	PDL-treated	
cover-slips	lying	in	24-well-plates	at	a	density	of	80	kc/well	and	cultivated	overnight	at	37	°C	and	
5	%	CO2.	Next	day,	medium	was	removed	and	cells	were	fixed	with	4	%	paraformaldehyde	for	30	
min	at	RT.	After	three	washing	steps	with	500	µL	PBS	for	15	min	at	37	°C,	cells	were	 incubated	
with	300	µL	blocking	buffer	 (Solution	3)	per	well	 for	1	h	at	37	°C.	Blocking	buffer	was	replaced	
with	250	µL	primary	antibody	(mouse	anti-HA,	2.4.1)	diluted	1:500	in	blocking	solution.	After	an	
incubation	of	1	h	at	37	°C,	extent	of	antibody	was	removed	by	three	washing	steps	with	PBS	and	
250	 µL	 secondary	 antibody	 (goat	 anti-mouse-Cy2,	 2.4.2)	 diluted	 1:500	 in	 blocking	 buffer	were	
added	to	the	wells.	Cells	were	incubated	for	1	h	at	37	°C	and	subsequently	washed	three	times	
with	PBS.	Finally,	8	µL	of	Mowiol	were	pipetted	onto	glass	object	holders	and	cover	 slips	were	
fixed	upside-down.	Samples	were	stored	at	4	°C	for	further	analysis.			
3.2.3.2 Data	determination	
Images	were	obtained	with	the	Zeiss®	Apotome.2	microscope	by	using	the	Plan-Apochromat	63x	
oil-objective	with	a	resolution	of	1.4	megapixels	and	the	Zeiss®	Axiocam	503	mono.	Pictures	were	
pseudo-colored	with	Zeiss®	ZEN	Imaging	Software.	All	experiments	were	conducted	at	least	three	
times	and	show	representative	images.	
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3.3 Methods	in	molecular	biology	
3.3.1 Preparation	of	LB	plates	
500	mL	of	Luria	Bertani	(LB)	agar	were	solved	and	cooled	down	to	50	°C	before	adding	100	µg/mL	
ampicillin.	Later,	agar	was	casted	into	petri	dishes	(30	mL/dish)	to	firm	up.	Plates	were	stored	at	4	
°C	with	agar-side	up.	
3.3.2 Heat	shock	transformation	
Transformation	 is	 a	 non-viral	 process	 by	which	 external	DNA	molecules	 are	 introduced	 in	 host	
cells,	 in	this	case,	E.coli	XL1Blue.	To	this	end,	chemically	competent	bacteria	were	thawed	for	5	
min	on	ice.	50	ng	of	plasmid	DNA	were	added,	mixed	carefully	and	left	to	incubate	for	30	min	on	
ice.	Subsequently,	bacteria	were	heat	shocked	at	42	°C	for	90	s	and	immediately	stored	for	2	min	
on	ice.	850	µL	of	LB	medium	were	added	and	solution	was	cultured	under	vigorous	shaking	(220	
rpm)	 for	 45	min	 at	 37	 °C.	 Following	 centrifugation	 at	 13,000	 rpm	 for	 1	min,	 supernatant	 was	
discarded	leaving	200	µL	in	the	eppendorf	vial.	Bacteria	were	resuspended	and	plated	onto	pre-
warmed	 LB	 plates	 containing	 100	µg/mL	 ampicillin.	 Plates	were	 incubated	 at	 37	 °C	 and	 clones	
were	picked	after	24	h.	
3.3.3 Cryopreservation	of	bacterial	strains	
For	 long-time	 storage	 of	 transformed	 bacterial	 strains,	 cells	 were	 cryopreserved	 as	 glycerol	
stocks.	For	that,	200	µL	glycerine	were	added	to	800	µL	bacterial	suspension	and	stored	at	-	80	
°C.		
3.3.4 Preparative	isolation	of	plasmid	DNA		
Preparative	 isolation	 of	 plasmid	 DNA	 such	 as	 necessary	 for	 transfection	 experiments	 was	
conducted	by	using	NucleoBond®	Xtra	Maxi	Kit.	 To	 this	end,	20	µL	of	 thawed	glycerine	 culture	
were	pipetted	in	300	mL	of	LB	medium	containing	the	respective	antibiotic	and	cultivated	under	
vigorous	 shaking	 (220	 rpm)	 overnight	 at	 37	 °C.	 Plasmid	 isolation	 was	 processed	 according	 to	
manufacturer’s	instructions.	
Methods	
	50	
3.3.5 Determination	of	nucleic	acid	concentration	by	photometrical	method	
DNA	concentrations	(ng/µL)	were	determined	with	Eppendorf	BioPhotometer®	D30	at	260	nm.	3	
µL	 of	 DNA	 sample	were	 analyzed	with	 the	 Eppendorf	 µCuvette®	G1.0.	 The	 purity	 of	 DNA	was	
estimated	by	validation	of	the	A260/A280	(should	be	1.8-2)	and	A260/A230	(should	be	≥	2)	ratio.	
3.3.6 Analysis	of	protein	expression	by	Western	blot	
3.3.6.1 Preparation	of	lysates	
In	order	to	analyse	protein	expression	in	HEK293	cells	by	Western	blot	analysis,	cell	lysates	were	
prepared.	 Cells	 were	 seeded	 and	 transfected	 like	 described	 in	 3.1.4.	 48	 h	 after	 transfection,	
medium	was	removed	and	cells	were	washed	twice	with	ice-cold	PBS.	Subsequently,	lysis	buffer	
(Solution	4)	containing	10	µL/mL	protease	inhibitors	was	added	and	lysed	cells	were	rotated	for	
20	min	at	4	°C.	Finally,	lysates	were	centrifuged	at	15,000	g	for	10	min	at	4	°C	and	supernatants	
were	frozen	at	-	20	°C.	
3.3.6.2 Determination	of	the	protein	content	of	lysates	
Protein	 concentration	 was	 determined	 by	 PierceTM
	
BCA	 Protein	 Assay	 Kit	 according	 to	 the	
manufacturer`s	 recommendations.	 The	 detection	 is	 based	 on	 reduction	 of	 Cu2+	 to	 Cu1+	 in	 an	
alkaline	 medium	 followed	 by	 a	 chelation	 of	 two	 bicinchoninic	 acid	 (BCA)	 molecules	 with	 one	
cuprous	ion.	The	incurred	chelate	complex	exhibits	a	strong	linear	absorbance	at	562	nm	within	
increasing	concentrations	of	proteins.	In	brief,	10	µL	of	each	sample	were	diluted	1:5	with	0.1	M	
NaOH	and	a	standard	dilution	series	of	bovine	serum	albumin	(0	µg/µL	-	10	µg/µL)	was	prepared.	
200	 µL	 of	 fresh	 protein	 detection	 reagent	 were	 added	 to	 each	 sample	 and	 mixtures	 were	
incubated	 for	 30	 min	 at	 37	 °C.	 Finally,	 absorption	 was	 measured	 at	 560	 nm	 using	 the	 Tecan	
Sunrise	reader.	Protein	concentrations	were	computed	based	on	the	BSA	standard	curve.	
3.3.6.3 SDS-Polyacrylamide-Gel-Electrophoresis	(SDS-PAGE)	
After	 determination	 of	 protein	 amount,	 NuPage®	 Sample	 Reducing	 Agent	 (10x)	 and	 NuPage®	
Sample	Buffer	(2-4x)	were	added	to	15	µg	cell	lysate.	Proteins	were	separated	by	their	mass	at	60	
V	for	3	h	in	10	%	NuPage®	Bis-Tris	Protein	Gels.	Gels	were	fixed	in	a	chamber	with	running	buffer,	
while	 the	 inner	 part	 of	 the	 chamber	 was	 subjoined	 with	 500	 µL	 NuPage	 Antioxidant.	 5	 µL	
Kaleidoscope	marker	and	2.5	µl	Magic	marker	were	used	as	molecular	weight	standards.		
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3.3.6.4 Western	blot	analysis	
Following	separation,	protein	transfer	procedure	was	conducted	at	25	V	 for	2	h	by	using	a	wet	
blotting	 module.	 Briefly,	 a	 sandwich	 of	 successive	 layers	 of	 prewetted	 sponges,	 filter	 papers,	
protein	gel	and	nitrocellulose	membrane	was	prepared	and	 fixed	 in	 the	blotting	chamber	 filled	
with	NuPage®	Transfer	Buffer	including	20	%	of	methanol.	
3.3.6.5 Protein	detection	
After	blotting,	membranes	were	rinsed	twice	with	washing	buffer	(Solution	5)	and	blocked	with	
Roti-Block®	in	50	mL	tubes,	rotating	for	1	h	at	RT.	First	antibody,	diluted	in	blocking	solution,	was	
added	and	 incubated	at	4	 °C	overnight.	Next	morning,	 the	extent	of	antibody	was	 removed	by	
three	washing	steps,	each	5	min	at	RT.	Membranes	were	 incubated	for	1	h	with	the	respective	
horseradish	 peroxidase-conjugated	 secondary	 antibody	 and	 washed	 again	 three	 times	 with	
washing	 buffer.	 Finally,	 proteins	 were	 detected	 by	 chemiluminescence	 using	 Amersham	 ECL	
Prime	Western	Blotting	Detection	Reagent	according	to	the	manufacturer’s	recommendations.			
3.3.6.6 Data	determination	
Quantification	was	achieved	by	 scanning	 the	blot	with	an	 imager	and	densitometric	analysis	of	
bands	using	Gel	scan	software.	To	account	for	possible	loading	as	well	as	transfer	errors,	samples	
were	 normalized	 to	 β-actin	 acting	 as	 an	 internal	 loading	 control.	 All	 data	 are	 shown	 as	means	
(+SEM).	
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3.4 Zebrafish	maintenance	and	rearing	conditions	
Zebrafish	 lines	 were	maintained	 at	 28	 °C	 in	 the	 Zebrafish	 facility	 of	 the	 Institute	 of	 Anatomy,	
University	of	Bonn	according	to	previously	described	standard	protocols	(Westerfield,	2007).		
Embryos	were	collected	from	mating	pairs	and	reared	at	28.5	°C	in	30	%	Danieau	egg	water	(17.4	
mM	 NaCl,	 0.21	 mM	 KCl,	 0.12	 mM	MgSO4,	 0.18	 mM	 CaCl2,	 1.5	 mM	 HEPES)	 containing	 10-5	 %	
methylene	blue	for	the	first	24	h.	To	inhibit	pigmentation	of	embryos	older	than	1	dpf,	egg	water	
was	 supplemented	 with	 0.003	 %	 phenylthiourea	 (PTU).	 Embryos	 were	 staged	 to	 hours	 post	
fertilization	(hpf)	or	days	post	 fertilization	(dpf).	All	experiments	were	conducted	 in	compliance	
with	the	Belgium	and	European	laws	(Ethical	commission	protocols	ULg1076	and	ULg624).	
3.5 Microinjections	of	zebrafish	embryos	
3.5.1 Morpholino	injections	
The	 antisense	 zfAgpr17	 morpholino	 (MO)	 5’GTTCTHTCAAGGAGGACTCCATTT3’	 and	 a	 control	
morpholino	 5’	 CCTCTTACCTCAGTTACAATTTATA3’	 were	 purchased	 as	 lyophilized	 stocks	 from	
Gene	 Tools,	 LLC,	 and	 solved	 in	 sterile	 DEPC	 water	 to	 a	 stock	 concentrations	 of	 2	 mM.	 For	
injections	a	20	µL	master	mix	containing	0.25	mM	MO,	5	%	cutsmart	buffer	10x	and	10	%	phenol	
red	were	heated	for	10	min	to	65	°C	and	filled	in	a	pulled	class	capillary	micropipette	opened	with	
forceps.	The	injection	volume	was	calibrated	by	adjusting	the	diameter	of	droplets	spreading	in	
mineral	oil	to	135	µm	on	micrometer	slides.	This	spawned	a	droplet	of	1.3	nL	containing	2.75	ng	
zfAgpr17	 MO.	 Once	 the	 parameters	 were	 adjusted,	 embryos	 at	 one-	 or	 two-cell	 stage	 were	
placed	in	an	injection	mold	and	injected	into	the	yolk.	
The	 amount	 of	 injected	 MO	 was	 calibrated	 by	 the	 master	 student	 Philip	 Reinoß.	 For	 further	
information	refer	to	the	master	thesis	‘Functional	analysis	of	the	transmembrane	receptor	Gpr17	
in	CNS	myelination	in	zebrafish’	(Reinoß,	2014).	
	 	
	Methods	
	 53	
𝑉!"#$%&!!" =  43  × 𝜋 ×  135 µ𝑚2 ! = 12288249 µ𝑚!	1 µ𝑚!  =  1 × 10!! µ𝐿	
12288249 µ𝑚! × 1 10!! µ𝐿µ𝑚! = 0,0013 µ𝐿 =  1,3 𝑛𝐿	
𝑛 =  𝑐 × 𝑉 =  0,25 × 10!!  𝑚𝑜𝑙𝐿 × 1,3 × 10!! 𝐿 = 3,25 ×10!!" 𝑚𝑜𝑙	
𝑚 = 𝑛 × 𝑀 =  3,25 × 10!!" 𝑚𝑜𝑙 𝑥 8465 𝑔𝑚𝑜𝑙 =  2,1 × 10!! 𝑔 =  2,75 𝑛𝑔	
Figure	4:	Calculation	of	injected	amount	of	morpholino.	
3.5.2 RNA	injections		
3.5.2.1 RNA	synthesis	
For	the	in	vitro	synthesis	of	zfA	and	zfBgpr17	as	well	as	tdTomato	RNA	the	mMessage	Maschine	
Kit	T7	Ultra	Kit®	was	used.	Therefore,	plasmids	of	3HA-tagged	Gpr17	constructs	(Table	16)	were	
linearized	 with	 XhoI	 and	 transcribed	 as	 mentioned	 in	 the	 protocol.	 Linearization	 of	 control	
tdTomato	 plasmid	 was	 conducted	 with	 MfeI.	 Finally,	 RNA	 was	 obtained	 by	 lithium	 chloride	
precipitation,	quantified	with	the	Qubit	RNA	HA	Assay	Kit®	and	frozen	as	aliquots	at	-	80	°C.	
3.5.2.2 Overexpression	
RNA	injections	were	performed	 like	described	 in	chapter	3.5.1.	2.2	µg	of	zfA	and	zfBgpr17	RNA	
were	diluted	with	1	µL	phenol	red	and	RNase-free	water	to	5	µL.	Finally	1.8	nL	(refers	to	150	µm	
droplets	diameter)	containing	800	pg	RNA	were	injected	into	the	yolk	of	embryos	at	the	one-	cell	
stage.	 As	 a	 control	 for	 the	 successful	 in	 vivo	 transcription	 tdTomato	 RNA	 was	 generated	 and	
injected	equally.		
3.5.2.3 Rescue	experiment	
For	the	rescue	experiment	3	µg	RNA	were	mixed	with	2.5	µL	pre-heated	MO	stock	solution	(0.5	
mM)	and	adjusted	with	RNase-free	water	to	5	µL.	Finally	1.3	nL	(refers	to	a	droplets	diameter	of	
135	µm)	containing	800	pg	RNA	and	2.75	ng	zfAgpr17	MO	were	injected	into	embryos	at	the	one-
cell	stage.	
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3.6 Drug	treatment	of	zebrafish	
3.6.1 Bathing	in	MDL29,951	
Before	 treatment	was	 applied,	 1	 dpf	 embryos	were	 enzymatically	 removed	 from	 their	 chorion	
with	 2	mg/mL	pronase	 in	 30	%	Danieau.	 10	mM	MDL29,951/DMSO	 stock	 solution	was	 diluted	
with	30	mL	30	%	Danieau	containing	0.003	%	PTU	to	10	and	30	µM	working	solution.	0.1	%	and	
0.3	%	DMSO	were	used	as	controls.	Larvae	were	exposed	to	the	compound	for	5	days	in	a	light	
cycle	 incubator	 at	 28.5	 °C.	 The	 treatment	 solution	was	 renewed	 every	 24	 h.	 Therefore	 1.5	mL	
solution	with	all	embryos	were	transferred	 in	an	Eppendorf	 tube	and	28.5	mL	of	 fresh	Danieau	
solution	 containing	 MDL29,951	 were	 poured	 in	 a	 new	 petri	 dish.	 Finally	 1.5	 mL	 of	 zebrafish	
embryos	 were	 added	 to	 the	 renewed	 drug	 solution.	 At	 5	 dpf	 zebrafish	 were	 imaged	 like	
described	in	chapter	3.7.1	or	collected	for	qPCR	and	Western	blot	analysis.	
3.6.2 TSA	treatment	
Treatment	 with	 Trichostatin	 A	 (TSA)	 was	 carried	 out	 as	 described	 in	 3.6.1.	 Zebrafish	 were	
exposed	to	100	ng/mL	TSA	for	5	days	analysed	by	WISH	as	described	in	chapter	3.7.3.4.		
3.7 Zebrafish	based	methods	
3.7.1 Two-photon	imaging	
Two-photon	 imaging	experiments	were	conducted	by	using	the	scan	head	based	 laser-scanning	
microscope	TriMScope	 (LaVision,	BioTec,	Bielefeld,	Germany).	 Spinal	 cord	 segments	4–10	were	
imaged	with	a	20x	water-immersion	objective	lens	(NA	1.0,	W	Plan-Apochromat,	Zeiss®)	directing	
the	 laser	beam	 (930	nm)	of	a	near-infrared	 laser	 (InSightTM	DeeepSeeTM,	Spectra-Physics,	 Santa	
Clara,	USA)	into	the	sample.	Images	were	acquired	as	z-stacks	(z-step	2	µm)	with	a	field	of	view	of	
449	µm	x	111	µm	and	a	resolution	of	2730	x	678	pixel	(1	pixel	was	0.16	µm).		
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3.7.1.1 Mounting	of	zebrafish	
To	inhibit	pigmentation	interfering	with	the	imaging	process,	embryos	were	maintained	after	24	
h	 in	30	%	Danieau	containing	0.003	%	PTU.	For	exempting	zebrafish	 larvae	from	their	chorions,	
embryos	were	 incubated	with	2	mg/mL	pronase	 in	30	%	Danieau	 for	5-10	min	at	28	 °C.	Larvae	
were	 mounted	 laterally	 in	 1.25	 %	 low	 melting	 agarose	 containing	 5	 %	 MS222	 for	 preventing	
movement	during	the	imaging	procedure.	
3.7.1.2 Analysis	
Analysis	 of	 the	 images	was	 performed	 blindly	 by	 using	 Image	 J®.	 Cells	 were	 counted	 in	 single	
stacks	 and	 numbers	 were	 transferred	 to	 GraphPad	 Prism®.	 For	 all	 experiments	 D’Agostino-
Pearson	 omnibus	 normality	 test	was	 used	 to	 check	 the	 distribution	 of	 the	 values.	 In	 case	 of	 a	
Gaussian	distribution,	one-way	ANOVA	(parametric)	was	applied	for	statistical	analysis.	When	the	
assumption	of	normality	was	not	met,	the	non-parametric	Kruskal-Wallis	test	was	conducted.		
3.7.2 EnSightTM	imaging	
The	EnSightTM	 is	a	 label-free,	well	 imaging	multimode	reader	that	was	used	for	high-throughput	
imaging	and	analysis	of	fluorescent	zebrafish.	The	master	student	Enrico	Mingardo	established	a	
protocol	as	an	alternative	 for	 the	 time	consuming	 screening	with	Two-photon	microscopy.	The	
fluorescent	excitation	measurements	were	performed	at	465	nm	with	an	exposure	time	of	50	ms.	
To	visualized	the	entire	animal,	each	well	was	imaged	as	a	stack	of	six	distinct	focus	channels	with	
a	 height	 of	 25	 µm.	 Images	 were	 analysed	 using	 a	 semi-automatic	 counting	 plugin	 installed	 in	
ImageJ®.	 For	 more	 detailed	 information	 refer	 to	 the	 master	 thesis	 of	 Enrico	 Mingardo	 titled	
‘Establishing	 a	 multi-well	 plate	 reader	 system	 for	 high-	 throughput	 imaging	 and	 analysis	 of	
fluorescent	zebrafish	larvae	to	investigate	the	central	nervous	system’	(Mingardo,	2017).		
3.7.2.1 Mounting	of	zebrafish	in	the	96-well	plate	
After	anaesthetizing	with	MS222	in	the	petri	dish,	one	zebrafish	per	well	was	transferred	to	a	96-
well	glass	bottom	plate.	The	larvae	were	mounted	laterally	with	an	injection	tip	in	the	middle	of	
the	well	and	subsequently	centrifuged	at	300	rpm	for	5	s.	
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3.7.3 Whole-mount	in	situ	hybridization	
The	Whole-mount	 in	 situ	 hybridization	 (WISH)	 protocol	 used	 in	 this	 thesis	 was	 adapted	 from	
Thisse	Lab	–	In	situ	hybridization	Protocol	–	Update	2010	(Thisse	and	Thisse,	2008).	The	principle	
is	based	on	the	complementary	hybridization	of	digoxigenin-labelled	RNA	to	the	specific	RNA	of	
interest.	 Subsequently,	 an	 alkaline	 phosphatase-conjugated	 antibody	 binds	 to	 digoxigenin	 and	
finally	converts	the	colourless	NBT/BCIP	compound	by	removing	phosphate	into	a	purple	dye.	
3.7.3.1 RNA	preparation	
For	 RNA	 transcription,	 plasmids	 including	 T7/T3/SP6	 promoters	 were	 linearized	 with	
corresponding	enzymes	(Table	21)	at	37	°C	overnight.	The	next	day,	templates	were	separated	in	
a	1	%	agarose	gel	and	extracted	from	the	gel	by	using	the	NucleoSpin	Gel	and	PCR	Clean-UP	Kit.	
Afterwards,	 probes	were	 synthesized	 as	 described	 in	 the	 protocol	 of	 the	DIG	RNA	 Labeling	 Kit	
(SP6/T7)	from	Roche.		
	
Table	21:	Probes	for	WISH	
Plasmid	 Probe	 Restriction	enzyme	 Promoter	
mbpA	in	pGEM®-T	Easy	Vektor		 antisense	
sense	
SpeI,	SacI	
BamHI,	ApaI	
T7	
SP6	
nkx2.2	in	pBlueSkriptII	SK		 antisense	 SacII,	XbaI	 T7	
	 sense	 XhoI,	KpnI-HF	 T3	
zfAGpr17	in	pBlueSkript	II	SK	 antisense	 HindII,	EcoRI	 T7	
	 sense	 XhoI,	KpnI-HF	 T3	
	
	
RNA	precipitation	was	conducted	by	adding	10	µL	3	M	natrium	acetate	and	200	µL	100	%	ethanol	
to	100	µL	sample.	After	vortexing	thoroughly,	samples	were	chilled	at	-	20	°C	at	least	for	30	min	
and	subsequently	centrifuged	with	13,000	rpm	for	30	min	at	4	 °C.	Finally,	 the	supernatant	was	
discarded	and	the	pellet	resolved	in	RNase-free	water	after	air-drying	under	the	hood.	
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3.7.3.2 Dot	blot		
To	 determine	 labelling	 efficiency	 and	 concentration	 of	 each	 probe,	 spots	 of	 different	 dilutions	
(1:10,	1:50,	1:100,	1:500,	1:1000)	were	applied	to	a	hybond	membrane.	Nucleic	acids	were	fixed	
on	the	membrane	by	baking	at	120	°C	for	30	min.	Afterwards,	membranes	were	washed	twice	for	
5	min	under	gentle	agitation	with	Dot	blot	buffer	I	(Solution	8)	and	incubated	in	Dot	blot	buffer	II	
(Solution	9)	at	RT	for	30	min.	Anti-DIG	antibody	was	diluted	1:2000	in	buffer	II	and	added	for	30	
min.	After	removing	the	excess	of	antibody	by	washing	twice	with	Dot	blot	buffer	I,	membranes	
were	incubated	for	5	min	in	Dot	blot	buffer	III	(Solution	10).	At	least,	50	µL	NBT	and	37	µL	BCIP	
were	mixed	with	10	mL	Dot	blot	buffer	III	and	added	for	5	min	to	the	membrane	until	the	spots	
were	visible.	The	intensity	of	the	different	spots	indicated	the	required	dilution	of	the	probe	for	
the	WISH.	
3.7.3.3 Larvae	preparation	
After	 24	 hpf,	 30	 %	 Danieau	 fish	 water	 should	 include	 PTU,	 since	 pigmentation	 needs	 to	 be	
prevented	 for	 WISH.	 Larvae	 younger	 than	 3	 dpf	 were	 removed	 from	 their	 chorions	 by	 using	
pronase	 enzyme	 like	 described	 in	 chapter	 3.6.1.	 In	 brief,	 larvae	 were	 fixed	 with	 4	 %	
paraformaldehyde	in	PBS	at	4	°C	overnight	and	dehydrated	the	next	day	in	a	series	of	25	%,	50	%	
and	 75	%	methanol	 in	 PBS	 for	 20	min,	 respectively.	 Finally	 the	 samples	were	 stored	 in	 100	%	
methanol	at	-	20	°C	at	least	for	2	h	before	use.		
3.7.3.4 In	situ	hybridization		
At	the	first	day,	zebrafish	samples	were	rehydrated	like	described	in	the	Thisse	protocol,	always	
for	 10	min.	 For	 permeabilization,	 zebrafish	 embryos	 were	 digested	 with	 proteinase	 K	 in	 PBST	
(final	 concentration	 of	 20	 µg/mL)	 for	 different	 periods	 of	 time	 depending	 on	 the	 age	 of	 the	
animal	(Table	22).		
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Table	22.	Incubation	times	for	permeabilization	of	zebrafish	embryos	
Age	of	zebrafish	(dpf)	 Incubation	time	with	proteinase	K	(min)	
1	 15	
2	 30	
3	 40	
4	 75	
5	 90	
Likewise,	 the	 post	 fixation	 time	 in	 paraformaldehyde	 was	 enhanced	 to	 30	 min.	 After	 pre-
hybridization	for	3	h	at	70	°C	in	hybridization	buffer	(HM)	(Solution	11),	samples	were	dosed	with	
the	digoxigenin-labelled	probe	diluted	in	HM	(1:400	for	zfAgpr17	and	mpb,	1:500	for	nkx2.2)	and	
incubated	at	70	°C	overnight.	Next	morning,	the	probe	was	washed	out	like	described	by	Thisse,	
however	 for	 20	 min	 instead	 of	 10	 min.	 Subsequently,	 three	 longer	 washing	 steps	 followed,	
including	 30	 min	 with	 0.2x	 SSC	 and	 two	 times	 30	 min	 with	 0.1x	 SSC	 at	 70	 °C.	 All	 room	
temperature	washing	steps	were	conducted	with	0.1x	SSC	diluted	in	the	described	concentration	
with	PBST.	After	blocking	 for	2-3	h	with	2	mg/mL	BSA	 /2	%	Sheep	 serum/	PBST,	 samples	were	
exposed	 to	 the	 anti-DIG	 antibody	 (1:20,000)	 at	 4	 °C	 overnight.	 Next	 morning	 embryos	 were	
washed	with	 PBST	 and	 pre-incubated	 in	 alkaline	 tris	 buffer	 (Solution	 13)	 like	 described	 in	 the	
protocol.	 Afterwards,	 alkaline	 tris	 buffer	 was	 replaced	 by	 700	 µL	 labelling	 solution	 including	
NBT/BCIP	(Solution	14).	Once	the	desired	staining	intensity	was	reached,	1	mM	EDTA	(pH	5.5)	in	
PBS	was	used	 to	 stop	 the	 labelling	 reaction.	 For	 reducing	 the	background,	3	dehydration	 steps	
with	25	%	and	two	times	with	50	%	methanol	 in	PBST	 followed.	Samples	were	kept	 for	several	
days	 in	 100	%	methanol	 at	 4	 °C	 and	 rehydrated	with	 the	 solutions	mentioned	 before.	 Finally,	
stained	embryos	were	stored	in	100	%	glycerol	prevented	from	light	at	4	°C.	
3.7.3.5 Imaging	
All	images	were	acquired	by	using	the	NIS-Elements	Viewer	4.20	on	a	Nikon	Eclipse	microscope.	
For	imaging,	embryos	were	transferred	with	a	pipette	on	an	object	slide	and	mounted	laterally	or	
dorsally	with	a	cat	whisker	fixed	tip	in	100	%	glycerol.		
	Methods	
	 59	
3.7.4 Quantitative	real	time	polymerase	chain	reaction		
The	 combination	 of	 a	 reverse	 transcription	 (RT)	 followed	 by	 a	 quantitative	 polymerase	 chain	
reaction	 (qPCR)	 is	 a	 powerful	 tool	 to	 quantify	 the	 expression	 of	 genes	 (Livak	 and	 Schmittgen,	
2001).	 In	 this	 thesis,	 gene-specific	 fluorescent	 probes	 including	 a	 reporter	 dye	 at	 the	 5’	 and	 a	
quencher	at	the	3’	were	used	for	the	quantitative	detection	of	the	amplicons.	The	probe	binding	
between	 the	 primer	 pairs	 is	 hydrolysed	 by	 the	 polymerase	 and	 due	 to	 the	 separation	 of	
fluorophore	and	quencher	a	fluorescent	signal	arises.	The	signal	increases	equally	to	the	amount	
of	generated	DNA.	
3.7.4.1 RNA	isolation	
For	qPCR	experiments	25	zebrafish	per	sample	were	collected	at	different	time	points	and	stored	
without	water	at	-	80	°C.	RNA	was	extracted	using	1	mL	of	TRIzol	Reagent	per	sample.	Solutions	
were	 transferred	 to	 Precellys	 tubes	 filled	 with	 beads	 and	 homogenized	 with	 the	 Precellys	 24	
setting	5000-1x10-005.	 Following	homogenization,	 supernatants	were	pipetted	 into	RNase-free	
tubes	and	centrifuged	at	12,000	x	g	for	10	min	at	4	°C.	Subsequently,	samples	were	incubated	for	
5	min	at	RT,	mixed	with	0.2	mL	chloroform	and	vortexed	for	15	s.	After	incubation	of	2-3	min	at	
RT	a	centrifugation	at	12,000	x	g	 for	15	min	at	4	 °C	 followed.	The	upper	aqueous	phases	were	
placed	 into	 new	 RNAse-free	 tubes	 and	 supplemented	 with	 100	 %	 isopropanol.	 After	 briefly	
vortexing,	samples	were	incubated	again	for	10	min	at	RT	and	centrifuged	again	at	12,000	x	g	for	
10	min	 at	 4	 °C.	 Supernatants	were	discarded	 and	 the	pellets	were	washed	with	 70	%	ethanol.	
Finally	the	air-dried	pellets	were	resolved	in	20	µL	RNase-free	water	and	RNA	concentration	was	
determined	with	Qubit	RNA	HA	Assay	Kit®.	Until	needed,	samples	were	stored	at	-	80	°C.	
3.7.4.2 cDNA	preparation	
Reverse	transcription	of	1	ug	RNA	was	carried	out	with	iScriptTM	cDNA	synthesis	Kit	following	the	
manufacturer’s	instructions.		
3.7.4.3 Polymerase	chain	reaction	
Primers	listed	in	Table	14	were	designed	by	using	Sigma	Oligoarchitect.	To	amplify	mbp	and	plp,	
as	 well	 as	 the	 controls	 ef1a	 and	 β-actin,	 DyNAmo	 Flash	 Probe	 qPCR	 Kit	 was	 used	 and	 qPCR	
conducted	in	the	CFX96TM	Real-Time	System.	All	reactions	had	a	volume	of	20	µL	containing	2	µL	
cDNA	mix,	0.4	µL	of	each	forward	and	reverse	primer	(25	µM),	0.2	µL	respective	probe	(25	µM),	
10	µL	Polymerase	mix	and	7	µL	DEPC	water.	The	reactions	run	under	following	conditions:	95	°C	
for	7	min,	followed	by	40	cycles	at	95	°C	for	5	s	and	60	°C	for	30	s.	
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3.7.4.4 Analysis	
Samples	were	analysed	by	using	the	relative	quantification	method	ΔΔCq-method	that	is	based	on	
the	expression	 level	of	a	target	gene	relative	to	a	reference	gene	(Livak	and	Schmittgen,	2001).	
The	calculation	uses	Cq	values,	which	represent	the	number	of	cycles	that	are	needed	to	generate	
a	constant	defined	fluorescent	level.	Cq	values	were	generated	after	importing	the	data	into	the	
CFX	Manager,	labelling	the	wells,	choosing	the	fluorophore	and	setting	the	thresholds.	Triplicates	
of	the	Cq	values	were	averaged	and	the	expression	of	the	target	genes	(Cq(TAR))	was	normalized	to	
the	 non-targeted	 reference	 gene	 expression	 (Cq(REF))	within	 the	 same	 sample	 to	 determine	 ΔCq	
(Cq(TAR)-Cq(REF)).	Afterwards	ΔCq	values	of	the	control	groups	(ΔCq(Control))	were	subtracted	from	the	
treatment	groups	(ΔCq(Treatment))	to	achieve	ΔΔCq.	Finally,	ΔΔCq	was	exponentially	transformed	to	2-
ΔΔCq.	This	calculation	assumes	amplification	efficiencies	of	the	target	and	references	genes	of	100	
%	 (E=	2).	All	 calculations	were	conducted	with	 this	assumed	efficiency	of	2.	The	 threshold	 that	
was	used	to	generate	the	Cq	values	was	manually	determined	by	analysing	different	dilutions	of	
pooled	RNA	from	1-10	dpf	old	zebrafish	and	taken	for	all	experiments.	Results	were	obtained	by	
using	D’Agostino	&	Pearson	omnibus	tests	to	check	for	equal	variances	and	normality	of	data	and	
one-way	 ANOVA	 or	 two-tailed	 Student’s	 t-test	 for	 statistical	 significance.	 All	 error	 bars	 were	
expressed	as	standard	errors	of	the	mean	(±	SEM).		
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3.7.5 Whole-mount	immunohistochemistry	
The	Whole-mount	immunohistochemistry	(IHC)	is	a	useful	technique	to	determine	the	expression	
of	protein	within	 retained	 tissues.	Genetex	–	Whole-mount	 IHC	protocol	 for	 zebrafish	embryos	
was	modified	in	spots	and	used	for	all	experiments.	
3.7.5.1 Larvae	preparation	
The	rearing	the	 larvae	was	as	described	in	3.7.3.3.	4	dpf	old	zebrafish	were	fixed	for	2	h	 in	4	%	
paraformaldehyde	at	RT	and	subsequently	washed	three	times	for	10	min	with	PBS.	Afterwards,	
dehydration	steps	(3.7.3.3)	followed	and	samples	were	stored	in	100	%	methanol	at	-	20	°C.	
3.7.5.2 	Immunohistochemistry	
Initially,	zebrafish	were	rehydrated	like	described	in	chapter	3.7.3.4	and	washed	three	times	for	5	
min	 with	 PBST.	 To	 break	methylene	 bridges	 formed	 during	 the	 fixation,	 heat-induced	 epitope	
retrieval	was	performed	with	150	mM	Tris	buffer	 (Solution	15)	 for	5	min	at	RT,	 followed	by	an	
incubation	with	 exchanged	 solution	 for	 15	min	 at	 70	 °C	 in	 the	water	 bath.	 After	 two	washing	
steps	with	 PBST	 for	 5	min,	 4	 dpf	 embryos	were	 permeabilized	with	 10	mg/mL	 proteinase	 K	 in	
PBST	for	90	min	at	RT.	Digestion	was	stopped	with	4	%	paraformaldehyde	for	20	min	at	RT.	For	
the	entire	removal	of	the	fixation	solution,	embryos	were	washed	five	times	for	5	min	with	PBST	
and	 subsequently	 blocked	with	NGS/BSA/PBTx	 blocking	 solution	 	 (Solution	 18)	 for	 4	 h	 at	 4	 °C.	
Mbp	 antibody	 (Table	 9)	 was	 diluted	 1:200	 in	 blocking	 solution	 with	 2	 %	 normal	 goat	 serum	
(Solution	19)	and	incubated	for	three	days	at	4	°C.	After	washing	five	times	with	PBTx	for	1	h	at	
RT,	AlexaFluor546	secondary	antibody	(Table	10)	diluted	1:1000	in	Solution	19	was	added	to	the	
sample.	The	incubation	was	carried	out	for	two	days	at	4	°C	protected	from	light.	For	the	removal	
of	unbound	antibody	and	the	reduction	of	background	signal,	samples	were	washed	once	again	
six	 times	 for	 15	 min	 and	 five	 times	 for	 5	 min	 with	 PBST.	 A	 post-fixation	 with	 4	 %	
paraformaldehyde	for	20	min	at	RT	followed.	Embryos	were	washed	again	five	times	for	5	min	at	
RT	and	finally	 immersed	through	a	series	of	25	%	glycerol,	50	%	glycerol,	75	%	glycerol	 in	PBST,	
for	20	min	respectively.	Protected	from	light,	samples	were	stored	at	4	°C	in	100	%	glycerol.	
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3.7.5.3 Imaging	
Images	 of	 embryos	 laterally	 mounted	 in	 100	 %	 agarose	 were	 recorded	 with	 TriMScope	
microscope	 (3.7.1)	and	a	 laser	beam	of	860	nm.	Thicknesses	of	myelin	sheaths	were	measured	
using	Image	J®	and	statistical	analysis	was	carried	out	with	GraphPad	Prism®.	All	data	are	shown	
as	means	(+	SEM).	
3.7.6 Immunohistochemistry	of	zebrafish	sections		
Immunohistochemistry	 analysis	 (IHC)	 of	 zebrafish	 spinal	 cord	 sections	 were	 conducted	 by	 Dr.	
Anna	 Sophia	 Japp	 (Institute	 of	 Neuropathology,	 Medical	 Centre,	 University	 of	 Bonn).	 3	 dpf	
zebrafish	 were	 fixed	 in	 4	 %	 formalin	 and	 stored	 at	 4	 °C.	 All	 experiments	 were	 performed	 on	
Ventana	Benchmark	XT	Immunostainer	(Roche	Ventana,	Darmstadt,	Germany)	with	the	antibody	
against	 Cleaved	 Caspase-3	 (2.4.1)	 diluted	 1:200.	Object	 slides	were	 automatically	 scanned	 and	
adapted	with	Panoramic	Viewer.		
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3.7.7 Western	blot	analysis	
3.7.7.1 Protein	sample	preparation	
To	analyze	protein	expression,	 20	 zebrafish	embryos	were	 collected	 in	 a	pre-cooled	Eppendorf	
tube.	 After	 anaesthetization	 on	 ice	 for	 5	 min	 and	 entire	 removal	 of	 water,	 zebrafish	 were	
solubilized	with	 90	 µl	 ice	 cold	 RIPA	 lysis	 buffer	 supplemented	with	 protease	 inhibitor	mix	 and	
rotated	for	30	min	at	4	°C.	Subsequently,	by	using	a	pellet	pestle	fish	tissues	were	homogenized	
until	uniform	in	consistency	and	centrifuged	at	13,000	rpm	for	30	min	at	4	°C.	The	supernatant	
was	transferred	to	another	tube	and	frozen	by	-	20	°C.	
3.7.7.2 Determination	of	protein	concentration		
Protein	 concentration	was	 analyzed	 by	 the	 Bradford	 dye	 assay	 that	 is	 based	 on	 a	 colorimetric	
change	 of	 Coomassie	 Blue	 G-250	 dye.	While	 under	 acid	 conditions	 the	 dye	 is	 protonated	 and	
shines	brown,	binding	of	protein	stabilizes	the	blue	form	that	has	an	absorption	maximum	at	595	
nm.	The	increase	of	absorbance	is	proportional	to	the	amount	of	protein	present	in	the	sample.	
Therefore,	2	µL	of	each	sample	was	diluted	with	38	µl	of	0.1	M	NaOH	and	a	standard	of	bovine	
serum	albumin	(0	µg/µl-1	µg/µl)	was	prepared.	10	µL	samples	as	duplicates	were	transferred	to	a	
96-well	flat	bottom	plate	and	diluted	with	200	µl	Bradford	reagent.	After	5	min	absorption	of	the	
blue	protein/dye	complex	was	measured	at	595	nm	with	Tecan	Sunrise	reader	and	calculation	of	
protein	concentrations	was	performed	by	BSA	standard	curve.		
3.7.7.3 SDS-Polyacrylamide-Gel-Electrophoresis		
SDS-polyacrylamide-gel-electrophoresis	 (SDS-PAGE)	 was	 conducted	 like	 described	 in	 3.3.6.3.		
However,	70	µg	 lysate	mixed	with	NuPage®	Sample	Reducing	Agent	(10x)	and	NuPage®	Sample	
Buffer	(2-4x)	were	heated	for	5	min	at	95	°C	before	loading	on	the	gel.	
3.7.7.4 Western	blot	
Western	blotting	procedure	was	carried	out	like	already	described	in	3.3.6.4.	
3.7.7.5 Protein	detection	
To	prevent	unspecific	binding,	membranes	were	blocked	in	blocking	solution	(5	%	non-fat	dried	
milk	diluted	 in	TBST	0.01	%)	by	rotating	at	4	°C	overnight.	Protein	detection	was	carried	out	by	
using	 the	 vacuum	 driven	 SNAP	 i.d.	 2.0	 Protein	 detection	 system.	 Therefore,	membranes	were	
inserted	in	a	blot	holder	placed	in	a	blot	holder	frame	and	spilled	with	30	mL	of	blocking	solution.	
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The	 vacuum	was	 applied	 until	 the	 frame	 was	 completely	 empty.	 Next,	 7	 mL	 of	 first	 antibody	
diluted	 in	 blocking	 solution	 were	 added	 to	 the	 blot	 holder	 frame	 and	 incubated	 for	 10	 min.		
Membranes	were	washed	 three	 times	with	30	mL	washing	buffer	 (TBST	0.01	%)	and	 incubated	
again	 with	 10	 mL	 of	 the	 respective	 horseradish	 peroxidase-conjugated	 secondary	 antibody	
diluted	 in	 blocking	 buffer.	 After	 three	 additional	 washing	 steps	 with	 30	 mL	 washing	 buffer,	
proteins	 were	 detected	 by	 chemiluminescence	 using	 Amersham	 ECL	 Prime	 Western	 Blotting	
Detection	Reagent	according	to	the	manufacturer’s	recommendations.	
3.7.7.6 Data	determination	
Data	were	determined	like	described	in	3.3.6.6.		
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4 Results	
4.1 Functional	analysis	of	zebrafish	Gpr17	in	HEK293	cells	
The	 first	 chapter	 will	 explore	 receptor	 functionality	 of	 zebrafish	 Gpr17	 in	mammalian	 HEK293	
cells.	 Since	 signalling	 of	 zebrafish	 Gpr17	 was	 unknown,	 the	 pathway-unbiased	 DMR	 assay	
represented	an	elaborate	method	to	study	live-cell	responses	upon	receptor	activation.	
4.1.1 Zebrafish	Gpr17	version	A	is	unresponsive	to	uracil	nucleotides	and	
cysteinyl	leukotrienes		
Previous	published	data	postulated	uracil	nucleotides	and	cysteinyl	 leukotrienes	as	endogenous	
ligands	 of	 the	 G-protein	 coupled	 receptor	 17	 (Ciana,	 Fumagalli,	M.	 L.	 Trincavelli,	 et	 al.,	 2006).	
However,	several	independent	laboratories	failed	to	confirm	the	deorphaning	report	(Heise	et	al.,	
2000;	 Maekawa	 et	 al.,	 2009;	 Benned-Jensen	 and	 Rosenkilde,	 2010;	 Simon	 et	 al.,	 2017).	 As	
differences	in	activity	of	GPCR	agonists	are	known	to	occur	among	species	orthologues	(Milligan,	
2011),	it	was	essential	to	interrogate	whether	the	putative	agonists	which	are	inactive	on	human,	
mouse	and	rat	orthologues,	might	stimulate	zebrafish	Gpr17.	
To	this	end,	HEK293	cells	transiently	transfected	with	zebrafish	Gpr17	version	A	(zfAGpr17)	were	
exposed	 to	 the	 purported	 endogenous	 agonists	 and	 receptor	 mediated	 cell-responses	 were	
monitored	by	holistic	DMR	assays.	None	of	the	ligands	displayed	any	sign	of	activity	at	all	applied	
concentrations	 (Figure	 5).	 Loss	 of	 cell	 viability	 as	 reason	 for	 the	 missing	 response	 can	 be	
excluded,	 since	 carbachol	 and	ATP	 elicited	 robust	DMR	 signals	 in	HEK293	 cells	 upon	 acting	 on	
endogenously	expressed	muscarinic	M3	and	adenosine	A1	receptors.	
These	 data	 demonstrate	 that	 zfAGpr17	 is	 completely	 inert	 towards	 uracil	 nucleotides	 and	
cysteinyl	 leukotrienes,	 supporting	once	more	 the	notion	 that	Gpr17	must	still	be	considered	as	
orphan. 
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Figure	 5:	 Zebrafish	 Gpr17	 version	 A	 is	 unresponsive	 towards	 uracil	 nucleotides	 and	 cysteinyl	
leukotrienes.	HEK293	cells	transiently	transfected	with	zfAGpr17	revealed	no	receptor	specific	 functional	
activity	 after	 stimulation	 with	 putative	 endogenous	 ligands	 (LTC4,	 LTD4,	 UDP,	 UDP-gal,	 UDP-glc)	 (A-E).	
Signatures	 are	 representative	 traces	 (means	 +	 SEM)	 from	 at	 least	 three	 independent	 experiments,	 each	
performed	 in	 triplicates.	 Concentration-effect	 curves	 (F)	 were	 generated	 by	 calculation	 of	 the	 maximal	
response	within	1800	s	(means	±	SEM).		
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4.1.2 MDL29,951	fails	to	evoke	DMR	responses	on	zebrafish	Gpr17		
Besides	uracil	nucleotides	and	cysteinyl	leukotrienes,	a	small	synthetic	molecule,	MDL29,951	(2-
carboxy-4,6-dichloro-1H-indole-3-propionic	 acid),	 has	 been	 identified	 in	 previous	 studies	 as	 a	
selective	agonist	 for	human	and	rodent	Gpr17	(Hennen	et	al.,	2013b).	Further	studies	reported	
that	 Oli-neu	 cells	 and	 primary	 rat	 oligodendrocytes,	 which	 endogenously	 express	 Gpr17,	
displayed	decreased	myelin	 expression	 upon	 stimulation	with	MDL29,951	 (Simon	et	 al.,	 2016).	
Hence,	in	search	to	find	a	compound	serving	as	a	tool	to	study	receptor	functionality	and	role	of	
zebrafish	 Gpr17	 in	 vivo,	 whole-cell	 activity	 of	 zebrafish	 Gpr17	 towards	 MDL29,951	 was	
determined	by	DMR	assays.		
3HA-tagged	 zebrafish	Gpr17	version	A	 (zfA)	and	B	 (zfB),	 transiently	 transfected	 in	HEK293	cells	
were	 seeded	 in	 DMR	 plates	 and	 treated	 with	 increasing	 concentrations	 of	 the	 agonist.	 Cells	
transfected	 with	 empty	 pcDNA3.1	 vector	 remained	 unaffected	 towards	 MDL29,951,	 which	
indicates	 that	 the	 agonist	 did	 not	 evoke	 unspecific	 background	 responses	 (Figure	 6,	 A).	 As	
expected,	MDL29,951	led	to	robust,	concentration-dependent	traces	on	HEK293	cells	expressing	
human	 Gpr17	 (Figure	 6,	 B,	 E),	 thereby	 reaffirming	 the	 functionality	 on	 this	 species.	 However,	
MDL29,951	even	in	the	highest	concentration,	displayed	no	functional	activity	on	zfA	(Figure	6,	C,	
E)	and	zfBGpr17	(Figure	6,	D,	E).		
Together,	 these	data	demonstrate	 that	zebrafish	Gpr17	was	neither	sensitive	 to	 the	postulated	
agonists	nor	 to	MDL29,951.	The	unresponsiveness	 towards	MDL29,951	was	 rather	unexpected,	
since	human	and	zfAGpr17	display	55	%	homology.	Hence,	reasons	for	the	lacking	response	were	
examined	by	further	experiments.		
Results	
	68	
	
Figure	6:	Stimulation	of	zebrafish	Gpr17	with	MDL29,951	does	not	display	any	sign	of	activity	in	holistic	
DMR	assays.	In	DMR	experiments,	MDL29,951	did	not	produce	a	signal	in	cells	lacking	Gpr17	(A).	HEK293	
cells	 transiently	 transfected	 with	 3HA-tagged	 zebrafish	 Gpr17	 versions	 A	 (C)	 and	 B	 (D)	 showed	 no	
responses	 towards	 MDL29,951,	 while	 human	 3HA-Gpr17	 (B)	 displayed	 robust	 concentration-dependent	
signals	 after	 stimulation	 with	 agonist.	 Label-free	 recordings	 are	 shown	 as	 representative	 traces,	 each	
performed	in	triplicates	(means	+	SEM)	(E).	Concentration	response	curves	were	quantified	by	calculation	
of	 the	relative	maximum	DMR	response	within	1800	s.	Data	are	means	 (±	SEM)	 from	three	 independent	
experiments.	
4.1.3 Zebrafish	Gpr17	receptors	display	sufficient	cell	surface	expression	in	
HEK293	cells	
To	 account	 for	 potential	 discrepancies	 in	 subcellular	 localisation	 of	 the	 orthologous	 receptors,	
cell	 surface	 expression	 of	 3HA-tagged	 Gpr17	 constructs	 was	 analysed	 by	 fluorescent	
Immunocytochemistry	(ICC).	Thereby,	80,000	HEK293	cells	seeded	on	coverslips	were	imaged	48	
h	 post	 transfection.	 The	 data	 revealed	 equivalent	 membrane	 expression	 within	 all	 constructs	
(Figure	 7,	 B,	 C,	 D),	 while	 control	 transfection	 with	 pcDNA3.1	 displayed	 no	 fluorescence	 at	 all	
(Figure	7,	A).	Accumulation	of	receptors	in	the	cytosol	was	comparable.		
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Figure	 7:	 Immunocytochemical	 localisation	 of	 3HA-tagged	 Gpr17	 constructs	 reveals	 no	 difference.	
Representative	images	of	HEK293	cells,	transiently	transfected	with	human	(B)	and	zebrafish	Gpr17	(C,	D),	
were	obtained	48	h	after	transfection.	Cells	were	treated	with	an	antibody	directed	against	the	N-terminal	
3HA-Tag	 of	 Gpr17	 constructs	 and	 then	 incubated	 with	 a	 Cy2-conjugated	 goat	 anti-mouse	 antibody.	 No	
specific	fluorescence	was	detected	in	empty	vector	control	transfected	HEK293	cells	(A).	Experiments	were	
conducted	at	least	three	times.		
To	 further	 quantify	 expression	 levels,	 Enzyme-linked	 immunosorbent	 assays	 (ELISA)	 were	
performed.	Empty	HEK293	cells	as	well	as	HEK293	cells	transiently	expressing	3HA-tagged	Gpr17	
constructs	 were	 seeded	 in	 96-well	 plates	 at	 a	 density	 of	 50	 kc/well	 and	 analysed	 48	 h	 after	
transfection.	The	obtained	cell	surface	expressions	were	remarkably	similar	between	human	and	
both	zebrafish	Gpr17s	(Figure	8).		
In	conclusion,	the	lack	of	agonist	activity	of	MDL29,951	at	the	zebrafish	Gpr17	receptors	was	not	
caused	by	impaired	cell	surface	expression.	Therefore	it	became	evident	that	either	the	zebrafish	
receptors	did	not	respond	towards	the	agonist	or	the	mammalian	cell	background	was	unsuitable	
for	functional	analysis	of	zebrafish	receptors.	To	address	the	latter,	a	fibroblast	zebrafish	cell	line	
was	taken	into	account.	
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Figure	 8:	 Quantification	 of	 cell	 surface	 expression	 of	 Gpr17	 constructs	 displays	 almost	 equivalent	
expression	levels	in	HEK293	cells.	48	h	after	transient	transfection,	cell	surface	expression	of	3HA-tagged	
Gpr17	constructs	was	determined	by	ELISA.	3HA-epitope	allowed	a	comparable	quantification	of	protein	
expression	 in	 the	 cell	 membrane.	 Shown	 are	 representative	 data	 (means	 +	 SEM)	 of	 at	 least	 three	
independent	experiments.	
4.1.4 No	expression	of	zebrafish	Gpr17	in	fibroblast	zebrafish	cell	line	
There	 are	 several	 publications	 studying	 zebrafish	 receptors	 in	 mammalian	 cell	 lines,	 however	
some	 of	 them	 claim	 about	 discrepancies	 in	 functional	 assays	 due	 to	 the	 distinct	 cellular	
background	 (Ringvall,	 Berglund	 and	 Larhammar,	 1997;	 Starback	 et	 al.,	 1999).	 To	 this	 end,	 a	
fibroblast	zebrafish	(PAC2)	cell	line,	kindly	provided	by	Prof.	Dr.	Foulkes	of	Karlsruhe	Institute	of	
Technology	(KIT),	was	transiently	transfected	with	human	and	zebrafish	Gpr17	to	be	analysed	in	
DMR	 assay	 for	 receptor	 function.	 Various	 amounts	 of	 DNA	 as	 well	 as	 different	 transfection	
methods	were	applied.	Notably,	 it	was	not	possible	to	achieve	agonistic	activities	neither	at	the	
human	(Figure	9,	B)	nor	at	the	zebrafish	Gpr17	(Figure	9,	C).	Cells	lacking	Gpr17	receptors	(Figure	
9,	A)	displayed	similar	trace	shapes.	The	FCS	control	elicited	responses	on	all	cell	lines,	indicating	
that	 cell	 viability	 and	 assay	 conditions	 were	 suitable.	 Carbachol	 and	 ATP	 were	 unusable	 as	
positive	controls,	since	their	receptors	are	not	expressed	in	this	zebrafish	cell	line.		
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Figure	9:	MDL29,951	does	not	elicit	Gpr17	 specific	DMR	responses	 in	 zebrafish	PAC2	cells.	 The	agonist	
was	 applied	 in	 increasing	 concentrations	 to	 PAC2	 cells	 that	were	 either	 untransfected	 (A)	 or	 transiently	
transfected	 (FuGENE)	with	human	 (B)	 and	 zfA	 (C)	Gpr17.	 FCS	 control	 signals	were	not	 influenced	by	 the	
absence	 or	 the	 presence	 of	 Gpr17	 receptors.	 DMR	 responses	 were	 recorded	 for	 3600	 s.	 Shown	 are	
representative	traces	(means	+	SEM)	of	three	independent	experiments.	
Given	 this	pattern,	 cell	 surface	expression	was	determined	by	ELISA	assay.	 PAC2	 cells	 revealed	
deficient	 expression	 of	Gpr17	 receptors	 on	 the	 cell	membrane	 similar	 to	 empty	 vector	 control	
transfected	 cells	 (Figure	10).	 Thus,	 the	 lacking	DMR	 response	arose	 from	absentee	 cell	 surface	
expression	 of	Gpr17	 receptors.	 Therefore, the	 need	 of	 a	 fish	 cellular	 background	 for	 sufficient	
signalling	of	zebrafish	Gpr17	cannot	be	concluded	from	this	experiment.	
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Figure	10:	ELISA	 results	display	absent	 cell	 surface	expression	of	orthologous	Gpr17	 receptors	 in	PAC2	
cells.	 Cell	 surface	 expression	 was	 measured	 with	 ELISA	 in	 fibroblast	 zebrafish	 cells	 and	 HEK293	 cells	
transiently	transfected	(FuGENE)	with	6	µg	of	3HA-tagged	Gpr17	receptors.	Cells	were	seeded	in	a	96-well	
plate	 and	 3HA-epitope	was	 detected	 48	 h	 after	 transfection.	While	HEK293	 cells	 revealed	 sufficient	 cell	
surface	expression	of	Gpr17	receptors,	expression	in	PAC2	cells	was	similar	to	empty	vector	control.	Shown	
are	the	summarized	mean	values	of	one	representative	experiment.	
4.2 Analysis	of	zebrafish	embryos	after	bath	treatment	with	MDL29,951		
Since	MDL29,951	failed	to	evoke	DMR	responses	at	zebrafish	Gpr17	in	mammalian	HEK293	cells	
and	 investigation	 in	 a	 zebrafish	 cell	 line	 proved	 to	 be	 complicated,	 the	 zebrafish	 itself	 was	
exposed	 for	 several	 days	 to	 the	 compound.	 In	 this	 case,	 zebrafish	Gpr17	was	 subjected	 to	 the	
drug	in	its	native	environment,	which	could	provide	advantages	for	receptor	signalling.		
4.2.1 Differentiation	of	oligodendrocytes	is	unaffected	by	MDL29,951	
treatment	
The	use	of	the	zebrafish	as	an	animal	to	screen	for	compounds	which	modulate	myelination	has	
become	 increasingly	popular	during	 the	 last	decades	 (Preston	and	Macklin,	 2015).	 In	 search	of	
potential	 compounds,	 Buckley	 et	 al.	 developed	 a	 screening	 method	 by	 counting	 migrating	
oligodendrocyte	 lineage	 cells	 in	 the	 dorsal	 region	 of	 the	 CNS	 of	 transgenic	 zebrafish	 embryos	
after	bathing	exposure.	Drugs	that	significantly	changed	cell	numbers	were	further	 investigated	
by	 quantitative	 Polymerase	 chain	 reaction	 (qPCR),	 revealing	 direct	 effects	 on	 myelination	
(Buckley	et	al.,	 2010).	Hence,	 tg(claudink:EGFP)	 zebrafish	embryos	were	bath	exposed	 for	96	h	
with	10	µM	MDL29,951	and	total	number	of	claudin	K	positive	cells	were	analyzed	at	5	dpf.	Since	
Claudin	 K	 is	 a	 myelin-associated	 protein,	 expressed	 in	 mature	 myelinating	 oligodendrocytes	
(Münzel	 et	 al.,	 2012),	 alterations	 in	 oligodendrocyte	 development	 induced	 by	 drug	 treatment	
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should	 be	 recognized	 by	 imaging	 this	 transgenic	 zebrafish	 line.	 No	 difference	 in	 numbers	 of	
dorsally	 migrated	 cells	 of	 treated	 animals	 compared	 to	 DMSO	 control	 animals	 was	 detected	
(Figure	11).	These	data	suggest	that	migration	and	differentiation	of	the	oligodendrocyte	lineage	
is	not	altered	by	MDL29,951	treatment.	
	
Figure	11:	Bath	exposure	with	MDL29,951	does	not	alter	number	of	claudin	K	positive	dorsally	migrated	
cells.	After	24	h,	tg(claudink:EGFP)	zebrafish	were	treated	for	96	h	with	10	µM	MDL29,951	and	imaged	at	5	
dpf.	Numbers	of	dorsally	migrated	claudin	K	positive	cells	of	MDL29,951	treated	and	DMSO	control	animals	
were	almost	comparable	 (A).	Cells	were	counted	 in	segments	1	 to	6.	Presented	data	are	mean	values	 (±	
SEM)	and	represent	two	independent	experiments.	(B)	shows	representative	lateral	views,	anterior	to	the	
left,	dorsal	up,	obtained	by	Two-photon	microscopy	(TriM	Scope2,	LaVision).		
4.2.2 MDL29,951	treatment	does	not	alter	myelin	gene	transcripts	levels	
Even	though	MDL29,951	did	not	influence	the	number	of	myelinating	cells,	the	question	arose	if	
drug	 treatment	 directly	 affects	myelination.	 To	 this	 end,	mbp	 and	plp	 transcript	 levels	 of	 drug	
exposed	and	control	embryos	were	examined	by	qPCR.	Since	cell	number	was	not	altered	with	10	
µM	 MDL29,951,	 embryos	 were	 treated	 with	 an	 additional	 concentration	 of	 30	 µM.	 Drug	
treatment	yielded	no	difference	in	myelin	gene	expression	levels	of	treated	larvae	compared	to	
the	controls	at	5	dpf	(Figure	12).	Even	the	higher	compound	concentration	was	inefficient.		
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Figure	 12:	 Mbp	 and	 plp	 expression	 levels	 of	 5	 dpf	 old	 zebrafish	 embryos	 are	 not	 influenced	 after	
MDL29,951	treatment.	1	dpf	zebrafish	larvae	were	treated	for	96	h	with	MDL29,951	and	analysed	at	5	dpf	
by	qPCR.	Drug	treatment	with	10	and	30	µM	MDL29,951	did	not	significantly	alter	mbp	and	plp	expression	
levels,	 respectively.	 Data	 shown	 are	 mean	 values	 (+	 SEM)	 and	 represent	 at	 least	 four	 independent	
experiments,	each	performed	in	triplicates	with	25	embryos	per	group.	ns	=	no	significant	effect	to	DMSO	
control	group	according	to	the	non-parametric	Mann	Whitney	test.	
4.2.3 Myelination	is	not	impaired	after	MDL29,951	treatment	
To	 further	 verify	 preceding	data,	which	 assumed	 that	 drug	 treatment	with	MDL29,951	did	 not	
affect	myelination	 in	 vivo,	Western	blot	analysis	were	performed	 to	quantify	 the	expression	of	
36k,	 a	 short-chain	 dehydrogenase	 that	 is	 expressed	 in	 oligodendrocytes	 as	 well	 as	 in	 myelin	
sheaths	 in	 the	 CNS	 of	 teleosts	 (Morris	 et	 al.,	 2004).	 In	 congruence	 with	 the	 qPCR	 results,	
application	 of	 10	 and	 30	 µM	 MDL29,951	 did	 not	 modulate	 36k	 expression	 levels	 of	 treated	
animals	compared	to	the	controls	(Figure	13).		
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Figure	 13:	MDL29,951	 bath	 exposure	 does	 not	 affect	 expression	 of	 36k	myelin	 protein.	 Western	 blot	
analysis	of	MDL29,951	 treated	zebrafish	 larvae	 revealed	no	difference	 in	expression	of	36k	compared	 to	
control	 treated	 embryos	 at	 5	 dpf.	 Adult	 zebrafish	 brain	 served	 as	 a	 positive	 control.	 Shown	 are	
densitometric	 analysis	 of	 36k	 immunoreactive	 bands,	 quantified	 means	 (+	 SEM)	 from	 five	 independent	
experiments	(A).	(B)	depicts	a	representative	Western	blot.	
Taken	 together,	 these	 results	 indicate	 that	 MDL29,951	 treatment	 does	 not	 modulate	
developmental	myelinating	processes	in	zebrafish,	neither	by	altering	migration	or	differentiation	
of	oligodendrocyte	 lineage	cells	nor	by	directly	effecting	myelin	gene	expression.	Furthermore, 
this	 correlates	 with	 the	 in	 vitro	 results	 generated	 in	 HEK293	 cells,	 where	 the	 activation	 of	
zebrafish	 Gpr17	 by	 the	 agonist	 could	 not	 be	 portrayed.	 Therefore,	 the	 notion	 became	 more	
evident	that	the	unresponsiveness	of	zebrafish	Gpr17	could	arise	from	impaired	 ligand	binding.	
Nonetheless,	the	actual	reason	could	not	be	firmly	concluded.	
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4.3 Construction	and	functional	analysis	of	chimeric	receptors	
Previous	experiments	suggested	that	the	unresponsiveness	of	zebrafish	Gpr17	versions	could	be	
a	 consequence	 of	 impaired	 ligand	 binding.	 To	 address	 this,	 chimeric	 GPCRs	 containing	 the	
extracellular	domains	and	transmembrane	regions	of	the	human	Gpr17	and	intracellular	loops	of	
the	zebrafish	receptors	(h+zfA;	h+zfBGpr17)	were	constructed	(Figure	14).	Additionally,	chimeric	
receptors	 consisting	 of	 zebrafish	 Gpr17	 with	 intracellular	 loops	 of	 the	 human	 Gpr17	 (zfA+h;	
zfB+hGpr17)	were	generated	and	analysed	upon	expression	 in	HEK293	cells	by	DMR,	ELISA	and	
ICC	assays.		
	
Figure	 14:	 Schematic	 prediction	 of	 chimeric	 h+zfAGpr17	 receptor	 topology	 in	 the	 cell	 membrane.	
Chimeric	receptors	were	constructed	by	replacing	the	intracellular	loops	of	the	human	Gpr17	(black)	by	the	
loops	 of	 the	 zebrafish	 Gpr17	 receptors	 (cyan).	 Shown	 is	 a	 representative	 prediction	 schematic	 of	
h+zfAGpr17.	 Receptors	 were	 produced	 and	 codon	 optimized	 for	 zebrafish	 by	 GeneCust.	 For	 prediction	
HMMTOP	software	was	used.	
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4.3.1 Chimeric	receptors	are	localized	in	the	cell	surface	membrane	
Thus	 far,	 it	 was	 examined	 that	 the	 native	 zebrafish	 Gpr17	 receptors	 were	 expressed	 in	 the	
membrane	 of	 HEK293	 cells,	 although	 no	 functionality	was	 observed	 after	 stimulation	with	 the	
agonist	MDL29,951.	To	validate	 if	 the	HA-tagged	chimeric	 receptors	were	equally	expressed	on	
the	cell	surface,	ICC	analysis	with	an	antibody	directed	against	the	3HA-epitope	was	performed.	
The	 obtained	 data	 revealed	 that	 all	 four	 chimeric	 receptors,	 transiently	 transfected	 in	 HEK293	
cells,	were	located	in	the	cell	surface	membrane	(Figure	15,	B,	C,	E,	F).		
	
Figure	 15:	 Chimeric	 Gpr17	 receptors	 are	 expressed	 in	 the	 cell	 surface	 membrane	 of	 transiently	
transfected	 HEK293	 cells.	 HEK293	 cells,	 transiently	 transfected	with	 the	 four	 chimeric	 Gpr17	 receptors,	
revealed	 receptor	 localisation	 on	 the	 cell	 membrane	 (B,	 C,	 E,	 F).	 Receptors	 were	 marked	 by	 their	 N-
terminal	3HA-Tag,	48	h	after	transfection.	A	secondary	Cy2-conjugated	goat	anti-mouse	antibody	finally	led	
to	 signals	 obtained	 by	 fluorescent	 microscopy.	 Control	 transfection	 with	 human	 Gpr17	 displayed	
comparable	expression	(D),	while	cells	transfected	with	empty	vector	revealed	no	specific	fluorescence	(A).	
Shown	pictures	represent	at	least	three	independent	experiments.	
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To	further	monitor	quantitative	changes	 in	receptor	cell	surface	expression	 levels,	HEK293	cells	
transiently	 transfected	 with	 Gpr17	 constructs	 were	 cultured	 for	 48	 h	 and	 analysed	 by	 ELISA	
assays.	All	chimeric	receptors	displayed	declined	expression	 in	the	cell	membrane	compared	to	
artless	Gpr17	orthologous	(Figure	16).		
	
Figure	16:	Cell	surface	expression	of	chimeric	Gpr17	constructs	was	declined	compared	to	artless	Gpr17	
orthologous.	 HEK293	 cells	 transiently	 expressing	 3HA-tagged	 Gpr17	 constructs	 were	 investigated	 48	 h	
after	 transfection	 by	 ELISA	 assays.	 Attenuated	 cell	 surface	 expression	 levels	 of	 chimeric	 constructs	
compared	 to	 human	 and	 zebrafish	 Gpr17	 were	 observed.	 Shown	 are	 the	 summarized	 means	 (+	 SEM),	
performed	in	three	independent	experiments,	each	in	triplicate.			
4.3.2 MDL29,951	induces	concentration-depended	DMR	responses	at	human	
Gpr17	with	intracellular	loops	of	zebrafish	receptor		
Both	ICC	and	ELISA	assays	revealed	that	the	chimeric	receptors	were	expressed	in	the	cell	surface	
membrane.	 To	 investigate	 whether	 these	 receptors	 are	 functional,	 transiently	 transfected	
HEK293	cells	were	examined	by	DMR	assays.	Cell	lines	expressing	human	Gpr17	with	intracellular	
loops	 of	 zfA	 (Figure	 17,	 A)	 or	 zfBGpr17	 (Figure	 17,	 B)	 generated	 label-free	 responses	 to	
MDL29,951	 in	 a	 concentration-dependent	 manner,	 although	 the	 responses	 were	 diminished	
compared	to	human	Gpr17	(Figure	17,	C,	F).	To	the	contrary,	zfA	(Figure	17,	D)	and	zfB	(Figure	
17,	 E)	 Gpr17	 containing	 intracellular	 loops	 of	 human	 Gpr17	 remained	 unresponsive	 to	 the	
agonist.	 Finally,	 these	 data	 argued	 for	 an	 impaired	 binding	 of	 MDL29,951	 at	 the	 zebrafish	
receptors.		
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Figure	17:	MDL29,951	evokes	DMR	responses	on	human	Gpr17	containing	intracellular	loops	of	zebrafish	
Gpr17.	 48	 h	 after	 transfection	 of	 HEK293	 cells,	 functional	 analysis	 of	 chimeric	 Gpr17	 receptors	 was	
performed	 by	 DMR.	 Responses	 to	 MDL29,951	 and	 carbachol	 were	 recorded	 over	 3600	 s.	 The	 agonist	
induced	diminished	traces	at	h+zfA	(A)	and	h+zfB	(B)	Gpr17s	compared	to	human	Gpr17	(C),	while	zfA+h	
(D)	and	zfB+h	(E)	Gpr17	remained	unresponsive.	Shown	are	representative	traces	(means	+	SEM)	of	at	least	
three	independent	experiments.	(F)	Concentration-effect	curves	are	mean	values	(±	SEM). 	
Taken	 together,	 these	 observations	 lead	 to	 the	 assumption	 that	 MDL29,951	 did	 not	 activate	
zebrafish	Gpr17	 receptors	both	 in	vitro	 and	 in	vivo	 analysis.	Given	 the	 functionality	of	 chimeric	
receptors	 containing	 the	 human	 agonist	 binding	 side,	 it	 becomes	more	 evident	 that	 impaired	
ligand	binding	provoked	the	lack	of	activity	at	the	fish	receptors.		
Moreover,	 the	data	displayed	that	 the	h+zfA	and	h+zfB	chimeric	Gpr17	receptors	 retained	wild	
type	characteristic,	even	though	functionality	was	attenuated.	Since	MDL29,951	did	not	induced	
effects	in	vivo,	it	might	be	possible	that	MDL29,951	treatment	on	zebrafish	transiently	expressing	
the	 chimeric	 Gpr17	 receptors	 causes	 alterations	 in	 myelination.	 If	 this	 proves	 to	 be	 true,	 the	
chimeric	receptors	could	represent	new	valuable	tools	for	screening	of	compounds	with	activity	
on	human	Gpr17	 that	promote	 remyelination	 in	humans.	But	 first	as	a	matter	of	principle,	 the	
role	of	zebrafish	Gpr17	in	vivo	has	to	be	examined.	
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4.4 Gpr17	expression	in	zebrafish		
While	preceding	 investigations	have	 focused	on	 the	 functional	 analysis	of	 zebrafish	Gpr17,	 this	
chapter	will	explore	the	temporal	and	local	expression	of	Gpr17	in	vivo.		
4.4.1 Whole-mount	in	situ	hybridization	reveals	gpr17	expression	during	
oligodendrocyte	development	
Previously	 published	 data	 indicate	 that	 Gpr17	 is	 abundant	 in	 pre-oligodendrocytes	 (pre-OLs)	
during	 mouse	 CNS	 development,	 but	 not	 detectable	 in	 mature	 oligodendrocytes	 (Chen	 et	 al.,	
2009).	 Since	 the	 zebrafish	 represent	 an	 ideal	 model	 system	 to	 study	 oligodendrocyte	
development	 and	 myelination	 in	 vivo	 (Preston	 and	 Macklin,	 2015),	 gpr17	 RNA	 expression	 in	
zebrafish	embryos	was	determined	by	Whole-mount	in	situ	hybridization	(WISH).		
Robust	 Gpr17	 expression	 was	 found	 throughout	 the	 CNS	 from	 1	 to	 5	 dpf.	 Initially,	 a	 diffuse	
distribution	of	RNA	was	observed	in	all	regions	of	the	spinal	cord,	in	the	ventral	and	the	dorsal,	as	
well	as	 in	the	primary	motor	neuron	domain	(pMN)	of	the	neural	tube	(Figure	18,	A).	At	2	dpf,	
when	oligodendrocyte	precursor	cells	(OPCs)	specify	(Kirby	et	al.,	2006),	mainly	the	pMN	domain	
displayed	high	gpr17	expression	levels	(Figure	18,	B),	that	shifted	to	the	dorsal	area	of	the	spinal	
cord,	once	OPCs	actively	start	migrating	and	dividing,	and	persisted	until	5	dpf	(Figure	18,	C	-	E).	
Sense	control	animals	did	not	exhibit	any	signal,	indicating	that	the	staining	specifically	portrayed	
gpr17	expression	(Figure	18,	E).	Since	expression	appeared	only	in	the	spinal	cord	midline	(Figure	
18,	G-K),	it	can	be	concluded	that	gpr17	is	abundant	in	the	CNS,	while	missing	in	the	PNS.		
These	 findings	 demonstrate	 gpr17	 expression	 within	 the	 CNS,	 particularly	 in	 dorsal	 migrating	
oligodendrocyte-like	cells.	
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Figure	 18:	WISH	 of	 1	 to	 5	 dpf	 old	 zebrafish	 larvae	 reveals	 zfAgpr17	 expression	within	 the	 CNS.	 (A-E)	
Lateral	views	(dorsal	up,	anterior	to	the	left)	show	gpr17	expression	in	the	pMN	region	(big	arrows)	and	the	
dorsal	spinal	cord	(small	arrows)	of	1	to	5	dpf	old	zebrafish	embryos.	(G-K).	Dorsal	views	(anterior	to	the	
left)	depicted	gpr17	expression	in	the	CNS	(black	arrows),	while	it	was	missing	in	the	PNS	(white	arrows).	
Images	are	shown	represent	at	least	four	independent	experiments.		
To	 prove	 Gpr17	 localisation	 in	 oligodendrocyte	 lineage	 cells,	 zebrafish	 were	 treated	 with	
Trichostatin	 A	 (TSA),	 a	 histone	 deacetylase	 inhibitor. Takada	 et	 al.	 (2010)	 asserted	 that	 dorsal	
migration	of	OPCs	is	prevented	with	TSA.	Assuming	that	Gpr17	is	expressed	in	OPCs,	expression	
of	gpr17	was	expected	to	be	vanished	in	the	dorsal	spinal	cord	after	treatment	with	TSA.	Indeed,	
zebrafish	treated	with	TSA	revealed	significantly	decreased	gpr17	expression	in	the	dorsal	region	
of	the	spinal	cord	compared	to	control	animals	at	4	dpf	(P<0.0001,	student’s	t-test)	(Figure	19).	In	
conclusion,	our	findings	strongly	suggest	that	gpr17	is	expressed	in	dorsally	migrating	OPCs.	
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Figure	19:	ZfAgpr17	expression	is	missing	in	dorsal	spinal	cord	after	Trichostatin	A	treatment.	4	dpf	old	
zebrafish	 larvae	displayed	 significantly	diminished	gpr17	 expression	 (C)	 in	 the	dorsal	 region	of	 the	 spinal	
cord	after	treatment	with	TSA	(A),	while	control	animals	(B)	depicted	normal	localization	in	both	dorsal	and	
pMN	 regions.	 Data	 are	 shown	 as	 mean	 values	 (+	 SEM)	 from	 three	 independent	 experiments.	 ****;	
p<0.0001	according	to	student’s	t-test.		
4.4.2 Gpr17	protein	is	expressed	during	zebrafish	embryogenesis	
In	addition	to	preceding	findings	displaying	the	presence	of	gpr17	RNA	in	oligodendrocyte	lineage	
cells,	 expression	 of	 Gpr17	 protein	 was	 analysed	 by	 Western	 blot	 analysis.	 To	 this	 end,	 equal	
amounts	of	total	protein	lysates	were	isolated	from	entire	embryos	at	different	ages.	Throughout	
the	 time	 course,	 immunoreactive	 bands	 at	 sizes	 around	 40	 kDa	 were	 detected	 in	 samples	
harvested	 as	 early	 as	 3	 dpf.	 After	 72	 hpf,	 zfAGpr17	 levels	 increased	 until	 10	 dpf,	 however	 the	
band	with	 the	highest	 size	disappeared	 (Figure	20,	A).	Notably,	 lysates	of	adult	 zebrafish	brain	
lacked	zfAGpr17	(Figure	20,	B).	These	results	support	the	notion	that	Gpr17	plays	a	role	during	
CNS	development.		
On	the	contrary, zfBGpr17	could	not	be	portrayed	by	WISH	and	Western	blot	analysis.	Hence,	the	
following	in	vivo	experiments	mainly	focused	on	zfAGpr17.	
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Figure	20:	 ZfAGpr17	 is	 expressed	during	oligodendrocyte	development.	Western	blot	 analysis	of	Gpr17	
expression	in	zebrafish	larvae,	harvested	at	different	time	points	displayed	protein	expression	from	3	to	10	
dpf	 (A),	 while	 protein	 was	 absent	 in	 adult	 brain	 (B).	 Shown	 are	 representative	Western	 blots	 of	 three	
independent	experiments.		
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4.5 Role	of	Gpr17	in	zebrafish	
Given	 the	 expression	 pattern	 of	gpr17	 in	 the	 developing	 CNS	 of	 zebrafish,	 the	 question	 arose	
whether	 Gpr17	 may	 influence	 oligodendrocyte	 development.	 To	 this	 end,	 transient	
overexpression	 (OE)	and	morpholino	 (MO)	knockdown	studies	served	as	 tools	 for	exploring	the	
role	of	Gpr17	in	zebrafish.		
4.5.1 Transient	overexpression	of	Gpr17	in	zebrafish	embryos	does	not	affect	
oligodendrocyte	development	and	myelination	
Since	 oligodendrogenesis	 in	 zebrafish	 is	 accompanied	 by	 coordinated	 expression	 of	 distinct	
transcription	 factors	 and	 proteins	 (Kirby	 et	 al.,	 2006;	 Monk	 and	 Talbot,	 2009;	 Münzel	 et	 al.,	
2012),	 effects	 on	 oligodendrocyte	 progression	 and	 myelination	 induced	 by	 OE	 of	 Gpr17	 were	
determined	by	several	strategies	 including	marker	analysis	and	 imaging	of	fluorescent	zebrafish	
lines	at	different	developmental	time	points.		
4.5.1.1 Evaluation	of	RNA	amount	used	in	OE	studies	
To	 identify	 the	 suitable	 RNA	 concentration	 for	 transient	 OE	 experiments,	 mortality	 rates	 and	
phenotypes	of	 tg(olig2:EGFP)	 zebrafish	embryos,	 injected	with	 increasing	 concentrations	of	 zfA	
and	zfBgpr17	were	determined.	Since	preceding	experiments	displayed	abundances	of	gpr17	 in	
dorsally	migrating OPCs,	 numbers	 of	 olig2	 positive	 cells,	 which	 correspond	 to	 oligodendroglial	
cells	 expressing	 the	 transcription	 factor	 olig2,	 were	 counted	 in	 a	 representative	 region	 of	 the	
dorsal	 CNS	 (Figure	 21).	 Finally,	 success	 of	 microinjection	 was	 verified	 by	 monitoring	 the	
expression	of	injected	tdTomato	by	Two-photon	microscopy.		
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Figure	21:	Representative	region	in	the	dorsal	spinal	cord	of	a	3	dpf	tg(olig2:EGFP)	zebrafish	imaged	by	
Two-photon	microscopy.	 For	overexpression	 and	 knockdown	 studies,	 cell	 numbers	were	 counted	 in	 the	
depicted	dorsal	CNS	region	of	the	spinal	cord	that	encompassed	6	segments.	
Microinjections	 of	 increasing	 amounts	 of	 gpr17	 RNA	 in	 tg(olig2:EGFP)	 zebrafish	 exhibited	
enhanced	mortality	and	varied	phenotypes	 (Figure	22,	A-E).	Especially,	 injections	of	1000	pg	of	
zfBgpr17	 caused	 severe	mutations	 and	 death	 rates	 in	 about	 50	%	 of	 zebrafish	 embryos,	while	
phenotypes	of	embryos	injected	with	zfAgpr17	were	less	pronounced.	OE	of	zfB	RNA	did	not	alter	
numbers	of	dorsally	located	olig2	positive	cells	(Figure	22,	F-I)	compared	to	zfA	injections,	which	
produced	a	significant	decrease	in	cell	number	(P<0.05,	one-way	ANOVA)	(Figure	22,	I).	However,	
the	decrease	does	not	necessarily	relate	to	an	effect	caused	by	OE	since	the	difference	was	only	
detectable	with	 the	 highest	 concentration,	which	 could	 possibly	 evoked	 toxic	 side	 effects	 that	
influenced	CNS	development,	including	cell	numbers.	
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Figure	22:	Calibration	of	RNA	amount	for	OE	studies	in	tg(olig2:EGFP)	zebrafish	embryos	suggests	800	pg	
RNA.	 3	 dpf	 old	 zebrafish	 embryos,	 injected	 in	 the	 one-cell	 stage	 with	 increasing	 RNA	 concentrations	
revealed	 dose-dependent	 increases	 in	 mortality	 as	 well	 as	 severe	 phenotypes,	 while	 control	 animals	
displayed	higher	survival	rates	and	normal	phenotypes	(A-E).	Numbers	of	dorsally	migrating	olig2	positive	
OPCs	were	not	significantly	altered	by	OE	of	zfA	and	zfBGpr17	compared	to	tdTomato	injected	animals	(F-
I),	exclusively	1000	pg	of	zfAgpr17	elicited	a	significant	decrease	in	cell	number	(I).	Data	are	shown	as	mean	
values	 (±	 SEM);	 each	 concentration	 presents	 one	 experiment.	 One-way	 ANOVA	was	 used	 for	 statistical	
significance.	*,	P<0.05.	
In	 order	 to	 verify	 the	 success	 of	 RNA	expression,	 zebrafish	 embryos	were	 additionally	 injected	
with	tdTomato.	The	red	fluorescent	protein	was	expressed	even	 in	 the	 lowest	concentration	of	
150	pg	(Figure	23).	Furthermore,	RNA	stability	studies	with	tg(claudinK:EGFP)	zebrafish	revealed	
stable	 expression	 of	 TdTomato	 protein	 over	 96	 h	 (Supplementary	 Figure	 1)	 concluding	 that	
Gpr17	should	be	expressed	in	the	same	manner.	
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Figure	23:	Stable	RNA	expression	after	microinjection	of	150	pg	tdTomato	in	zebrafish	embryos.	3	dpf	old	
tg(olig2:EGFP)	zebrafish	embryos,	injected	with	150	pg	tdTomato	exhibited	stable	protein	expression	in	the	
spinal	cord.	Shown	are	representative	images	from	one	experiment.		
The	 fact	 that	 tdTomato	 control	 injections	 revealed	 mellowed	 death	 rates	 compared	 to	 gpr17	
injections	 (Figure	 22,	 A-E)	 infers	 even	 more	 that	 high	 amounts	 of	 gpr17	 influences	 zebrafish	
development	 in	a	certain	manner.	Hence,	further	OE	studies	were	conducted	with	800	pg	RNA.	
Injected	animals	displayed	normal	phenotypes	(Figure	24)	and	mortality	rates	about	20	%.		
	
Figure	24:	3	dpf	old	tg(olig2:EGFP)	zebrafish	embryos	display	normal	phenotypes	after	injection	of	800	pg	
RNA.	Shown	are	representative	images	of	transgenic	zebrafish	larvae	at	3	dpf,	injected	with	800	pg	zfA	and	
zfBgpr17	RNA.	Success	of	OE	was	verified	by	injection	of	tdTomato	RNA.	
	 	
            25µm 
 olig2 
 tdTomato 
 merge 
!!!!!!!!!!!!!!
3dpf 
  1000 µm    uninjected!! !tdTomato- !zfAgpr17- !zfBgpr17-
!800!pg!!
Results	
	88	
4.5.1.2 Maturation	of	oligodendrocytes	is	not	influenced	by	Gpr17	OE	
Since	OE	of	GPR17	 inhibits	oligodendrocyte	development	and	myelination	 in	mice	 (Chen	et	al.,	
2009),	 it	 was	 first	 examined	 whether	 Gpr17	 OE	 in	 zebrafish	 interferes	 with	 oligodendrocyte	
maturation.	3	dpf	old	tg(claudinK:EGFP)	zebrafish,	injected	with	800	pg	gpr17	RNA	were	imaged	
at	 3,	 4	 and	 5	 dpf	 by	 Two-photon	microscopy	 and	 cell	 numbers	 were	 ascertained	 by	 counting	
claudin	K	positive	cells	in	the	dorsal	region	of	the	spinal	cord.	Tg(claudinK:EGFP)	zebrafish	exhibit	
expression	 of	 exaggerated	 green	 fluorescent	 protein	 (EGFP)	 that	 is	 driven	 by	 the	 claudin	 k	
promoter	(Münzel	et	al.,	2012),	hence	EGFP	is	representative	for	the	generation	of	Claudin	k	and	
differentiation	 of	 oligodendrocyte	 lineage	 cells.	 Numbers	 of	 claudin	 k	 positive	 cells	 did	 not	
significantly	 differ	 between	gpr17	 and	 control	 injected	 animals,	 neither	 at	 72	 hpf,	 when	OPCs	
start	differentiating,	nor	at	80	and	96	hpf,	when	first	myelin	sheaths	are	constructed	(Figure	25).	
Uninjected	animals	revealed	equal	cell	numbers,	indicating	that	injection	procedure	had	no	effect	
on	oligodendrocyte	development.		
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Figure	25:	Maturation	of	oligodendrocyte	 lineage	cells	expressing	claudin	k	 is	not	altered	by	Gpr17	OE.	
Tg(claudink:EGFP)	zebrafish,	injected	with	800	pg	RNA	were	imaged	by	Two-photon	microscopy	at	72	(A),	
80	(B)	and	96	hpf	(C).	Numbers	of	dorsally	migrated	claudin	k	positive	cells	did	not	differ	between	gpr17	
injected,	control	injected	and	uninjected	animals	at	any	time	point.	Data	are	presented	as	mean	values	(±	
SEM)	of	at	 least	four	independent	experiments.	(D,E,F)	show	representative	lateral	views	(anterior	to	the	
left,	dorsal	up).	
4.5.1.3 Gpr17	OE	does	not	impair	expression	of	myelin	proteins	
To	 question	 whether	 unaltered	 numbers	 of	 myelinating	 oligodendrocytes	 in	 overexpressed	
zebrafish	 mirror	 myelin	 formation,	 expression	 of	 myelin	 proteins	 was	 analysed	 by	
Immunohistochemistry	 (IHC)	 and	 Western	 blot	 analysis.	 At	 first,	 expression	 of	 Myelin	 basic	
protein	 (Mbp)	was	determined	 in	 the	 spinal	 cord	of	4	dpf	old	RNA	 injected	zebrafish	 larvae	by	
Whole-mount	 IHC	analysis.	By	using	an	antibody	 to	Mbp,	 generated	data	 revealed	 that	OE	did	
not	 alter	 expression	 of	Myelin	 protein	 in	 the	 anterior	 (Figure	 26,	 A)	 and	middle	 region	 of	 the	
spinal	cord	(Figure	26,	B)	compared	to	control	injected	and	uninjected	embryos.		
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Figure	26:	OE	of	Gpr17	does	not	alter	myelination	in	4	dpf	old	zebrafish	larvae.	Shown	are	representative	
images	of	Mbp	expression	in	the	spinal	cord	of	4	dpf	old	zebrafish,	injected	with	800	pg	zfA	and	zfBgpr17.	
Injected	 zebrafish	 exhibited	no	difference	 in	Myelin	basic	 protein	 expression	 in	 the	 anterior	 (A)	 and	 the	
middle	(B)	region	of	the	spinal	cord	compared	to	tdTomato	injected	and	uninjected	animals,	evaluated	by	
immunolabelling	 for	 Mbp.	 Data	 are	 shown	 are	 lateral	 views	 (dorsal	 up,	 anterior	 to	 the	 left)	 from	 two	
independent	experiments.	
Furthermore,	 Western	 blot	 analysis,	 evaluating	 the	 expression	 of	 myelin-associated	 protein	
Claudin	K	(Münzel	et	al.,	2012)	(Supplementary	Figure	2),	displayed	no	difference	in	expression	
levels	 between	gpr17	 injected	 and	 control	 injected	 animals	 at	 4	 dpf	 (Figure	 27).	 These	 results	
suggest	that	OE	of	Gpr17	does	not	influence	the	expression	of	myelin	proteins	in	4	dpf	zebrafish	
embryos.	
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Figure	27:	4	dpf	old	zebrafish	larvae	exhibit	no	difference	in	Claudin	K	expression	levels	after	Gpr17	OE.	
Quantitative	 evaluation	 of	 4	 dpf	 old	 zebrafish	 larvae,	 injected	 with	 800	 pg	 gpr17	 RNA	 displayed	 no	
difference	in	expression	of	myelin	protein	Claudin	K	compared	to	control	animals	(A).	(B)	shows	illustrative	
Western	 blot	 from	 four	 separate	 experiments.	Data	 are	 shown	 as	mean	 values	 (+	 SEM).	un=	 uninjected	
animals,	tom=	tdTomato	injected	animals.	
4.5.1.4 OE	of	Gpr17	does	not	alter	number	of	olig2	positive	dorsally	migrated	OPCs	
To	 ascertain	 whether	 OE	 directly	 effects	 development	 of	 OPCs,	 tg(olig2:EGFP)	 zebrafish	 were	
injected	with	800	pg	RNA	and	imaged	by	Two-photon	microscopy	not	only	at	3	dpf	but	also	2	dpf,	
when	OPCs	proliferate	and	begin	to	migrate	dorsally.	Although	a	wide	dispersion	was	obtained,	
no	significant	difference	in	numbers	of	dorsally	migrated	olig2	positive	cells	between	gpr17	and	
control	injected	animals	was	found	(Figure	28).		
To	sum	up,	data	obtained	with	transgenic	zebrafish	lines	demonstrate	that	OE	of	Gpr17	does	not	
disturb	migration	and	differentiation	of	oligodendrocyte	lineage	cells.	
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Figure	28:	Oligodendrocyte	 lineage	 cells	 expressing	 transcription	 factor	olig2	 display	normal	migration	
after	 Gpr17	 OE.	 Numbers	 of	 olig2	 positive	 dorsally	 migrated	 cells	 revealed	 no	 significant	 difference	
between	 gpr17	 and	 tdTomato	 (800	 pg)	 injected	 zebrafish	 embryos	 at	 2	 and	 3	 dpf	 (A,B).	 Shown	 are	
quantified	data	(means	±	SEM)	and	representative	lateral	views	(dorsal	up,	anterior	to	the	left)	(C,D)	of	at	
least	three	independent	experiments.		
4.5.1.5 Myelin	gene	expression	levels	are	unaffected	by	Gpr17	OE		
To	 evaluate	 the	 effect	 of	 Gpr17	 OE	 on	 mbp	 and	 plp	 expression	 levels,	 WISH	 and	 qPCR	
experiments	were	implemented.	To	this	end,	injected	zebrafish	embryos	were	analysed	at	3	and	
4	dpf,	at	the	time	when	myelination	initiates.	At	both	days,	myelin	gene	expression	levels	were	
not	 significantly	 altered	 between	 gpr17	 and	 control	 group,	 as	 measured	 by	 qPCR	 (Figure	 29).		
Even	 the	 slight	 increase	 in	 plp	 expression	 in	 4	 dpf	 old	 animals	 displayed	 no	 significant	
upregulation	 (Figure	 29,	 D).	 Again,	 myelin	 protein	 expression	 in	 control	 injected	 animals	
resembled	expression	in	uninjected	animals,	indicating	that	injection	procedure	did	not	influence	
RNA	expression.				
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Figure	29:	Quantitative	polymerase	chain	reaction	revealed	no	difference	in	expression	levels	of	myelin	
proteins	mbp	and	plp	after	Gpr17	OE.	Zebrafish	embryos,	injected	with	800	pg	RNA	were	analysed	at	3	and	
4	dpf	 by	qPCR.	 Expression	 levels	 of	mbp	 (A,	B)	 and	plp	 (C,	D)	were	not	 significantly	 altered	between	all	
groups.	Mean	values	(+	SEM)	of	four	independent	were	summarized,	each	performed	in	triplicates	with	25	
zebrafish	 per	 group.	 ns	 =	 no	 significant	 effect	 to	 tdTomato	 injected	 zebrafish	 according	 to	 the	 non-
parametric	Kruskal-Wallis	test.	
Consistent	with	the	qPCR	data	presented	above,	mbp	expression	ascertained	by	WISH	showed	no	
difference,	whether	in	the	CNS	including	spinal	cord	and	brain	regions,	nor	in	the	PNS	of	3	and	4	
dpf	zebrafish	embryos	(Figure	30).	
Taken	together	these	findings	 indicate	that	OE	of	Gpr17	does	not	affect	transcription	of	myelin	
proteins	mbp	and	plp.		
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Figure	30:	Mbp	expression	pattern	determined	by	WISH	is	not	influenced	by	Gpr17	OE.	WISH	of	3	and	4	
dpf	 old	 zebrafish	 embryos	 revealed	 similar	 expression	of	mbp	 in	 the	CNS	 at	 the	 level	 of	 the	 spinal	 cord	
(small	 black	 arrows)	 and	 brain	 (big	 black	 arrows)	 as	 well	 as	 in	 the	 PNS	 (white	 arrows).	 Panels	 show	
representative	images	(dorsal	up)	of	two	independent	experiments.	
4.5.1.6 Initiation	of	oligodendrocyte	differentiation	is	not	impaired	by	Gpr17	OE	
During	oligodendrocyte	progression,	maturation	of	oligodendrocyte	lineage	cells	 is	controlled	in	
addition	to	others	by	the	expression	of	the	transcription	factor	Nkx2.2.	OPCs	expressing	Nkx2.2	
turn	 into	 pre-OLs	 and	 finally	 into	 mature	 myelinating	 oligodendrocytes,	 while	 OPCs	 lacking	
Nkx2.2	 remain	 as	 non-myelinating	 progenitor	 cells	 (Kucenas,	 Snell	 and	 Appel,	 2010).	 Since	
preceding	results	of	 this	 thesis	demonstrated	that	both,	generation	of	OPCs	and	differentiation	
into	myelinating	oligodendrocytes	are	not	 impaired	by	Gpr17	OE,	 it	was	to	 investigate	whether	
OE	 influences	 the	 initial	 stage	 of	 differentiation	 at	 the	 level	 of	 nkx2.2	 expressing	 pre-OLs.	
Therefore,	WISH	of	2.5	dpf	old	zebrafish	embryos	was	conducted.	Expression	of	nkx2.2	gene	 in	
the	CNS	of	 zebrafish	overexpressing	Gpr17	did	not	differ	 from	control	 injected	animals	 (Figure	
31).	These	findings	indicate	that	the	generation	of	pre-OLs	is	not	altered	by	Gpr17	OE.	
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Figure	 31:	WISH	 of	 2.5	 dpf	 old	 zebrafish	 embryos	 displays	 equal	 nkx2.2	 expression	 in	 the	 CNS.	WISH	
images	 of	 zebrafish	 embryos	 showed	 no	 difference	 in	 nkx2.2	 expression	 between	 gpr17	 and	 control	
injected	 animals	 (800pg)	 in	 the	 CNS	 at	 2.5	 dpf.	 Depicted	 are	 representative	 images	 of	 at	 least	 two	
independent	experiments.		
To	sum	up,	these	data	indicate	that	OE	does	not	affect	oligodendrocyte	development,	neither	by	
changing	maturation	of	oligodendrocyte	lineage	cells	nor	by	altering	their	function	to	myelinate	
axons.	Hence,	previous	published	data	 sets	obtained	 in	mice,	 indicating	 that	Gpr17	OE	 inhibits	
onset	of	myelination	cannot	not	be	confirmed	by	using	zebrafish	as	model	species.		
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4.5.2 ZfAgpr17	morpholino	injections	in	zebrafish	embryos	causes	reduced	
oligodendrocyte	numbers	and	an	impaired	myelination		
The	fact	that	Gpr17	OE	did	not	alter	oligodendrocyte	formation,	differentiation	and	myelination	
in	zebrafish	argues	against	zebrafish	as	a	suitable	model	to	study	Gpr17	in	vivo.	Nevertheless,	to	
definitively	 decipher	 the	 role	 of	 this	 receptor	 in	 zebrafish,	 a	 morpholino-modified	 antisense	
oligonucleotide	mediated	gene	knockdown	(Corey	and	Abrams,	2001)	was	generated	(Figure	32).	
Since	zebrafish	A	version	(zfA)	of	Gpr17	is	highly	conserved	from	zebrafish	to	human	showing	56	
%	homology	with	 the	human	Gpr17,	all	knockdown	studies	were	conducted	with	a	morpholino	
that	inhibited	the	translation	of	zfAgpr17.	Thereby,	zebrafish	embryos	were	injected	at	the	one-
cell	 stage	 and	 effects	 on	 oligodendrocyte	 progression	 were	 evaluated	 by	 distinct	 methods	
throughout	the	first	days	of	development.	
	
Figure	 32:	 Structure	 of	 morpholino	 antisense	 oligonucleotide	 and	 native	 DNA.	 25	 base	 pairs	 long	
morpholino	antisense	oligonucleotides	 containing	an	altered	backbone	bind	 to	 complementary	DNA	and	
inhibit	the	translation	process.	Figure	adapted	from	(Corey	and	Abrams,	2001).	
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4.5.2.1 Morpholino	injected	animals	display	smaller	sizes	and	heart	oedema	
Injections	 of	 2.75	 ng	 zfAgpr17	 morpholino	 (MO)	 at	 the	 one-cell	 stage	 of	 zebrafish	 embryos	
caused	weak	phenotypes,	exhibiting	smaller	sizes	and	heart	oedema,	while	control	MO	injected	
compared	to	uninjected	animals	did	not	display	any	abnormalities	(Figure	33).	However,	because	
the survival	 rate	 of	 zfAgpr17	morphants	 compared	 to	 control	 and	 uninjected	 animals	was	 not	
significantly	 altered,	 all	 knockdown	 experiments	 were	 conducted	 with	 2.75	 ng	 zfAgpr17	MO	
(Reinoß,	2014;	Kleinert,	2018).	
	
Figure	33:	ZfAgpr17	morpholino	injections	cause	weak	phenotypes.	Wild	type	zebrafish	injected	with	2.75	
ng	zfAgpr17	MO	displayed	weak	phenotypes	including	smaller	size	and	heart	oedema	compared	to	control	
MO	 injected	 and	 uninjected	 zebrafish.	 Shown	 are	 representative	 images	 of	 at	 least	 three	 independent	
experiments.	
4.5.2.2 Western	blot	analysis	confirm	zfAGpr17	knockdown	
To	 verify	 the	 specificity	 of	 zfAgpr17	 MO,	 zfAGpr17	 expression	 in	 3,	 4	 and	 5	 dpf	 old	 zebrafish	
embryos	was	determined	by	Western	blot	analysis	after	injection	of	2.75	ng	MO.	Protein	analysis	
revealed	 a	 decrease	 in	 Gpr17	 expression	 levels	 in	 zfAGpr17	 morphants	 compared	 to	 control	
animals	 (Figure	 34).	 However,	 the	 reduction	 displayed	 only	 significance	 in	 4	 dpf	 old	 embryos	
(P<0.05,	two-way	ANOVA)	(Kleinert,	2018).		
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Figure	 34:	 Western	 blot	 analysis	 reveal	 Gpr17	 knockdown	 after	 injection	 of	 zfAgpr17	 morpholino.	
Zebrafish	 embryos	 injected	 with	 2.75	 ng	 zfAgpr17	 MO	 displayed	 decreased	 Gpr17	 expression	 levels	
compared	 to	 control	 and	 uninjected	 animals,	while	 reduction	was	 only	 significant	 in	 4	 dpf	 old	 embryos	
(Kleinert,	 2018).	 Shown	are	mean	 values	 (+	 SEM)	 from	 four	 independent	 experiments.	 Two-way	ANOVA	
test	was	used	for	statistical	significance.	*,	P<0.05.	Data	were	generated	by	Philip	Reinoß	in	the	Institute	of	
Anatomy,	University	of	Bonn.	
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ZfAGpr17	knockdown	causes	impaired	expression	of	myelin	proteins	in	the	CNS	
Regarding	previously	published	data	 that	demonstrated	an	early	onset	of	myelination	 in	Gpr17	
knockout	mice	 (Chen	 et	 al.,	 2009),	 expression	 of	 myelin	 proteins	 in	 zfAGpr17	morphants	 was	
analysed	by	Whole-mount	IHC	and	Western	blot	assays.		
Using	an	anti-Mbp	antibody,	Myelin	basic	protein	expression	was	imaged	in	the	spinal	cord	of	4	
dpf	 old	 zebrafish	 embryos.	 By	 comparison	 to	 control	MO	 and	 uninjected	 animals	 a	 significant	
decrease	in	Mbp	signal	(P<0.05,	one-way	ANOVA)	was	found	in	the	anterior	and	middle	region	of	
the	spinal	cord	of	embryos	injected	with	zfAgpr17	MO	(Figure	35).		
	
Figure	 35:	 Mbp	 expression	 in	 the	 spinal	 cord	 of	 4	 dpf	 old	 zebrafish	 embryos	 is	 impaired	 following	
zfAGpr17	 knockdown.	 Lateral	 views	 (dorsal	 up,	 anterior	 to	 the	 left)	 of	 zebrafish	 embryos	 (C,D)	 injected	
with	zfAgpr17	and	control	MO	were	obtained	at	4	dpf.	Whole-mount	IHC	was	conducted	with	an	antibody	
directed	 against	Mbp	 coupling	 to	 an	 AlexaFluor546-conjugated	 goat	 anti-guinea	 pig	 antibody.	 One-way	
ANOVA	test	comparing	MO	with	control	MO	injected	zebrafish	embryos,	revealed	a	significant	reduction	in	
Mbp	 signal	 in	 the	 anterior	 (A,C)	 and	 middle	 (B,D)	 spinal	 cord,	 while	 control	 MO	 injected	 resembled	
uninjected	animals.	Data	are	shown	as	mean	values	(+	SEM)	from	two	independent	experiments.	One-way	
ANOVA	using	Bonferroni’s	multiple	comparison	test;	*,p<0.016;	**,	p<0.0006.	
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Additionally	 expression	 of	 myelin-associated	 protein	 Claudin	 K	 and	 myelin	 Protein	 zero	 (P0)	
(Schweitzer,	 Becker	 and	 Becker,	 2003)	 in	 4	 dpf	 old	 zebrafish	 was	 examined	 by	 Western	 blot	
analysis.	 While	 zfAgpr17	 MO	 injections	 caused	 weak	 decreases	 in	 Claudin	 K	 expression	 levels	
compared	to	control	and	uninjected	embryos,	a	significant	 reduction	 in	protein	expression	was	
observed	for	P0	(P<0.0009,	one-way	ANOVA)		(Figure	36).	
To	sum	up,	the	obtained	data	reveal	 impaired	myelination	following	zfAGpr17	knockdown,	thus	
demonstrating	the	opposing	effect	observed	in	knockout	mice.		
	
Figure	36:	Western	blot	analysis	of	zfAGpr17	morphants	reveals	declined	expression	of	myelin	proteins.	
Expression	of	myelin	proteins	Claudin	K	and	P0	was	determined	 in	4	dpf	old	zebrafish	embryos,	 injected	
with	zfAgpr17	and	control	morpholino	by	Western	blot	analysis.	Data	presented	as	mean	values	(+	SEM),	
displayed	a	decrease	in	expression	of	both	proteins	(A,	C),	while	reduction	was	only	significant	for	P0	(C).	
Shown	 is	 the	 representative	Western	blot	 (B)	 of	 at	 least	 three	 independent	experiments.	 ***;	 P<0.0009	
according	to	one-way	ANOVA	using	Bonferroni’s	multiple	comparison	test.	un	=	uninjected	animals;	control	
=	control	injected	morphants;	zfA	=	zfAgpr17	MO	injected	animals.	
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4.5.2.3 WISH	 demonstrates	 reduced	 expression	 of	 myelin	 basic	 protein	 in	 zfAGpr17	
morphants		
In	 order	 to	 strengthen	 the	 IHC	 assay	 revealing	 narrowed	Mbp	expression	 in	 the	 spinal	 cord	 of	
zfAgpr17	 morpholino	 injected	 zebrafish	 (Figure	 35),	 expression	 of	 mbp	 at	 the	 level	 of	
transcription	was	ascertained	by	WISH.		
Thereby,	mbp	 signal	 in	 MO	 injected	 zebrafish	 was	 compared	 to	 control	 MO	 injected	 and	WT	
animals	at	3	and	4	dpf.	While	expression	of	myelin	basic	protein	was	remarkably	reduced	in	the	
CNS	and	in	the	PNS	of	3	dpf	old	morphants	(Figure	37,	A),	the	difference	was	less	noticeable	at	4	
dpf	 (Figure	 37,	 B).	Moreover,	 similarly	 assayed	 tg(olig2:EGFP)	 zebrafish,	 sorted	 by	 fluorescent	
imaging	 prior	 the	 WISH,	 revealed	 the	 same	 expression	 pattern,	 thus	 supporting	 previously	
achieved	WISH	data	(Supplementary	Figure	3).		
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Figure	 37:	 ZfAGpr17	 morphants	 reveal	 decreased	mbp	 expression	 in	 the	 CNS	 and	 PNS.	 zfAgpr17	 MO	
injected	embryos	displayed	a	decrease	in	mbp	expression	in	the	CNS	at	the	level	of	the	spinal	cord	(small	
black	arrows)	and	brain	(big	black	arrows)	as	well	as	 in	the	PNS	(white	arrows)	at	3	dpf	 (A).	At	4	dpf	the	
difference	was	still	noticeable,	albeit	it	was	diminished	(B).	Shown	are	representative	images	(dorsal	up)	of	
two	independent	experiments.	
4.5.2.4 Numbers	of	mature	oligodendrocytes	are	narrowed	in	zfAGpr17	morphants	
One	 explanation	 for	 the	 narrowed	myelination	 in	 zfAGpr17	morphants	 could	 be	 fewer	mature	
oligodendrocytes.		
To	 test	 this,	 Two-photon	 microscopy	 images	 of	 representative	 spinal	 cord	 regions	 of	
tg(claudink:EGFP)	 zebrafish	 were	 acquired	 to	 quantify	 cell	 numbers	 in	 zfAgpr17	 MO	 injected	
embryos.	 At	 3	 dpf,	 zfAGpr17	 morphants	 revealed	 a	 significantly	 reduced	 number	 of	 dorsally	
migrated	 claudin	 k	 positive	 oligodendrocytes	 (P<0.0025,	 one-way	 ANOVA)	 compared	 with	 the	
controls	(Figure	38),	indicating	diminished	oligodendrocyte	maturation.		
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Figure	38:	ZfAGpr17	morphants	reveal	reduced	numbers	of	claudin	k	expressing	dorsally	migrated	cells.	
Tg(claudink:EGFP)	 zebrafish,	 injected	 with	 2.75	 ng	 zfAgpr17	 MO	 RNA	 were	 imaged	 by	 Two-photon	
microscopy	at	3	dpf.	Numbers	of	dorsally	migrated	claudin	k	positive	cells	 significantly	differed	between	
zfAgpr17	 and	control	MO	 injected	animals	 (A).	 Figure	 (B)	 shows	 representative	 lateral	views	 (anterior	 to	
the	left,	dorsal	up)	of	spinal	cord	regions.	Data	are	presented	as	mean	values	(±	SEM)	from	at	least	three	
independent	experiments.	One-way	ANOVA	was	performed	using	Bonferroni’s	multiple	 comparison	 test.	
**,	P<0.0025.	
4.5.2.5 ZfAGpr17	morphants	display	reduced	numbers	of	dorsally	migrated	olig2	positive	cells	
Since	oligodendrocytes	 differentiate	 from	Olig2	positive	OPCs,	 it	was	 to	delineate	whether	 the	
reduction	 in	 number	 of	 dorsally	 located	 claudin	 k	 positive	 oligodendrocyte	 in	 zfAGpr17	
morphants	resulted	from	fewer	OPCs.	
Hence,	fluorescent	images	of	spinal	cord	regions	of	tg(olig2:EGFP)	zebrafish	injected	with	2.75	ng	
zfAgpr17	MO	were	taken	by	Two-photon	microscopy.	A	significant	reduction	(P<0.0001,	one-way	
ANOVA)	 in	 the	 percentage	 of	 olig2	 positive	 cell	 numbers	 in	 mutant	 embryos	 compared	 with	
control	 and	WT	was	 found	 at	 3	 dpf	 (Figure	 39,	 A,	 C).	 These	 results	were	 also	 reproducible	 by	
imaging	higher	numbers	of	injected	zebrafish	with	the	EnSight	plate	reader®	representing	a	high-
throughput	zebrafish	imaging	technology	(Figure	39,	B).	
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Figure	39:	Migration	of	olig2	positive	OPCs	is	inhibited	after	zfAGpr17	knockdown.	At	3	dpf,	injections	of	
2.75	 ng	 zfAgpr17	MO	 in	 tg(olig2:EGFP)	 zebrafish	 caused	 a	 significant	 reduction	 in	olig2	 positive	 dorsally	
migrated	 cells	 in	 morphants	 compared	 to	 control	 injected	 and	 WT	 animals	 (A).	 Results	 achieved	 with	
EnSight®	plate	reader	confirmed	data	obtained	by	Two-photon	microscopy	(B).	Figure	(C)	presents	lateral	
views	(dorsal	up,	anterior	to	the	left)	of	representative	spinal	cord	regions.	Shown	are	mean	values	(±	SEM)	
from	 three	 independent	 experiments.	 ****;	 P<0.0001	 according	 to	 one-way	 ANOVA	 using	 Bonferroni’s	
multiple	comparison	test.	Results	obtained	with	EnSight®	were	generated	by	Enrico	Mingardo	in	the	lab	of	
Prof.	Dr.	Evi	Kostenis,	University	of	Bonn.	
Collectively,	 the	 imaging	 data	 demonstrate,	 that	 zfAGpr17	 knockdown	 reduces	 numbers	 of	
dorsally	located	oligodendrocyte	lineage	cells	in	two	stages	of	development,	at	the	level	of	OPC	
proliferation/migration	 and	 at	 the	 level	 of	 oligodendrocyte	 differentiation.	Hence,	 the	 reduced	
cell	 numbers	 could	 result	 either	 from	 decreased	 OPC	 proliferation	 and	 differentiation,	 and/or	
increased	 death.	 To	 distinguish	 between	 these	 possibilities,	 IHC	 and	 WISH	 analysis	 were	
conducted.	
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4.5.2.6 ZfAGpr17	knockdown	does	not	induce	apoptosis	
To	 determine	 whether	 the	 reduced	 numbers	 of	 oligodendrocyte	 lineage	 cells	 in	 zfAGpr17	
morphants	 resulted	 from	 increased	 cell	 death,	 whole-mount	 zebrafish	 embryos,	 injected	 with	
zfAgpr17	and	control	MO	were	labelled	for	the	active	form	of	Caspase-3	(Cleaved	Caspase-3)	at	3	
dpf.	Numbers	of	 cells	 that	 stained	positive	 for	Caspase-3	did	not	markedly	differ	 between	MO	
and	control	MO	 injected	animals	 (Figure	40),	 indicating	 that	zfAgpr17	MO	does	not	 induce	cell	
death	in	the	spinal	cord	of	zebrafish	embryos.	
	
Figure	40:	Cleaved	Caspase-3	is	not	upregulated	in	3	dpf	zebrafish	embryos	after	zfAgpr17	MO	injection.	
Expression	of	Cleaved	Caspase-3	was	determined	in	3	dpf	old	zebrafish,	injected	with	zfAgpr17	and	control	
MO	by	 IHC	assay.	Cells	 stained	positive	 for	Cleaved	Capsase-3	 (white	arrow)	were	not	markedly	present	
after	 zfAgpr17	 MO	 injections	 compared	 to	 control	 MO	 injected	 and	 uninjected	 animals.	 Data	 are	
representative	images	of	two	independent	experiments.	Stainings	and	images	were	generated	by	Dr.	Anna	
Japp	in	the	lab	of	Prof.	Dr.	Torsten	Pietsch,	Medical	Centre,	University	of	Bonn.	
4.5.2.7 Enhanced	nkx2.2	expression	in	zfAGpr17	morphants	indicates	precocious	initiation	of	
oligodendrocyte	differentiation	
As	 expression	 of	 the	 transcription	 factor	 Nkx2.2	 initiates	 the	 terminal	 differentiation	 pathway,	
allowing	OPCs	 turn	 into	 pre-OLs	 (Kucenas,	 Snell	 and	Appel,	 2010),	 it	was	 to	 ascertain	whether	
Gpr17	knockdown	intervene	in	this	developmental	stage.		
To	test	this,	nkx2.2	expression	 in	zfAGpr17	morphants	and	control	embryos	was	determined	by	
WISH.	ZfAgpr17	MO	injected	zebrafish	revealed	a	markedly	increase	in	nkx2.2	gene	expression	in	
the	spinal	cord	compared	to	control	animals	at	2.5	dpf	(Figure	41),	suggesting	that	differentiation	
of	OPCs	into	pre-OLs	is	not	inhibited	but	rather	preceded	compared	WT	animals.	
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Figure	41:	Nkx2.2	 expression	 in	 the	 spinal	 cord	of	 zfAGpr17	morphants	was	markedly	 increased	at	2.5	
dpf.	WT	zebrafish	 injected	with	2.75	ng	zfAgpr17	MO	exhibited	enhanced	nkx2.2	 gene	expression	 in	 the	
spinal	cord	at	2.5	dpf	compared	to	control	MO	injected	and	uninjected	animals.	Shown	are	representative	
lateral	views	(dorsal	up)	of	two	independent	experiments.	
Together,	these	data	suggest	that	Gpr17	knockdown	induced	precocious	differentiation	of	OPCs	
into	nkx2.2	expressing	pre-OLs.	However,	as	being	restrained	in	the	pMN	region,	oligodendrocyte	
lineage	cells	 fail	 to	migrate	 into	the	dorsal	spinal	cord	region,	which	 finally	 leads	 to	 insufficient	
myelination.	Whether	Gpr17	knockdown	affects	OPC	proliferation	cannot	be	concluded	by	these	
experiments.	
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4.5.2.8 zfAgpr17	 RNA	 rescues	 morpholino-induced	 reduction	 of	 dorsally	 migrated	
oligodendrocyte	lineage	cells		
Since	 preceding	 studies	 revealed	 that	 OE	 of	 Gpr17	 by	 RNA	 injections	 did	 not	 affect	
oligodendrocyte	development,	one	could	argue	that	protein	is	not	translated.	Hence,	the	ability	
of	zfAgpr17	RNA	to	rescue	MO-induced	reduction	of	dorsally	migrated	cells	was	determined	by	
co-injection	 of	 zfAgpr17	 MO	 and	 RNA.	 As	 expected,	 injections	 of	 zfAgpr17	 MO	 caused	 a	
significant	 decrease	 in	 numbers	 of	 olig2	 positive	 cells	 at	 3	 dpf	 (P<0.0001,	 one-way	 ANOVA).	
Notably,	co-injection	of	800	pg	zfAgpr17	RNA	rescued	the	amounts	of	olig2	positive	cells	(Figure	
42).	No	significant	differences	were	observed	between	control	injected	and	co-injected	animals.	
Together,	these	data	indicate	both	successful	translation	of	gpr17	RNA	within	zebrafish	embryos	
as	well	as	specificity	of	zfAgpr17	MO.		
	
Figure	 42:	 Reduction	 in	 numbers	 of	 olig2	 positive	 cells	 in	 zfAGpr17	 morphants	 can	 be	 rescued	 by	
zfAgpr17	 RNA.	 Gpr17	 rescue	was	 evaluated	 by	 imaging	 representative	 spinal	 cord	 regions	 of	 3	 dpf	 old	
tg(olig2:EGFP)	zebrafish	embryos,	injected	with	zfAgpr17	MO	alone	as	well	as	together	with	zfAgpr17	RNA.	
While	MO	injected	animals	displayed	a	significant	difference	in	number	of	dorsally	migrated	olig2	positive	
cells	 compared	 to	 control	 injected	 animals,	 the	 reduction	 was	 completely	 rescued	 after	 co-injection	 of	
zfAgpr17	MO	with	RNA	 (A).	 (B)	 shows	 representative	 lateral	 views	 (dorsal	up,	 anterior	 to	 the	 left).	Data	
presented	 as	 mean	 values	 (±	 SEM)	 of	 at	 least	 three	 independent	 experiments.	 One-way	 ANOVA	 was	
performed	using	Bonferroni’s	multiple	comparison	test.	****;	P<0.0001.		
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5 Discussion	
Myelination,	the	deposition	of	multi-layered	membrane	sheaths	on	axons	by	specialized	glia	cells,	
constitutes	the	basis	 for	several	neurophysiological	processes	 in	 the	vertebrate	nervous	system	
(Pfeiffer,	 Warrington	 and	 Bansal,	 1993).	 However,	 to	 date,	 the	 underlying	 mechanism	 of	
myelination	is	not	completely	clarified;	consequently,	ongoing	research	in	this	field	is	crucial.	An	
improved	understanding	of	myelination	would	further	support	the	investigation	of	diseases	such	
as	multiple	 sclerosis	 (MS)	 (Compston	 and	 Coles,	 2008),	 Alzheimer’s	 disease	 (George	 Bartzokis,	
2011),	cerebral	palsy	(Azzarelli	et	al.,	1996)	or	schizophrenia	(Azzarelli	et	al.,	1996),	all	displaying	
demyelination	as	pathological	feature.	
Recently,	 G-protein	 coupled	 receptors	 have	 been	 identified	 as	 key	 regulators	 during	
oligodendrocyte	 development	 and	 myelination	 (Mogha,	 Rozario	 and	 Monk,	 2016),	 and	 may	
therefore	 promise	 new	 targets	 in	 the	 treatment	 of	 demyelinating	 diseases.	 One	 of	 them,	 the	
orphan	 rhodopsin	 family	 G-protein	 coupled	 receptor	 17,	 which	 is	 enriched	 in	 oligodendrocyte	
lineage	 cells,	 has	 been	 implicated	 in	 the	 maturation	 of	 oligodendrocytes	 (Chen	 et	 al.,	 2009;	
Fumagalli	et	al.,	 2011).	 In	addition	 to	 its	 role	during	oligodendrocyte	development,	GPR17	was	
found	 to	 be	 upregulated	 in	 human	 white	 matter	 plaques	 of	 MS	 patients	 (Chen	 et	 al.,	 2009).	
However	 its	 function	 in	 the	 disease	 remains	 speculative	 at	 the	 time.	 Despite	 the	 intensive	
knowledge	 about	 this	 GPCR,	 published	 literature	 reveals	 inconsistences	 concerning	 expression	
pattern,	role	and	activation	by	distinct	ligands;	thus,	there	is	an	urgent	need	of	further	research	
clarifying	outstanding	issues	(Marucci	et	al.,	2016).	
Herein,	 the	 zebrafish	 (Danio	 rerio),	 a	 freshwater	 teleost	 (Kari,	Rodeck	and	Dicker,	2007),	might	
represent	 a	 potential	 model	 organism	 to	 gain	 new	 insights	 in	 the	 role	 of	 Gpr17	 in	
oligodendrocyte	myelination,	not	only	during	development	but	also	in	disease.	This	chapter	will	
discuss	receptor	functionality	of	zebrafish	Gpr17	examined	in	in	vitro	and	in	vivo	assays	as	well	as	
the	 potential	 of	 artificial	 chimeric	 Gpr17	 receptors	 as	 promising	 screening	 tools.	 Furthermore,	
specific	 in	 vivo	 results	 concerning	 receptor	 expression	 and	 function	 will	 be	 discussed	 and	
compared	 with	 existing	 literature	 to	 finally	 debate	 whether	 the	 zebrafish	 is	 a	 suitable	 animal	
model	as	in	vivo	screening	platform	for	new	ligands	of	human	Gpr17.	
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5.1.1 Zebrafish	Gpr17	lacks	functionality	in	vitro	
After	identification	and	characterization	of	the	orphan	G-protein	coupled	receptor	17	(Raport	et	
al.,	1996;	Bläsius	et	al.,	1998;	Heise	et	al.,	2000),	researchers	aimed	to	ascertain	the	ligand	that	
endogenously	activates	this	GPCR.	In	2006,	Ciana	et	aI.	postulated	a	dual	pharmacological	profile,	
whereupon	Gpr17	responds	to	both	uracil	nucleotides	and	cysteinyl	leukotrienes.	Based	on	that	
deorphaning	 report,	 follow-up	 studies	 by	 the	 same	 group	 examined	 function	 of	 this	 receptor	
during	 oligodendrocyte	 development	 by	 using	 the	 two	 family	 ligands,	with	 the	 conclusion	 that	
Gpr17	 activation	 promotes	 oligodendrocyte	maturation	 (Lecca	et	 al.,	 2008;	 Ceruti	et	 al.,	 2009;	
Fumagalli	et	al.,	2011).	However,	Gpr17	activation	 through	 the	proposed	agonists	could	not	be	
verified	by	several	 independent	 laboratories	(Heise	et	al.,	2000;	Maekawa	et	al.,	2009;	Benned-
Jensen	 and	 Rosenkilde,	 2010;	 Simon	 et	 al.,	 2017).	 Additionally,	 Hennen	 and	 collaborators	
identified	 a	 small-molecule	 agonist,	 MDL29,951,	 which	 activated	 Gpr17	 mainly,	 but	 not	
exclusively,	 via	 the	 Gαi/o	 pathway	 in	 a	 concentration-dependent	 manner.	 Noteworthy,	
experimental	 results	 from	 this	 group	emphasised	 an	 inhibitory	 role	of	Gpr17	on	maturation	of	
oligodendrocytes	 (Hennen	 et	 al.,	 2013a;	 Simon	 et	 al.,	 2016),	 in	 agreement	 with	 reports	 from	
several	independent	laboratories	(Chen	et	al.,	2009;	Daniele	et	al.,	2014).	
In	 an	 attempt	 to	 clarify	 these	 conflicting	 data,	 ongoing	 research	 should	 focus	 on	 finding	 new	
model	 systems	 in	which	 the	 activation	 and	 role	 of	Gpr17	 can	 be	 analysed.	While	 prior	 studies	
utilized	 rodent	 models	 to	 study	 Gpr17	 in	 myelination	 (Lecca	 et	 al.,	 2008;	 Chen	 et	 al.,	 2009;	
Fumagalli	et	al.,	2011;	Hennen	et	al.,	2013a;	Simon	et	al.,	2016),	future	efforts	might	consider	the	
smaller	vertebrate	model	zebrafish,	which	displays	a	powerful	alternative	to	study	myelination	in	
vivo	 (Driever	 et	 al.,	 1994;	 Buckley,	 Goldsmith	 and	 Franklin,	 2008;	 Ackerman	 and	Monk,	 2015;	
Preston	 and	 Macklin,	 2015).	 Hence,	 primary	 experiments	 of	 this	 work	 aimed	 to	 answer	 two	
questions:	firstly,	whether	zebrafish	Gpr17	can	be	activated	by	postulated	uracil	nucleotides	and	
cysteinyl	 leukotrienes;	 and	 secondly,	 whether	 MDL29,951	 could	 induce	 robust	 responses	
comparable	to	those	on	human,	mouse	and	rat	Gpr17	(Hennen	et	al.,	2013).		
The	data	obtained	in	label-free	Dynamic	mass	redistribution	assays	revealed	missing	responses	of	
zebrafish	Gpr17	 transfected	mammalian	HEK293	 cells	 towards	 both	 the	 proposed	 endogenous	
agonists	and	MDL29,951.	The	 lack	of	activity	of	uracil	nucleotides	and	cysteinyl	 leukotrienes	on	
zebrafish	Gpr17	was	rather	expected	and	entirely	consistent	with	previous	observations	showing	
unresponsiveness	 of	 human,	 mouse	 and	 rat	 Gpr17	 in	 various	 recombinant,	 immortalized	 and	
primary	cells	(Simon	et	al.,	2017).	Thus,	the	notion	of	Simon	and	collaborators	considering	Gpr17	
as	orphan	 is	 further	 supported	by	 the	 results	of	 this	work.	 Conversely,	 the	 lacking	 response	of	
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MDL29,951	on	zebrafish	Gpr17	examined	within	this	work	was	rather	surprising,	since	Simon	and	
collaborators	proved	that	MDL29,951	activates	Gpr17	orthologous	from	human,	mouse	and	rat	in	
a	 similar	 manner.	 The	missing	 response	may	 be	 grounded	 on	 three	 reasons:	 Firstly,	 zebrafish	
Gpr17	 is	 insufficiently	 expressed	 in	 the	 cell	 membrane	 of	 the	 mammalian	 HEK293	 cell	 line.	
Secondly,	 the	 intracellular	 interaction	 between	 the	 zebrafish	 receptor	 and	 the	 mammalian	 G-	
proteins	is	circumvented.	Thirdly,	the	small	molecule	agonist	does	not	bind	appropriately	to	the	
zebrafish	receptor.		
Beginning	 with	 the	 membrane	 availability	 of	 the	 receptor,	 ELISA	 and	 ICC	 assays	 verified	 its	
expression	on	 the	cell	 surface,	 thus	a	 lack	of	 response	based	on	missing	membrane	expression	
can	 be	 actually	 excluded.	 Nevertheless,	 it	 might	 be	 possible	 that	 zebrafish	 receptors	 need	
increased	 expression	 levels	 in	mammalian	 cell	 lines	 for	 an	 appropriate	 detectable	 signaling.	 A	
future	 generation	 of	 a	 stable	 cell	 line	 expressing	 the	 zebrafish	 Gpr17	 at	 a	 higher	 level	 than	
transient	 transfected	 cells	 might	 offer	 better	 signalling	 conditions	 in	 the	 extrinsic	 mammalian	
background.		
Intricacies	 in	 the	 analysis	 of	 zebrafish	 receptors	 in	 mammalian	 cell	 lines	 have	 already	 been	
described	by	existing	literature.	Studies	of	Ringvall	and	collaborators	demonstrated	lower	binding	
affinities	and	less	potency	of	zebrafish	neuropeptide	Y	(NPY)	receptors	in	CHO	cells	compared	to	
mammalian	 NPY	 receptors	 (Ringvall,	 Berglund	 and	 Larhammar,	 1997).	 Thereby,	 inappropriate	
interaction	 of	 mammalian	 G-proteins	 with	 zebrafish	 receptors	 was	 assumed	 to	 be	 the	 cause.	
Within	 this	work,	 this	assumption	was	supposed	to	be	resolved	by	use	of	a	zebrafish	 fibroblast	
cell	 line,	 which	 exhibits	 zebrafish	 G-proteins.	 However,	 sufficient	 zebrafish	 Gpr17	 expression	
levels	could	not	be	achieved	upon	transfection	into	this	cell	line.	Since	zebrafish	cell	lines	do	not	
appear	in	current	literature	to	date,	their	use	as	an	in	vitro	platform	might	be	inappropriate.		
In	a	multiple	alignment,	human	Gpr17	(Gpr17-S)	shared	56	%	identical	residues	with	zfA	and	44	%	
with	 zfBGpr17.	 Moreover,	 according	 to	 mutagenesis	 studies	 (unpublished	 data),	 the	 residue	
motif	 involved	 in	 receptor	 activation	 by	 MDL29,951	 is	 identical	 from	 zebrafish	 to	 mammals.	
Therefore,	considering	the	level	of	conservation,	there	are	no	actual	reasons	for	a	lack	of	agonist	
binding	 at	 the	 zebrafish	 receptors.	 However,	 the	 missing	 receptor	 functionality	 queried	 the	
binding	capacity	of	MDL29,951.	One	way	to	overcome	this	open	question	was	the	construction	of	
chimeric	receptors,	exchanging	the	extracellular	loops	together	with	the	transmembrane	regions,	
which	contain	the	ligand	binding	domain,	between	human	and	zebrafish	Gpr17s.	In	DMR	assays,	
chimeras	 containing	 the	human	binding	domain	 region	and	either	 zfA	or	 zfBGpr17	 intracellular	
loops	 showed	 functionality	 after	 stimulation	 with	 MDL29,951,	 although	 the	 responses	 were	
diminished	 compared	 to	human	Gpr17.	 Conversely,	 chimeric	 receptors	 exhibiting	 the	 zebrafish	
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binding	 domain	 remained	 unresponsive,	 despite	 containing	 the	 human	 intracellular	 loops	
responsible	for	the	interaction	with	G-proteins	in	HEK293	cells.	Altogether,	these	results	suggest	
an	 impaired	 binding	 of	 MDL29,951	 on	 zebrafish	 Gpr17.	 Clearly,	 future	 GTPγS-binding	 analysis	
should	be	carried	out	to	prove	this	hypothesis.		
Even	though	our	results	suggest	an	 impeded	receptor-ligand	interaction,	 it	may	have	happened	
that	the	fish	receptor	lacked	its	normal	microenvironment.	In	the	animal,	zebrafish	Gpr17	signals	
at	28°C,	while	experiments	conducted	within	this	work	in	the	HEK293	cell	line	were	performed	at	
37°C.	 The	 temperature	 may	 influence	 the	 folding	 of	 the	 receptor	 and	 the	 following	 signalling	
behaviour.	 Thus,	 it	 could	 have	 occurred	 that	 although	membrane	 expression	was	 present,	 the	
receptor	 remained	 non-functional	 in	 this	 cell	 line.	 Therefore,	 functionality	 of	 zebrafish	 Gpr17	
should	be	also	analysed	in	its	native	signalling	environment.	
5.1.2 MDL29,951	treatment	of	zebrafish	embryos	does	not	influence	
myelination	in	vivo	
The	 highly	 important	 research	 area	 of	 developmental	 and	 disease	 biology	 has	 been	
complemented	during	the	last	two	decades	by	the	small	fresh-water	vertebrate	zebrafish	since	it	
provides	 an	 ideal	 in	 vivo	model	organism	 for	 gene	and	 target	 validation,	 as	well	 as	 for	disease	
investigations.	 The	 high	 genome	 conservation	 between	 zebrafish	 and	 humans	 makes	 them	 a	
popular	 and	 currently	 used	 model	 organism	 in	 many	 important	 medical	 areas	 (Langheinrich,	
2003;	Taylor	et	al.,	2010;	Howe	et	al.,	2013).	Especially	in	the	field	of	myelination,	several	genes	
and	 cell	 lineage	 properties	 are	 highly	 conserved	 between	 zebrafish	 and	 mammals,	 wherefore	
questions	 concerning	 CNS	 development,	 myelin	 function	 and	 repair	 can	 be	 investigated	 with	
zebrafish	(Brösamle	and	Halpern,	2002;	Raphael	and	Talbot,	2011;	Czopka,	2015).	
Furthermore,	due	to	 its	small	size	and	rich	fertility,	 the	animal	provides	also	optimal	conditions	
for	drug	discovery	studies	by	high-throughput	screenings	of	large	compound	libraries.	Particularly	
suited	for	this	purpose	 is	the	zebrafish	embryo	since	 it	 is	permeable	to	drugs	and	can	be	easily	
genetically	 modified.	 For	 instance,	 Buckley	 et	 al.	 used	 a	 transgenic	 reporter	 line	 for	 high-
throughput	screening	of	drugs	with	pro-myelinating	features.	Compounds	that	altered	numbers	
of	oligodendrocyte	lineage	cells	were	further	examined	by	qPCR	and	finally	evaluated	in	tertiary	
screens	 for	 suitability	 for	 research	 progression	 (Buckley	 et	 al.,	 2010).	 Likewise,	 Fang	 et	 al.	
demonstrated	 that	 treatment	 of	 zebrafish	 embryos	 with	 metronidazole	 caused	 demyelination	
that	 regenerated	after	metronidazole	withdrawal	within	seven	days	 (Fang	et	al.,	2014).	 In	both	
studies,	drugs	were	easily	applied	in	the	aquaria	water	where	the	zebrafish	were	housed	in.	
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Accordingly,	 an	 effect	 of	 MDL29,951	 acting	 on	 zebrafish	 Gpr17	 and	 thereby	 influencing	 the	
myelination	process	could	be	examined	 in	an	analogous	way.	On	 this	occasion,	 functionality	of	
zebrafish	Gpr17	would	be	analysed	 in	 its	native	signalling	environment.	Obviously,	 this	method	
cannot	 exclude	 target	 unspecific	 effects	 and	 merely	 yields	 an	 indirect	 way	 to	 analyse	
responsiveness	 of	MDL29,951	 at	 zebrafish	 Gpr17.	 However,	 it	 substantiates	 evidence	whether	
distinct	 signalling	 backgrounds	 influence	 receptor	 signal	 transduction	 in	 a	 certain	manner	 and	
whether	knockout	approaches	are	essential	for	further	studies.	
Similar	to	Buckley	and	collaborators	(Buckley	et	al.,	2010),	who	used	imaging	methods	as	a	first	
and	quick	experiment	in	the	entire	drug-screening	cascade,	numbers	of	migrated	mature	claudin	
K	 positive	 oligodendrocytes	 of	 treated	 and	 control	 animals	 were	 evaluated	 at	 5	 dpf.	 While	
Buckley	et	al.	screened	for	immature	oligodendrocyte	precursor	cells	at	earlier	time	points,	hence	
achieving	 further	 premonitions	 about	 cell	 proliferation	 and	migration,	 experiments	 within	 this	
work	 rather	 focused	on	myelin	producing	cells,	 aiming	 to	mirror	myelination.	The	 results	 show	
that	MDL29,951	treatment	of	zebrafish	embryos	for	 five	days	did	not	change	claudin	K	positive	
oligodendrocyte	 numbers,	 thus	 indicating	 no	 altered	 oligodendrocyte	 development	 nor	
myelination.	This	was	further	confirmed	by	Western	blot	analysis	of	5	dpf	old	embryos	revealing	
stable	 expression	 of	 myelin	 protein	 36k	 after	 MDL29,951	 treatment	 compared	 to	 untreated	
controls.	 Noteworthy,	 36k,	 a	 newly	 discovered	 myelin	 protein	 that	 was	 found	 to	 be	 highly	
expressed	in	oligodendrocytes	of	zebrafish	(Morris	et	al.,	2004),	may	not	represent	myelination	in	
the	approved	manner	as	prominent	myelin	proteins	such	as	Mbp	or	Plp	(Schweitzer	et	al.,	2006;	
Nawaz	 et	 al.,	 2013).	 However,	 antibodies	 detecting	 zebrafish	 Mbp	 and	 Plp	 did	 not	 work	 in	
Western	 blot	 analysis.	 Nevertheless,	 qPCR	 analysis	 reflected	 unaltered	 expression	 of	 myelin	
genes	 mbp	 and	 plp	 after	 MDL29,951	 treatment,	 further	 supporting	 the	 36k	 analysis.	 It	 is	
important	to	note	that	a	disadvantage	of	Western	blot	and	qPCR	studies	constitutes	the	sample	
acquisition,	 since	 entire	 embryos	were	 collected	 for	 analysis	 of	myelin	 protein	 expression	 and,	
consequently,	potential	differences	in	particular	regions	of	the	zebrafish	nervous	system	may	be	
undetectable.	Future	studies	using	electron	microscopy	of	transverse	spinal	cord	sections	would	
be	desirable	 in	order	to	screen	for	specific	potential	alterations	 in	myelinated	axons	(Ackerman	
and	Monk,	2015).	
Overall,	these	results	additionally	underscore	the	unresponsiveness	of	zebrafish	Gpr17	obtained	
in	preceding	 in	 vitro	 experiments	 and	plead	once	more	 for	 impaired	 ligand	binding.	 Therefore,	
MDL29,951,	 a	 selective	 activator	 for	Gpr17	of	 human,	 rat	 and	mouse	Gpr17,	 turned	out	 to	 be	
unsuitable	for	a	Gpr17-dependent	manipulation	of	oligodendrocyte	myelination	in	zebrafish.		
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5.1.3 Chimeric	Gpr17	receptors	may	represent	suitable	tools	for	target	
validation	and	drug	discovery	
While	the	Greek	mythology	delineates	chimeras	as	monstrous	fire-breathing	composites	of	parts	
from	 lion,	 goat	 and	 serpent,	 in	 the	 scientific	 literature	 the	 designation	 stands	 for	 molecules	
composed	 of	 domains	 from	 various	 receptors.	 Especially,	 the	 7-transmembrane	 G-protein	
coupled	 receptors	 comprising	 three	 basic	 domains	 (extracellular,	 intracellular	 and	
transmembrane	 region)	 can	be	perfectly	 converted	 into	 chimeras.	During	 the	 last	 two	decades	
several	 independent	 research	 groups	 established	 more	 than	 100	 chimeric	 receptors	 to	 study	
inter	alia	ligand	binding	and	downstream	signalling	(Yin	et	al.,	2004).	
While	existing	literature	occasionally	reports	about	chimeric	receptors	consisting	of	homologous	
receptors,	 first	 time	within	 this	work,	 orthologous	Gpr17	 receptors	 from	 zebrafish	 and	 human	
were	merged	 into	 chimeras	with	 the	 view	 to	 unravel	 the	 unresponsiveness	 of	 zebrafish	Gpr17	
towards	 a	 small	 molecule	 agonist.	 As	 described	 in	 preceding	 chapters,	 DMR	 assays	 proved	
functionality	 of	 chimeras	 containing	 the	 human	 binding	 site	 upon	 activation	 with	MDL29,951,	
while	 receptors	exhibiting	 the	zebrafish	binding	domain	remained	unresponsive.	The	 functional	
chimeric	 receptors	 provoked	 varied	 DMR	 traces	 and	 2-fold	 lower	 responses	 than	 those	 of	 the	
human	 Gpr17.	 One	 of	 the	 reasons	 for	 the	 constrained	 responses	 was	 the	 2-fold	 decreased	
membrane	 expression	 compared	 to	 the	 human	 receptor.	 The	 phenomenon	 of	 declined	
expression	of	 chimeric	 receptors	 is	 also	 found	 in	different	 studies	 (e.g.,	Gearing	et	al.	 studying	
ligand	 binding	 of	 chimeric	 leukotriene	 receptors	 (Gearing	 et	 al.,	 2003)).	 A	 second	 reason	 was	
elucidated	in	further	experiments	that	analyzed	chimeric	Gpr17	receptors	in	the	presence	of	the	
G-protein	 inhibitors	 pertussis	 toxin	 (PTX)	 and	 UBO-QIC.	 The	 obtained	 data	 revealed	 exclusive	
coupling	of	 the	 chimeric	 receptors	 through	Gαi,	 exemplified	by	 the	depressed,	 sharpened	 trace	
shape,	while	human	Gpr17	activates	both,	Gαi/o	and	Gαq	pathways	(Supplementary	Figure	4).	
In	particular,	the	established	chimeric	receptors	are	not	only	applicable	for	clarifying	the	binding	
incompatibilities	of	zebrafish	Gpr17,	but	may	also	represent	smart	tools	for	 in	vivo	screening	of	
compounds	 with	 activating	 or	 inhibiting	 properties	 on	 human	 Gpr17.	 Stably	 expressed	 in	
different	zebrafish	reporter	 lines,	endogenous	zebrafish	signalling	pathways	would	be	triggered	
while	 ligand	 binding	 and	 receptor	 activation	 would	 proceed	 as	 in	 humans.	 On	 this	 occasion,	
compounds	that	alter	myelination	in	zebrafish	would	allow	drawing	conclusion	concerning	effects	
in	humans.	Nevertheless,	 the	 reduced	membrane	expression	and	 impaired	signalling	behaviour	
of	 chimeric	 receptors	 observed	 in	 the	 mammalian	 cell	 line	 should	 not	 be	 disregarded	 when	
considering	potency	of	compounds	 in	vivo.	 It	may	be	 that	both	 restrictions	are	vanished	 in	 the	
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animal;	however,	it	remains	speculative	to	what	extent	that	impacts	on	the	effects.	In	the	same	
sense,	 to	 prevent	 biased	 results,	 the	 expression	 of	 chimeras	 in	 zebrafish	 Gpr17	 null	 mutants	
should	 be	 also	 considered.	 Although	MDL29,951	 failed	 in	 activating	 zebrafish	Gpr17,	 this	 does	
not	mean	that	other	compounds	act	in	the	same	way.		
To	 conclude,	 Gpr17	 chimeras	 would	 indeed	 facilitate	 the	 in	 vivo	 screening	 of	 human	 Gpr17	
targeting	 compounds,	 although	 their	 usability	 in	 vivo	 has	 to	 be	 shown	 in	 future	 experiments.	
Before	 this,	 however,	 additional	 investigations	 have	 to	 prove	 a	 crucial	 role	 of	 Gpr17	 in	
myelination	of	the	aquatic	vertebrate	zebrafish.	
5.1.4 Gpr17	is	expressed	in	developmental	stages	of	zebrafish	CNS		
In	2006,	Kirby	et	al.	 illustrated	oligodendrocyte	development	and	myelination	 in	zebrafish	by	 in	
vivo	 time-lapse	 imaging	 of	 transgenic	 reporter	 lines.	 Confocal	 images	 of	 zebrafish	 embryos	
revealed	that	at	2	dpf,	OPCs	derived	from	NP	cells	start	migrating	dorsally	from	the	pMN	region	
in	 the	neural	 tube.	Once	 they	 stop	proliferating	and	migrating,	OPCs	differentiate	 into	pre-OLs	
that	finally	transition	into	myelinating	oligodendrocytes,	so	that	at	5	dpf	first	myelin	sheaths	can	
be	 observed.	 Consistent	 with	 this	 reported	 zebrafish	 oligodendrocyte	 development,	 WISH	
experiments	of	this	work	displayed	an	expression	pattern	of	gpr17	RNA	within	the	first	five	days	
of	zebrafish	development.	Deletion	of	OPCs	with	TSA	(Takada	et	al.,	2010)	 induced	a	significant	
demise	of	gpr17	expression	 in	the	dorsal	spinal	cord	region,	 thus	suggesting	Gpr17	presence	 in	
dorsally	migrated	 oligodendrocyte	 lineage	 cells	 in	 zebrafish.	 Remarkably,	 diffuse	 expression	 of	
gpr17	 is	detected	already	at	1	dpf	within	 the	dorsal	 and	 the	ventral	 spinal	 cord,	 suggesting	an	
existence	 of	 gpr17	 before	 initiation	 of	 oligodendrocyte	 development.	 This	 presumption	 was	
previously	 described	 by	 Maisel	 et	 al.	 proposing	 gpr17	 gene	 as	 marker	 of	 adult	 NG2	 positive	
progenitor	cells	of	human	hippocampus	(Maisel,	Herr,	et	al.,	2007).	Whether	Gpr17	is	expressed	
in	 developmental	 NG2	 progenitor	 cells	 of	 the	 zebrafish	 has	 to	 be	 confirmed	 by	 future	
experiments.	Last	but	not	least,	WISH	experiments	revealed	missing	gpr17	expression	in	the	PNS,	
thereby	supporting	previously	published	data	obtained	with	mice	(Chen	et	al.,	2009).	Altogether,	
these	data	suggest	that	gpr17	is	expressed	in	oligodendroglial	cells.	Future	experiments	to	finally	
corroborate	this	finding	are	necessary,	such	as	co-localization	in	oligodendrocyte	lineage	cells	by	
simultaneous	 signal	 amplification	 of	 gpr17	 RNA	 with	 olig2	 or	 claudin	 K	 by	 RNAscope	
technology®,	or	by	IHC	assays	detecting	the	corresponding	proteins.	
In	addition	to	WISH	analysis	that	visualized	expression	of	gpr17	RNA,	implemented	Western	blot	
analysis	 displayed	 Gpr17	 protein	 abundance	 during	 embryogenesis,	 commencing	 at	 3	 dpf	 and	
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remaining	stable	until	10	dpf,	 the	period	when	myelination	progresses.	Moreover,	Gpr17	could	
not	be	detected	in	brains	of	healthy	adult	zebrafish.	These	results	correlate	with	the	pattern	of	
expression	found	in	mice,	where	Gpr17	is	present	during	the	period	of	myelinogenesis	from	P3	to	
P21,	whereupon	its	expression	declines	markedly	until	adulthood	(Chen	et	al.,	2009).		
To	 sum	 up,	 experiments	 of	 this	 work	 demonstrate	 Gpr17	 expression	 during	 zebrafish	 CNS	
development,	 which	 is	 consistent	 with	 the	 reported	 expression	 in	 mice	 and	 suggests	 an	
involvement	of	this	receptor	in	the	regulation	of	oligodendrocyte	development.		
	 	
	Discussion	
	 117	
5.1.5 The	impact	of	zebrafish	Gpr17	on	myelination	needs	to	be	further	
explored		
The	potential	of	zebrafish	serving	as	tool	in	drug	discovery	is	further	extended	by	its	utilization	in	
target	 identification	 and	 validation	 studies.	 Thus,	 zebrafish	 provide	 prominent	 platforms	 for	
genetic	 screens,	 either	 for	 forward	 screenings	 to	 identify	 mutated	 genes	 after	 inducing	
phenotypes	 by	 chemical	 mutagenesis	 or	 for	 investigations	 of	 specific	 phenotypes	 following	
mutations	of	disease-related	 targets.	The	 latter,	also	known	as	 reverse	 screening,	usually	 takes	
advantage	of	overexpression	 (OE)	and	knockout	 (KO)	methodologies	 implemented	 inter	alia	by	
use	 of	 the	 CRISPR/cas9	 system	 (Yoganantharjah	 and	 Gibert,	 2017).	While	 transient	 OE	 can	 be	
quickly	 achieved	 by	 injection	 of	 mRNA	 or	 plasmid	 DNA	 into	 the	 one-cell	 stage	 of	 zebrafish	
embryos,	the	generation	of	KO	animals	takes	far	longer.	A	timesaving	alternative	represents	the	
morpholino	 (MO)-induced	 gene	 knockdown.	 By	 complementary	 binding	 of	 backbone-altered	
oligomers	 to	 specific	 nucleic	 acid	 sequences,	 the	 translation	machinery	 is	 impaired	 (Corey	 and	
Abrams,	 2001).	 Noteworthy,	 during	 the	 last	 15	 years	 an	 growing	 number	 of	 scientists	 claimed	
about	MO-induced	off-target	effects	causing	misleading	results	and	thus	degrading	their	scientific	
relevance	 (Blum	et	al.,	 2015).	However,	 Stainier	 and	 co-workers	 recently	published	a	 guideline	
recommending	 utility	 of	 MO	 oligomers	 while	 taking	 account	 of	 some	 rules,	 for	 instance	 by	
verifying	MO-induced	effects	 in	rescue	experiments	 (Stainier	et	al.,	2017).	Hence,	 for	validating	
the	 role	of	Gpr17	during	oligodendrocyte	development	and	myelination,	Gpr17	expression	was	
manipulated	 by	 injections	 of	 3HA-tagged	 zfgpr17	mRNA	 or	MO	 oligonucleotides	 into	 one-cell	
stage	zebrafish	embryos.		
Transient	OE	of	Gpr17	within	the	first	days	of	zebrafish	life	had	no	influence	on	oligodendrocyte	
development	 or	 myelination.	 Imaging	 results	 of	 transgenic	 reporter	 lines	 revealed	 unaltered	
numbers	of	oligodendrocyte	lineage	cell	 in	both,	pre-mature	and	mature	developmental	stages.	
In	 addition,	 comparable	 expression	 pattern	 of	 the	 transcription	 factor	nkx2.2	 labelling	 pre-OLs	
indicated	 neither	 premature	 nor	 delayed	 initiation	 of	 oligodendrocyte	 development.	 Finally,	
unchanged	 expression	 of	 myelin	 genes	 such	 as	mbp	 and	 plp,	 evaluated	 by	 qPCR	 and	 WISH,	
coincided	with	Mbp	 expression	 obtained	 in	 IHC	 assays	 as	well	 as	myelin	 protein	 expression	 in	
Western	blot	analysis.	These	results	may	question	the	successful	OE	of	Gpr17;	however,	control	
injections	 of	 tdTomato	 resulted	 in	 sufficient	 protein	 expression,	 as	 verified	 by	 fluorescence	
microscopy.	Obviously,	that	control	is	not	evidence	that	Gpr17	is	translated	in	the	same	manner;	
nevertheless,	it	proved	an	effective	RNA	generation	as	well	as	a	flawless	injection	procedure.	
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The	lack	of	effect	of	Gpr17	OE	could	be	due	to	the	injection	procedure,	since	injection	of	mRNA	
into	the	one-cell	stage	causes	a	mosaic	expression	within	the	entire	animal.	This	means	that	the	
protein	 could	 be	 expressed	 in	 each	 cell	 type,	 while	 the	 abundance	 in	 cells	 endogenously	
expressing	the	protein	may	be	insufficient	for	inducing	clear	phenotypes.	This	limitation	could	be	
prevented	by	injecting	the	constructs	together	with	their	promoter,	although	that	is	unknown	for	
Gpr17.	 Alternatively,	 it	 might	 be	 used	 the	 Olig2	 promoter	 to	 drive	 expression	 in	 OPCs	 that	
presumably	express	Gpr17	and	mainly	contribute	to	oligodendrocyte	development.	Whether	this	
would	cause	distinct	phenotypes	might	be	investigated	in	future	studies.	Additionally,	coupling	of	
Gpr17	 with	 EGFP	 and	 subsequent	 injection	 could	 be	 a	 complementary	 alternative	 to	 visualize	
expression	of	Gpr17,	although	 it	 should	be	considered	 the	possibility	 that	 the	 large	 fluorescent	
protein	may	reduce	functionality	in	vivo.		
Intriguingly,	 OE	 of	 Gpr17	 in	mice	 that	 resulted	 in	 hypomyelination	was	 provoked	 in	 late-stage	
oligodendrocytes	 already	expressing	CNPase,	 thus	 at	 a	 time	point	when	Gpr17	 is	 almost	down	
regulated	 (Chen	 et	 al.,	 2009).	 On	 the	 contrary,	 in	 zebrafish	 embryos,	where	gpr17	mRNA	was	
injected	 in	 one-cell	 stage	 embryos,	 OE	 probably	 appears	 even	 before	 Gpr17	 is	 endogenously	
abundant.	Hence,	additional	amounts	of	Gpr17	 in	 that	stage	of	development	might	not	 further	
contribute	to	the	following	effect	of	endogenous	Gpr17,	wherefore	obtained	results	showed	no	
effect	 on	oligodendrocyte	development	 and	myelination.	 In	 comparison,	OE	of	Gpr56,	 another	
GPCR	 that	 is	 essential	 for	 oligodendrocyte	 proliferation	 and	 already	 present	 before	 OPC	
specification,	evoked	preceded	mbp	expression	in	2.5	dpf	old	zebrafish	embryos	(Ackerman	et	al.,	
2015).	 Contrarily	 to	 Gpr17,	 in	 this	 study	 OE	 was	 implemented	 in	 the	 stage	 of	 endogenous	
receptor	expression.		
However,	 further	experiments	demonstrating	 that	 injected	zebrafish	gpr17	mRNA	could	 rescue	
the	MO-induced	effect	finally	proved	the	successful	expression	of	Gpr17	OE	and,	moreover,	the	
specificity	of	the	gpr17	MO.	Additional	to	the	rescue	experiments,	Western	blot	analysis	verified	
MO-induced	knockdown	of	Gpr17,	albeit	 reduction	of	protein	amount	was	only	 significant	at	4	
dpf	 (Kleinert,	 2018).	Nevertheless,	 as	previously	mentioned,	 slight	differences	between	protein	
levels	seem	to	be	difficult	to	detect	by	this	method.	Collectively,	knockdown	of	Gpr17	adversely	
affected	oligodendrocyte	development	as	well	as	myelination.	 In	 the	almost	absence	of	Gpr17,	
OPCs	deficiently	migrated	into	the	dorsal	spinal	cord,	the	region	where	terminal	differentiation	is	
achieved.	 Subsequently,	 reduced	numbers	of	OPCs	 resulted	 in	 fewer	mature	oligodendrocytes,	
which	failed	to	sufficiently	myelinate	axons.	Impaired	myelination	was	demonstrated	by	reduced	
Mbp	expression	within	the	spinal	cord	and	further	by	Western	blot	analysis	revealing	mellowed	
levels	 of	 myelin	 proteins	 Claudin	 K	 and	 P0.	 Conversely,	 the	 apparent	 increase	 of	 nkx2.2	
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expression	within	the	pMN	region	of	morphants	at	2.5	dpf	is	likely	the	result	of	greater	numbers	
of	pre-OLs	at	that	developmental	stage,	suggesting	preceded	pre-maturation	of	oligodendrocyte	
lineage	 cells.	 This	 observation	 could	 be	 further	 confirmed	 by	 future	 experiments	 quantifying	
nkx2.2	 expression	 by	 qPCR	 and	 mbp	 expression	 within	 the	 pMN	 region	 by	 RNAscope	
technology®	or	immunostaining.	Since	a	MO-induced	cell	death	figured	as	Cleaved	Caspase-3	in	
IHC	assays	can	be	excluded	as	reason	for	the	reduced	cell	numbers,	summarized	data	argue	for	a	
Gpr17	knockdown-induced	premature	differentiation	of	OPCs	into	nkx2.2	expressing	pre-OLs.	As	
being	 restrained	 in	 the	 pMN	 region,	 pre-OLs	 fail	 to	migrate	 into	 the	 dorsal	 spinal	 cord,	which	
finally	leads	to	insufficient	myelination	in	this	region.	
This	hypothesis	approximately	correlates	with	findings	of	Chen	et	al.	demonstrating	a	preceded	
onset	 of	myelination	 in	 Gpr17	 null	 mutant	mice.	 Noteworthy,	 Chen	 and	 collaborators	 did	 not	
examine	numbers	or	migration	of	oligodendrocyte	lineage	cells.	Hence,	it	could	be	possible	that	
pre-mature	 myelin-forming	 oligodendrocytes	 of	 mice	 are	 still	 able	 to	 migrate	 and	 myelinate	
axons,	while	migration	in	zebrafish	might	be	additionally	inhibited	after	Gpr17	knockdown.	If	this	
proves	 true,	migration	 ability	 of	 oligodendrocyte	 lineage	 cells	 could	 be	 examined	 by	 time-laps	
imaging	 of	 distinct	 zebrafish	 reporter	 lines	 such	 as	 tg(olig2:EGFP)	 (Shin	 et	 al.,	 2003)	 or	
tg(nkx2.2a:GFP)	(Pauls	et	al.,	2007).	A	positive	influence	of	Gpr17	on	OPC	migration	was	already	
published	 by	 Coppi	 and	 collaborators	 (2013),	 however	 results	 were	 obtained	 by	 use	 of	 the	
dubious	UDP	ligands.		
Previous	 knockdown	 studies	 using	 specific	 small	 interfering	 RNAs	 (siRNAs)	 in	 primary	 OPCs	
observed	similar	effects	as	this	work,	particularly	reduced	numbers	of	Gpr17	positive	cells	as	well	
as	 mature	 myelin-forming	 oligodendrocytes	 (Fumagalli	 et	 al.,	 2011),	 though	 effects	 on	
myelination	 were	 not	 described.	 Nevertheless,	 one	 should	 be	 cautious	 when	 comparing	
knockdown	 with	 knockout	 results.	 The	 observation	 that	 knockdown	 strategies	 could	 cause	
distinct	 phenotypes	 than	 knockout	 approaches	was	 recently	 described	 in	 literature	 (El-Brolosy	
and	 Stainier,	 2017).	 For	 instance,	 Kok	 et	 al.	 demonstrated	 that	 different	 generated	 zebrafish	
knockout	mutants	could	not	recapitulate	those	phenotypes	obtained	in	previous	MO	knockdown	
studies.	Additionally,	another	working	group	examining	an	endothelial	extracellular	matrix	gene	
(egfl7)	 in	 zebrafish	 uncovered	 severe	 vascular	 defects	 in	MO	 injected	 animals,	 while	 knockout	
mutants	revealed	normal	phenotypes	(Rossi	et	al.,	2015).	
Hence,	 it	 becomes	 evident	 that	 Gpr17	 knockout	 animals	 are	 mandatorily	 required	 to	 further	
clarify	the	impact	of	Gpr17	on	oligodendrocyte	development	and	myelination.	
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5.1.6 Conclusion	&	outlook	
In	conclusion,	this	work	demonstrates	in	several	approaches	the	suitability	of	zebrafish	to	study	
G-protein	 coupled	 receptor	 17	 in	 vivo.	 Receptor	 expression	 in	 the	 CNS	 during	 the	 first	 days	
coincided	with	expression	pattern	 found	 in	mice	and	 indicates	a	crucial	 role	 in	oligodendrocyte	
development,	which	is	further	strengthened	by	reduced	cell	numbers,	impaired	myelination	and	
assumed	pre-maturation	of	oligodendrocytes	after	MO-induced	knockdown	of	Gpr17.		
Further	studies	are	clearly	necessary	to	finally	conclude	the	developmental	function	of	Gpr17	in	
zebrafish.	This	includes	the	confirmation	of	Gpr17	localisation	in	OPCs,	the	investigation	whether	
Gpr17	 additionally	 impacts	 on	 OPCs	 migration	 and	 the	 evidence	 of	 OPC	 pre-maturation	 after	
gene	 knockdown.	 Moreover,	 obtained	 knockdown	 experiments	 should	 be	 confronted	 to	
following	knockout	studies,	examining	whether	both	methodologies	evoke	the	same	or	distinct	
phenotypes.	Last	but	not	least,	Gpr17	mRNA	could	be	injected	once	more	into	the	yolk	of	1	dpf	
old	zebrafish	embryos	for	achieving	OE	during	endogenous	Gpr17	expression.		
Since	 the	overall	project	aims	 to	use	zebrafish	as	 screening	platform	 for	 substances	 interacting	
with	Gpr17	to	support	remyelination	in	demyelinating	diseases,	it	should	be	considered	that	this	
work	 investigated	 Gpr17	 during	 embryogenesis.	 It	 may	 be	 that	 the	 role	 of	 Gpr17	 during	
oligodendrocyte	development	differs	from	that	under	pathological	conditions	and	that	inhibition	
or	activation	of	Gpr17	may	have	distinct	 implications	on	disease	progression.	This	 is	underlined	
by	two	studies	investigating	the	role	of	Gpr37,	another	GPCR	involved	in	the	myelination	process.	
While	KO	of	Gpr37	 induced	hypermyelination	during	development	 (Yang	et	al.,	2016),	a	 recent	
study	demonstrated	that	absence	of	Gpr37	in	the	cuprizone	disease	model	resulted	in	increased	
susceptibility	 of	 demyelination	 (Smith	 et	 al.,	 2017).	 Therefore,	 function	 of	 Gpr17	 in	
neurodegenerative	pathologies	remains	also	speculative.	Although	Gpr17	is	found	upregulated	in	
several	demyelinating	conditions,	 such	as	 in	MS	plaques	of	human	white	matter	or	EAE	mouse	
models	(Chen	et	al.,	2009),	in	a	rat	neonatal	model	of	ischemic	periventricular	leukomalacia	(PVL)	
(Mao	et	al.,	2012),	in	post-traumatic	brain	injury	(Franke	et	al.,	2013)	or	in	a	transgenic	model	of	
Alzheimer’s	disease	(Boda	et	al.,	2011),	these	reports	implicate	that	depending	on	the	pathology	
either	 inhibition	 or	 activation	 of	 Gpr17	 positively	 contribute	 to	 the	 disease	 progression.	
Consequently,	further	investigations	clarifying	Gpr17	function	under	pathological	conditions	have	
to	be	driven,	for	instance,	by	use	of	an	adult	MOG-induced	EAE	zebrafish	model	(Kulkarni	et	al.,	
2017)	 or,	 otherwise,	 by	 induction	of	 spinal	 lesions	 in	 adult	 but	 also	 in	 juvenile	 zebrafish	might	
represent	 an	 alternative	 method.	 Nevertheless,	 high-throughput	 screening	 of	 compounds	
affecting	 myelination	 could	 be	 initially	 conducted	 in	 developing	 Gpr17	 zebrafish	 null	 mutants	
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stably	 expressing	 chimeric	 human/zebrafish	 Gpr17	 receptors.	 Subsequently,	 substances	 that	
induced	alterations	should	be	finally	tested	under	pathological	conditions.		
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6 Summary	
Myelination	of	axons	represents	an	obvious	evolutionary	condition	for	efficient	and	rapid	nerve	
conduction	 (Pfeiffer,	 Warrington	 and	 Bansal,	 1993).	 Although	 intense	 studies	 aimed	 to	 attain	
improved	 understanding	 of	 this	 essential	 process	 during	 the	 last	 decades,	 several	 questions	
pertaining	to	the	differentiation	of	myelinating	glia	cells	remain	unacknowledged.	In	this	context,	
ongoing	research	has	identified	G-protein	coupled	receptors	such	as	Gpr17	as	crucial	regulators	
of	oligodendrocyte	development	and	myelination	(Chen	et	al.,	2009;	Mogha,	Rozario	and	Monk,	
2016).	 Nevertheless,	 further	 investigations	 are	 required	 to	 finally	 conclude	 about	 function	 of	
GPCRs	in	CNS	development	but	also	in	demyelinating	pathologies	such	as	MS.	
Within	 this	 work,	 the	 zebrafish,	 a	 powerful	 model	 system	 for	 studying	 myelination	 in	 vivo	
(Preston	and	Macklin,	2015),	 served	as	animal	model	 to	gain	 further	 insights	 in	expression	and	
function	 of	 Gpr17	 during	 CNS	 development.	 Additionally,	 functionality	 of	 zebrafish	 Gpr17	
towards	proposed	agonists	was	evaluated	in	mammalian	cellular	backgrounds.		
In	the	first	part	of	this	work,	Dynamic	mass	redistribution	assays	revealed	missing	functionality	of	
zebrafish	Gpr17	towards	the	postulated	endogenous	 ligands	(Ciana,	Fumagalli,	M.	L.	Trincavelli,	
et	al.,	2006)	as	well	as	the	small	molecule	MDL29,951	(Hennen	et	al.,	2013b)	upon	transfection	in	
mammalian	 HEK293	 cells.	 Since	 results	 obtained	 with	 uracil	 nucleotides	 and	 cysteinyl	
leukotrienes	coincided	with	previous	reports,	further	experiments	focused	on	the	complete	lack	
of	response	of	MDL29,951.	Sufficient	cell	surface	expression	indicated	an	impaired	ligand	binding	
that	was	confirmed	by	the	analysis	of	chimeric	human/zebrafish	receptors.	Chimeric	constructs	
containing	 the	 binding	 and	 transmembrane	 domain	 of	 human	 and	 the	 intracellular	 loops	 of	
zebrafish	Gpr17	responded	to	MDL29,951	in	a	concentration-dependent	manner,	while	receptors	
exhibiting	 the	 zebrafish	 binding	 domain	 remained	 unresponsive.	 These	 preceded	 in	 vitro	 data	
were	 further	 validated	 by	 in	 vivo	 experiments,	 displaying	 unaltered	 oligodendrocyte	
development	and	myelination	in	5	dpf	old	zebrafish	embryos	after	a	5-day	bath	treatment	with	
MDL29,951.	Hence,	summarizing	data	revealed	the	unsuitability	of	this	small	molecule	agonist	as	
a	selective	manipulator	of	Gpr17	in	zebrafish.	 Interestingly,	chimeric	receptors	stably	expressed	
in	 zebrafish	 might	 represent	 a	 smart	 alternative	 for	 a	 MDL29,951-dependet	 activation	 and	
further	function	analyses	of	Gpr17	in	vivo.	
The	second	part	of	this	work	dealt	with	the	expression	and	role	of	zebrafish	Gpr17	in	vivo.	WISH	
and	Western	blot	experiments	verified	Gpr17	expression	 in	oligodendrocyte	 lineage	cells	of	the	
CNS	throughout	embryogenesis,	which	was	consistent	with	the	expression	pattern	found	in	mice	
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(Chen	et	 al.,	 2009),	 suggesting	 a	 role	 of	Gpr17	 during	 zebrafish	 oligodendrocyte	 development.	
While	 transient	 OE	 of	 Gpr17	 did	 not	 affect	 developing	 oligodendrocytes	 or	 myelination,	 MO-
induced	 receptor	 knockdown	 led	 to	 significant	 reduction	 of	 dorsally	migrated	 pre-mature	 and	
mature	 oligodendrocyte	 numbers	 as	 well	 as	 impaired	 myelination.	 Additional	 experiments	
indicated	 a	 preceded	 pre-maturation	 of	 pre-OLs,	 which	 were	 restrained	 in	 the	 region	 of	 OPC	
specification	 and	 thus	 impaired	 to	 migrate	 and	 myelinate	 dorsal	 axons.	 These	 findings	
approximately	 correlate	 with	 data	 obtained	 in	 Gpr17	 knockout	 mice,	 demonstrating	 an	 early	
onset	 of	 oligodendrocyte	 maturation	 (Chen	 et	 al.,	 2009).	 Due	 to	 the	 dissimilarity	 between	
knockdown	and	knockout	methodologies,	 further	knockout	 studies	 in	 zebrafish	are	 required	 to	
finally	clarify	the	role	of	Gpr17	in	this	animal	model.	
In	 summary,	 the	 present	 study	 reveals	 that	 Gpr17	 notably	 contributes	 to	 oligodendrocyte	
development	 and	 myelination	 in	 zebrafish.	 Clearly,	 upcoming	 studies	 with	 Gpr17	 knockout	
zebrafish	 have	 to	 be	 assessed	 for	 the	 future	 use	 of	 this	 aquaria	 animal	 model	 as	 screening	
platform	of	compounds	affecting	myelination.	 	
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7 Supplementary	
	
Supplementary	Figure	1:	Tg(claudinK:EGFP)	zebrafish	embryos	injected	with	800	pg	tdTomato	displayed	
stable	 RNA	 expression	 over	 96	 h.	 Transient	 microinjection	 of	 800	 pg	 tdTomato	 in	 tg(claudinK:EGFP)	
zebrafish	 embryos	 caused	 stable	protein	 expression	 for	 96	h.	 Shown	are	 representative	 images	of	 three	
independent	experiments.	
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Supplementary	 Figure	2:	 Expression	of	myelin	protein	Claudin	K	 in	1	 to	10	dpf	old	 zebrafish	embryos.	
Representative	Western	blot	displayed	expression	of	Claudin	K	starting	at	3	dpf,	when	myelination	initiates	
and	increasing	until	10	dpf.	Claudin	K	was	also	expressed	in	adult	zebrafish	brain	(data	are	not	shown).	
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Supplementary	 Figure	 3:	 Tg(olig2:EGFP)	 zebrafish	 revealed	 impaired	mbp	 expression	 in	 CNS	 and	 PNS	
after	 zfAgpr17	 MO	 injections.	 Tg(olig2:EGFP)	 zebrafish,	 exhibiting	 a	 decrease	 in	 numbers	 of	 dorsally	
migrated	olig2	positive	OPCs	after	 injections	of	zfAgpr17	MO,	were	sorted	for	WISH	experiments.	Lateral	
(A,	B)	 and	dorsal	 (C)	 views	 showed	markedly	decrease	 in	mbp	expression	 in	 the	CNS	at	 the	 level	 of	 the	
ventral	(big	black	arrows)	and	dorsal	(small	black	arrows)	spinal	cord	,	 in	the	brain	(big	white	arrows)	and	
PNS	(small	white	arrows)	at	3	and	4	dpf.	Presented	data	are	from	two	independent	experiments.	
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!!100µm!
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Supplementary	 Figure	 4:	 Chimeric	 Gpr17	 receptors	 exclusively	 couple	 via	 Gαi	 pathway.	 MDL29,951	
elicited	 DMR	 responses	 on	 3-HA	 tagged	 chimeric	 Gpr17	 transiently	 (A-C)	 and	 stably	 (D-F)	 expressed	 in	
HEK293	 cells.	 In	 the	 presence	 of	 PTX,	 responses	 of	 h+zfA	 (B)	 and	 h+zfBGpr17	 (E)	were	 abolished,	while	
stimulation	with	 UBO-QIC	merely	 eliminated	 carbachol	 signal	 (C,F).	 On	 the	 contrary,	 DMR	 responses	 of	
human	 Gpr17	 transiently	 expressed	 in	 HEK293	 cells	 (G-I)	 were	 diminished	 in	 the	 presence	 of	 both	
inhibitors,	 PTX	 (H)	 and	 UBO-QIC	 (I).	 Label-free	 recordings	 are	 shown	 as	 representative	 traces,	 each	
performed	 in	 triplicates	 (means	 +	 SEM).	 Data	 were	 generated	 by	 Dr.	 Nicole	Merten	 in	 the	 Institute	 of	
Pharmaceutical	Biology,	University	of	Bonn.	
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8 List	of	abbreviations	
ad		 latin	word	for	up	to		
Claudin	k	 Zebrafish	myelin-associated	protein	
CNS		 central	nervous	system		
CXCR4	 chemokine	4	receptor		
CysLTR	 cysteinyl	leukotriene	receptor	
dH2O	 demineralized water  
DMR	 dynamic	mass	redistribution		
dpf	 days	post	fertilization	
EAE		 experimental	autoimmune	encephalomyeli-	tis	
(animal	model	of	multiple	sclerosis)		
EGFP	 exaggerated	green	fluorescent	protein		
ELISA	 enzyme-linked	immunosorborent	assay	
et	al.		 Et	alii,	Latin	word	for	and	others		
FRET		 fluorescence	resonance	energy	transfer		
g		 acceleration	by	gravity		
GPCR		 G-protein	coupled	receptor		
G	protein		 guanine	nucleotide-binding	protein		
Gpr17		 G-protein	coupled	receptor	17		
Gpr30	 G-protein	coupled	receptor	37	
Gpr37	 G-protein	coupled	receptor	37	
Gpr56	 G-protein	coupled	receptor	56	
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Gpr98	 G-protein	coupled	receptor	98	
h	 human	
h	 hour(s)	
HA-tag	 human	influenza	hemagglutinin	Tag	
hpf	 hours	post	fertilization	
hGpr17	 Human	Gpr17	
h+zfAGpr17	 chimeric	human	(in)	and	zebrafish	version	A	
(out)	Gpr17	
h+zfBGpr17	 chimeric	human	(in)	and	zebrafish	version	B	
(out)	Gpr17	
IgM	 immunoglobuline	M	
ICC	 immunocytochemistry	
IHC	 immunohistochemistry	
KOR	 κ-Rezeptor	
Lingo-1	 leucine	rich	repeat	and	Ig-like	domain-
containing	Nogo	receptor	interacting	protein	1		
LTC4	 leukotriene	C4	
LTD4	 leukotriene	D4	
M	 molar	concentration	(mol/liter)		
MAG		 myelin	associated	glycoprotein		
MBP	 myelin	basic	protein	
mGlu4	 glutamate	receptor	4	
min	 minutes	
MO	 morpholino	anti-sense	oligonucleotide	
	List	of	abbreviations	
	 131	
MOG	 myelin	oligodendrocyte	glycoprotein	
ms	 milliseconds	
MS	 multiple	sclerosis	
µL	 microliter	
µM	 micromolar	
nm	 nanometer	
NG2	 neural/glial	antigen	2	proteoglycan		
Nkx2.2	 transcription	factor	
NP	 Neuronal	precursor	
OE	 overexpression	
OL	 oligodendrocytes	
Olig2	 transcription	factor	
OPC	 oligodendrocyte	precursor	cells	
P	 latin	abbreviation	for	after	birth	
PCR	 polymerase	chain	reaction	
qPCR	 quantitative	polymerase	chain	reaction	
Plp	 proteolipid	protein		
PNS	 peripheral	nervous	system		
Pre-OL	 pre-mature	oligodendrocyte	
PTX	 Pertussis	toxin		
PY2	receptors		 purinergic	receptors		
s	 seconds	
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S1P1	 sphingosin-1-phosphat	receptor	
siRNA	 small-interfering	RNA	
UDP	 uridine	diphosphate	
UDP-glc	 uridine	diphosphate-glucose	
UDP-gal	 uridine	diphosphate-galactose	
WISH	 whole-mount	in	situ	hybridization	
zf	 zebrafish	
zfAGpr17	 zebrafish	version	A	Gpr17	
zfA+hGpr17	 chimeric	zebrafish	version	A	(in)	and	human	
(out)	Gpr17	
zfBGpr17	 zebrafish	version	B	Gpr17	
zfB+hGpr17	 chimeric	zebrafish	version	B	(in)	and	human	
(out)	Gpr17	
36k	 zebrafish	myelin	protein	36k		
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